<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Open Biol</journal-id>
<journal-id journal-id-type="iso-abbrev">Open Biol</journal-id>
<journal-id journal-id-type="publisher-id">RSOB</journal-id>
<journal-id journal-id-type="hwp">royopenbio</journal-id>
<journal-title-group>
<journal-title>Open Biology</journal-title>
</journal-title-group>
<issn pub-type="epub">2046-2441</issn>
<publisher>
<publisher-name>The Royal Society</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30021882</article-id>
<article-id pub-id-type="pmc">6070720</article-id>
<article-id pub-id-type="doi">10.1098/rsob.180074</article-id>
<article-id pub-id-type="publisher-id">rsob180074</article-id>
<article-categories>
<subj-group subj-group-type="hwp-journal-coll">
<subject>129</subject>
<subject>197</subject>
<subject>198</subject>
<subject>133</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
<subj-group subj-group-type="leader">
<subject>Review Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Retrotransposon-induced mosaicism in the neural genome</article-title>
<alt-title alt-title-type="short">Retrotransposition in the brain</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Bodea</surname>
<given-names>Gabriela O.</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
<xref ref-type="aff" rid="af2">2</xref>
<xref ref-type="corresp" rid="cor1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>McKelvey</surname>
<given-names>Eleanor G. Z.</given-names>
</name>
<xref ref-type="aff" rid="af2">2</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0001-5769-4494</contrib-id>
<name>
<surname>Faulkner</surname>
<given-names>Geoffrey J.</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
<xref ref-type="aff" rid="af2">2</xref>
<xref ref-type="corresp" rid="cor2"></xref>
</contrib>
</contrib-group>
<aff id="af1"><label>1</label><institution>Mater Research Institute—University of Queensland</institution>, <addr-line>TRI Building, Brisbane, Queensland 4102</addr-line>, <country>Australia</country></aff>
<aff id="af2"><label>2</label><institution>Queensland Brain Institute, University of Queensland</institution>, <addr-line>Brisbane, Queensland 4072</addr-line>, <country>Australia</country></aff>
<author-notes>
<corresp id="cor1">e-mail: <email>gabriela.bodea@mater.uq.edu.au</email></corresp>
<corresp id="cor2">e-mail: <email>faulknergj@gmail.com</email></corresp>
</author-notes>
<pub-date pub-type="collection">
<month>7</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>18</day>
<month>7</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>18</day>
<month>7</month>
<year>2018</year>
</pub-date>
<!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. -->
<volume>8</volume>
<issue>7</issue>
<elocation-id>180074</elocation-id>
<history>
<date date-type="received">
<day>26</day>
<month>4</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>21</day>
<month>6</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>© 2018 The Authors.</copyright-statement>
<copyright-year>2018</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>Published by the Royal Society under the terms of the Creative Commons Attribution License <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>, which permits unrestricted use, provided the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="rsob-8-180074.pdf"></self-uri>
<self-uri content-type="reviewer_comments" xlink:href="rsob180074_review_history.pdf"></self-uri>
<self-uri xlink:href="rsob180074.thumb.gif" xlink:role="icon"></self-uri>
<abstract>
<p>Over the past decade, major discoveries in retrotransposon biology have depicted the neural genome as a dynamic structure during life. In particular, the retrotransposon LINE-1 (L1) has been shown to be transcribed and mobilized in the brain. Retrotransposition in the developing brain, as well as during adult neurogenesis, provides a milieu in which neural diversity can arise. Dysregulation of retrotransposon activity may also contribute to neurological disease. Here, we review recent reports of retrotransposon activity in the brain, and discuss the temporal nature of retrotransposition and its regulation in neural cells in response to stimuli. We also put forward hypotheses regarding the significance of retrotransposons for brain development and neurological function, and consider the potential implications of this phenomenon for neuropsychiatric and neurodegenerative conditions.</p>
</abstract>
<kwd-group>
<kwd>retrotransposon</kwd>
<kwd>LINE-1</kwd>
<kwd>neuron</kwd>
<kwd>neurogenesis</kwd>
<kwd>mosaicism</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution>NHMRC-ARC Research Fellowship</institution>
</institution-wrap>
</funding-source>
<award-id>GNT1108258</award-id>
</award-group>
<award-group>
<funding-source>
<institution-wrap>
<institution>CSL Centenary Fellowship</institution>
</institution-wrap>
</funding-source>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>July 2018</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="s1">
<label>1.</label>
<title>Introduction</title>
<p>The mammalian brain is remarkably complex in form and function. Neural cell diversity underpins this complexity, and has classically been defined in terms of the morphological differences between cell types, their diverse connectivity patterns, physiological and functional properties and the expression of various transcription factors (TFs), cell surface and secreted molecules [<xref ref-type="bibr" rid="RSOB180074C1">1</xref>,<xref ref-type="bibr" rid="RSOB180074C2">2</xref>]. At the same time, it has been assumed that the neural cells of any individual will all carry the same genetic instructions, or genotype, and that cellular diversity is achieved by changing how these instructions are read, for example, through epigenetic modifications [<xref ref-type="bibr" rid="RSOB180074C3">3</xref>]. However, recent advances in DNA sequencing and genetic analysis, as well as bioinformatics, have made it possible to identify mutations generating distinct genotypes among the neurons of an individual human brain. These mutations include single-nucleotide variants, copy number variants (CNVs) and retrotransposon insertions [<xref ref-type="bibr" rid="RSOB180074C4">4</xref>–<xref ref-type="bibr" rid="RSOB180074C10">10</xref>]. Collectively, these genetic variants form a landscape of somatic mosaicism within the brain.</p>
<p>Somatic mosaicism is defined as the existence of two or more cells with different genotypes within one individual. Depending on its developmental timing, mosaicism can encompass mutations that are heritable (germline mosaicism), non-heritable (somatic mosaicism) or a combination of these two outcomes [<xref ref-type="bibr" rid="RSOB180074C9">9</xref>,<xref ref-type="bibr" rid="RSOB180074C11">11</xref>–<xref ref-type="bibr" rid="RSOB180074C14">14</xref>]. Retrotransposons, colloquially referred to as ‘jumping genes’, are DNA fragments that have the ability to copy their sequences from one location in the genome and insert themselves into a new genomic position, causing mutations and changing the genomic landscape at the new integration site. It is now established that retrotransposons are endogenous mediators of somatic mosaicism in the brain [<xref ref-type="bibr" rid="RSOB180074C4">4</xref>–<xref ref-type="bibr" rid="RSOB180074C7">7</xref>,<xref ref-type="bibr" rid="RSOB180074C10">10</xref>,<xref ref-type="bibr" rid="RSOB180074C14">14</xref>]. As remnants of mammalian genome evolution, retrotransposons may occupy up to two-thirds of the human genome [<xref ref-type="bibr" rid="RSOB180074C15">15</xref>], but most human retrotransposon copies have lost their ability to mobilize further [<xref ref-type="bibr" rid="RSOB180074C16">16</xref>]. However, some elements are still capable of mobilization, in the germline and in the soma. Over the past decade, several studies have shown that retrotransposons contribute to intra-individual variation in neuronal genomes, defining a new layer of neural diversity and heterogeneity. Maintenance of this complex heterogeneity may be essential for healthy brain function, while its disruption may play a role in neurological diseases [<xref ref-type="bibr" rid="RSOB180074C17">17</xref>,<xref ref-type="bibr" rid="RSOB180074C18">18</xref>]. To provide a comprehensive understanding of the roles retrotransposons play in neural function, and their potential contribution to disease, we will first present an overview of the active retrotransposon families in humans, their mobilization mechanism, and experimental strategies for studying neuronal retrotransposition.</p>
</sec>
<sec id="s2">
<label>2.</label>
<title>Types of retrotransposons in the human genome</title>
<p>Retrotransposons are the main class of transposable elements found in most mammalian genomes. Based on the presence of long terminal repeats (LTR) in their structure, they are classified into LTR and non-LTR retrotransposons. The LTR group consists of ERVs (endogenous retroviruses), which comprise approximately 8% of the human genome and represent remnant retrovirus sequences incorporated into the host germline after ancient viral infections [<xref ref-type="bibr" rid="RSOB180074C19">19</xref>,<xref ref-type="bibr" rid="RSOB180074C20">20</xref>]. The non-LTR retrotransposon group is further subdivided based on the ability of elements to mobilize independently or only with the machinery encoded by another retrotransposon, into autonomous and non-autonomous elements, respectively. Long interspersed element 1 (LINE-1 or L1) is the only autonomous non-LTR retrotransposon in humans. In addition to its own mobilization <italic>in cis</italic>, L1 can mobilize <italic>in trans</italic> non-autonomous short interspersed element (SINE) retrotransposons. These include 7SL-derived <italic>Alu</italic> elements, composite SVA (SINE–variable number tandem repeat–<italic>Alu</italic>) elements, and cellular mRNAs, resulting in processed pseudogenes [<xref ref-type="bibr" rid="RSOB180074C21">21</xref>–<xref ref-type="bibr" rid="RSOB180074C25">25</xref>]. L1 copies can be over 6 kb in length and occupy the highest proportion of the human genome by sequence of all the transposable elements (approx. 17%) [<xref ref-type="bibr" rid="RSOB180074C19">19</xref>]. <italic>Alu</italic> copies are approximately 300 bp in size and represent the most abundant transposable element by copy number (approx. 11% by sequence) [<xref ref-type="bibr" rid="RSOB180074C19">19</xref>,<xref ref-type="bibr" rid="RSOB180074C26">26</xref>,<xref ref-type="bibr" rid="RSOB180074C27">27</xref>]. SVAs are approximately 2 kb in size, with far fewer copies than L1 or <italic>Alu</italic>, and comprise only about 0.2% of the genome sequence [<xref ref-type="bibr" rid="RSOB180074C19">19</xref>,<xref ref-type="bibr" rid="RSOB180074C28">28</xref>–<xref ref-type="bibr" rid="RSOB180074C30">30</xref>] (<xref ref-type="fig" rid="RSOB180074F1">figure 1</xref><italic>a</italic>).
<fig id="RSOB180074F1" orientation="portrait" position="float"><label>Figure 1.</label><caption><p>Human retrotransposon families and mobilization mechanism. (<italic>a</italic>) Types of retrotransposons, their mobilization capacity, size and number of copies in the human genome<italic>.</italic> HERV, human endogenous retroviruses consisting of two LTRs; gag, group-specific antigen; pol, polymerase; env, envelope gene; long interspersed element-1 (L1) structure: 5′ untranslated region (UTR) with open reading frame (ORF)0 and promoter activity; ORF1 and ORF2; 3′ UTR and poly(A) tail; SVA structure: CCCTCT hexamer repeats (HR), <italic>Alu</italic> sequence in reverse orientation (<italic>Alu</italic>-like); VNTR, variable number of tandem repeats; SINE-R, a short interspersed element of HERV origin; An, poly(A) tail; <italic>Alu</italic> structure: a left monomer with internal RNA polymerase III promoter binding sites (A, B boxes); AAA, adenosine-rich linker; right monomer ending in poly(A) tail (An); processed pseudogene: sequence derived from cellular messenger RNA, which has been reverse transcribed into DNA and has no introns; target side duplications are shown as white triangles. (<italic>b</italic>) L1 retrotransposition mechanism as an example of retrotransposon mobilization. A full-length, retrotransposition-competent L1 is present at one genomic locus (blue box in the left grey chromosome). The L1 encodes two proteins essential for its mobility, ORF1p (with nucleic acid chaperone activity [<xref ref-type="bibr" rid="RSOB180074C31">31</xref>,<xref ref-type="bibr" rid="RSOB180074C32">32</xref>]) and ORF2p (with endonuclease [<xref ref-type="bibr" rid="RSOB180074C33">33</xref>] and reverse transcriptase [<xref ref-type="bibr" rid="RSOB180074C34">34</xref>] activity), as well as an unusual antisense ORF0 that may facilitate retrotransposition [<xref ref-type="bibr" rid="RSOB180074C35">35</xref>]. L1 transcription results in a bicistronic, polyadenylated mRNA (blue rectangle), which is transported to the cytoplasm for translation. Upon translation, ORF1p and ORF2p (blue spheres) bind to their encoding L1 mRNA <italic>in</italic>
<italic>cis</italic> and form an RNP complex. Note that the L1 proteins can retrotranspose cellular mRNAs to generate processed pseudogenes, as well as SVA and <italic>Alu</italic> retrotransposons (purple, red and yellow wavy lines). Once the RNP is formed, it enters the nucleus through a still poorly understood process, where a new L1 insertion occurs by target-site primed reverse transcription (TPRT) [<xref ref-type="bibr" rid="RSOB180074C36">36</xref>,<xref ref-type="bibr" rid="RSOB180074C37">37</xref>]. During TPRT, the ORF2p endonuclease makes a first and second cleavage (red arrows) in the genomic DNA at the consensus sequence 5'-TTTT/AA [<xref ref-type="bibr" rid="RSOB180074C33">33</xref>], and releases a 3' hydroxyl (OH) group from which the ORF2p reverse transcriptase initiates reverse transcription of the attached L1 mRNA (indicated by the red dashed line arrow). The DNA fragment between the two cleavages is highlighted in green to indicate the formation of TSDs. The black dashed arrow indicates completing synthesis across the second strand of cDNA, resulting in a new L1 copy, and the TSDs, which flank the new L1 copy.</p></caption><graphic xlink:href="rsob-8-180074-g1"></graphic></fig></p>
<p>Owing to truncation, deletion, internal rearrangement and other mutations, the vast majority of human retrotransposon sequences are incapable of further mobilization and are considered molecular fossils [<xref ref-type="bibr" rid="RSOB180074C16">16</xref>]. Computational-, molecular- and genomics-based studies have to date identified and catalogued retrotransposons into evolutionary families and subfamilies. Only a few L1, <italic>Alu</italic> and SVA subfamilies remain mobile. Moreover, functional studies have identified that most retrotransposition-competent L1s are part of a small group of elements termed Ta (transcribed-active) L1s [<xref ref-type="bibr" rid="RSOB180074C38">38</xref>]. All of the L1s reported to be highly active <italic>in vitro</italic> to date belong to the L1-Ta and L1-preTa families [<xref ref-type="bibr" rid="RSOB180074C39">39</xref>–<xref ref-type="bibr" rid="RSOB180074C42">42</xref>]. Similarly, particular <italic>Alu</italic> subfamilies, such as AluYa5 and AluYb8 [<xref ref-type="bibr" rid="RSOB180074C43">43</xref>], and SVA E, F and F1 subfamilies [<xref ref-type="bibr" rid="RSOB180074C19">19</xref>,<xref ref-type="bibr" rid="RSOB180074C24">24</xref>,<xref ref-type="bibr" rid="RSOB180074C29">29</xref>] have been identified as the most active in humans. Human ERVs (HERVs) are considered to be immobile in modern humans, although a recent study revealed several polymorphic HERV-K insertions in the global population and a full-length, intact, insertion with potentially functional open reading frames (ORFs) [<xref ref-type="bibr" rid="RSOB180074C44">44</xref>]. However, it remains unclear whether this insertion is a recently integrated provirus or has simply been lost in some individuals.</p>
</sec>
<sec id="s3">
<label>3.</label>
<title>An overview of the retrotransposon mobilization mechanism</title>
<p>All retrotransposons mobilize via a replication mechanism involving an RNA intermediate [<xref ref-type="bibr" rid="RSOB180074C45">45</xref>]. During this process, termed retrotransposition, the host polymerase starts the synthesis of an RNA copy of the element and, subsequently, the RNA is reverse transcribed into DNA by an element-encoded reverse transcriptase. HERV reverse transcription takes place in the cytoplasm and the viral DNA is then transported into the nucleus and integrated into a viral integrase which catalyses insertion of the HERV into its new target site [<xref ref-type="bibr" rid="RSOB180074C46">46</xref>]. L1 produces a bicistronic mRNA that is transported to the cytoplasm and translated. L1 encodes proteins that present a strong <italic>cis</italic>-preference [<xref ref-type="bibr" rid="RSOB180074C47">47</xref>], meaning they tend to bind to their encoding mRNA. This results in the formation of ribonucleoprotein particles (RNPs) that may localize to cytoplasmic stress granules [<xref ref-type="bibr" rid="RSOB180074C48">48</xref>,<xref ref-type="bibr" rid="RSOB180074C49">49</xref>] or enter the nucleus. In the case of L1, reverse transcription occurs in the nucleus, where the L1-encoded endonuclease [<xref ref-type="bibr" rid="RSOB180074C33">33</xref>] makes a single-strand cleavage at the target DNA, exposing a 3' hydroxyl group, which is used as a primer for reverse transcription by the L1-encoded reverse transcriptase [<xref ref-type="bibr" rid="RSOB180074C34">34</xref>] (termed target-primed reverse transcription, or TPRT) [<xref ref-type="bibr" rid="RSOB180074C36">36</xref>,<xref ref-type="bibr" rid="RSOB180074C37">37</xref>]. TPRT typically results in L1 insertions with the following sequence features: insertion at an L1 endonuclease motif (5'-TTTT/AA), target site duplications (TSDs) and a poly(A) tail (<xref ref-type="fig" rid="RSOB180074F1">figure 1</xref><italic>b</italic>) [<xref ref-type="bibr" rid="RSOB180074C33">33</xref>,<xref ref-type="bibr" rid="RSOB180074C50">50</xref>,<xref ref-type="bibr" rid="RSOB180074C51">51</xref>].</p>
<p>Retrotransposition does not always result in the faithful duplication of an element, particularly in the case of L1. Owing to errors during reverse transcription, only approximately 40% of L1 copies are identical to their source, or donor, L1 [<xref ref-type="bibr" rid="RSOB180074C52">52</xref>]. Also, 5' truncation, which is a common characteristic of recent human L1 insertions [<xref ref-type="bibr" rid="RSOB180074C19">19</xref>,<xref ref-type="bibr" rid="RSOB180074C53">53</xref>], may occur, likely because of the premature dissociation of the reverse transcriptase from the L1 mRNA strand during TPRT. The precise mechanism through which 5' truncation occurs is not clearly understood, although it has been speculated that DNA repair may play a role as host DNA repair factors, such as ATM (ataxia telangiectasia mutated), may limit the size of L1 insertions [<xref ref-type="bibr" rid="RSOB180074C54">54</xref>].</p>
<p>As a result of 5' truncations, internal inversions or deletions [<xref ref-type="bibr" rid="RSOB180074C55">55</xref>] and point mutations, only about 80–100 [<xref ref-type="bibr" rid="RSOB180074C41">41</xref>,<xref ref-type="bibr" rid="RSOB180074C42">42</xref>] L1 copies are estimated to be able to retrotranspose per average human genome, with even fewer copies accounting for most new L1 insertions [<xref ref-type="bibr" rid="RSOB180074C41">41</xref>,<xref ref-type="bibr" rid="RSOB180074C56">56</xref>–<xref ref-type="bibr" rid="RSOB180074C58">58</xref>]. One new L1 insertion is generated per 100–200 human births [<xref ref-type="bibr" rid="RSOB180074C42">42</xref>,<xref ref-type="bibr" rid="RSOB180074C59">59</xref>]. By contrast, 3000 L1 copies [<xref ref-type="bibr" rid="RSOB180074C60">60</xref>] are estimated to be retrotransposition-competent in the mouse genome, with at least one in eight mice harbouring a new L1 insertion [<xref ref-type="bibr" rid="RSOB180074C11">11</xref>].</p>
</sec>
<sec id="s4">
<label>4.</label>
<title>Detection of retrotransposon activity in the healthy brain</title>
<p>Although nearly 70 years have passed since Barbara McClintock's seminal studies of transposable elements in maize [<xref ref-type="bibr" rid="RSOB180074C61">61</xref>,<xref ref-type="bibr" rid="RSOB180074C62">62</xref>], ongoing L1 retrotransposition in modern human genomes was only demonstrated in 1988 [<xref ref-type="bibr" rid="RSOB180074C63">63</xref>]. Subsequently, endogenous L1 retrotransposition has been described in early embryonic development, germ cells and various diseases, such as cancer [<xref ref-type="bibr" rid="RSOB180074C63">63</xref>–<xref ref-type="bibr" rid="RSOB180074C69">69</xref>]. Insertions arising during early development or in cancer cells are likely to undergo clonal expansion, resulting in a significant proportion of cells harbouring a particular insertion. Studying the contribution of L1 insertions to somatic mosaicism in normal tissues, however, presents a particular technical challenge, as these genomic variants may be found only in a limited number of cells.</p>
<p>Over the past decade, three main tools have facilitated the discovery and study of L1 retrotransposition in the brain. Firstly, an engineered L1 reporter construct, previously developed to recapitulate L1 retrotransposition in cultured cells [<xref ref-type="bibr" rid="RSOB180074C50">50</xref>,<xref ref-type="bibr" rid="RSOB180074C70">70</xref>], has been used as a functional read-out of L1 retrotransposition in human embryonic stem cell (hESC)-derived neural progenitor cells (NPCs), rodent NPC cultures and transgenic animal models [<xref ref-type="bibr" rid="RSOB180074C71">71</xref>]. The L1 construct consists of a human L1 sequence and a gene encoding enhanced green fluorescent protein (EGFP) in reverse orientation to the L1 transcript. The <italic>EGFP</italic> gene is interrupted by an intron in the same transcriptional orientation as the L1. Thus, only cells with successful L1 retrotransposition events can express GFP because the EGFP intron is removed from the RNA intermediate, followed by reverse transcription and integration into a genomic location. When the L1-EGFP system is employed in neuronal cultures, GFP co-localizes with neuronal markers Map2 and β-tubulin, whereas very little to no GFP co-localizes with astrocyte or oligodendrocyte markers [<xref ref-type="bibr" rid="RSOB180074C72">72</xref>]. Neurons obtained from transgenic L1-EGFP mouse brain sections were positive for GFP expression, in a variety of different brain areas, such as cortex, hypothalamus, amygdala and hippocampus [<xref ref-type="bibr" rid="RSOB180074C72">72</xref>–<xref ref-type="bibr" rid="RSOB180074C74">74</xref>]. Although the genomic location of the engineered L1 transgene may result in unknown epigenetic effects that do not necessarily recapitulate the regulation of endogenous L1 copies, this type of assay remains a valid tool to understand the effects of L1 and other retrotransposon activity on neural cell function. With recent advances in genome editing technology [<xref ref-type="bibr" rid="RSOB180074C75">75</xref>], the design of site-targeted reporter constructs, as well as conditional inducible constructs for temporal and cell-specificity, is more easily achievable and may be instrumental in dissecting the parameters of retrotransposition in the brain.</p>
<p>Secondly, to estimate the number of L1 copies across different tissues and brain areas, Coufal <italic>et al</italic>. [<xref ref-type="bibr" rid="RSOB180074C76">76</xref>] developed a TaqMan quantitative PCR-based L1 CNV assay. This assay estimated an enrichment of L1 copies in the human brain when compared with other tissues, with more L1 copies also found in the hippocampal dentate gyrus than in other brain areas [<xref ref-type="bibr" rid="RSOB180074C4">4</xref>,<xref ref-type="bibr" rid="RSOB180074C74">74</xref>,<xref ref-type="bibr" rid="RSOB180074C76">76</xref>]. The authors [<xref ref-type="bibr" rid="RSOB180074C76">76</xref>] estimated 80 somatic L1 insertions occurred per neuron. Owing to the high copy numbers of L1 sequences already present in the genome [<xref ref-type="bibr" rid="RSOB180074C19">19</xref>], this assay offers very limited sensitivity when attempting to quantify variation in the number of L1 insertions in somatic tissues. Moreover, the assay does not discriminate integrated copies generated by TPRT from potential extrachromosomal L1 DNAs or any other source of L1 CNV not arising from retrotransposition [<xref ref-type="bibr" rid="RSOB180074C77">77</xref>]. New quantitative PCR approaches, such as digital droplet PCR (ddPCR), may prove a better tool to quantify retrotransposon CNV in a more accurate but still cost-effective manner [<xref ref-type="bibr" rid="RSOB180074C78">78</xref>,<xref ref-type="bibr" rid="RSOB180074C79">79</xref>].</p>
<p>Thirdly, high-throughput DNA sequencing strategies have been developed to detect, quantify and resolve L1 insertions. Whole-genome sequencing (WGS) or targeted sequencing of retrotransposon–genome junctions has been applied to bulk brain, pooled neurons and whole-genome amplified (WGA) material from single neuronal nuclei from post-mortem human brain [<xref ref-type="bibr" rid="RSOB180074C4">4</xref>–<xref ref-type="bibr" rid="RSOB180074C7">7</xref>,<xref ref-type="bibr" rid="RSOB180074C10">10</xref>,<xref ref-type="bibr" rid="RSOB180074C80">80</xref>]. Tissues from other parts of the body, such as liver or blood, have been used to discriminate somatic and polymorphic insertions (i.e. insertions found in neurons and absent in non-brain tissue are annotated as somatic). Databases of known retrotransposon insertion polymorphisms can also be used to discriminate novel and known insertions. To fully characterize most new insertions, thorough PCR validation followed by Sanger sequencing is required [<xref ref-type="bibr" rid="RSOB180074C81">81</xref>,<xref ref-type="bibr" rid="RSOB180074C82">82</xref>]. One of the advantages of using high-throughput DNA sequencing is that it allows not only for detection and quantification of endogenous L1 variants, but also for resolving the structure and genomic location of these insertions. Resolving the structure of a specific insertion is paramount in understanding the potential functional impact of the insertion on the genome.</p>
<p>Providing a valuable orthogonal approach to single-cell genomic analysis, a recent study used somatic cell nuclear transfer to reprogramme postmitotic olfactory bulb neurons into enucleated oocytes and cloned the neuronal genome to produce enough DNA for WGS without the need for WGA. WGS analysis of the resulting clones revealed several de novo L1 insertions [<xref ref-type="bibr" rid="RSOB180074C14">14</xref>]. These studies altogether demonstrate that L1-driven somatic mosaicism can occur in the mammalian brain. However, with single-cell genomic analysis in its infancy, methodological variation, including the use of different cell populations as starting material, has led to estimates ranging from one L1 insertion per 25 neurons [<xref ref-type="bibr" rid="RSOB180074C5">5</xref>] to 13.7 L1 insertions per neuron [<xref ref-type="bibr" rid="RSOB180074C10">10</xref>]. Therefore, although these studies offer strong evidence of L1 retrotransposition in the brain, the frequency of retrotransposition in neural cells requires further investigation [<xref ref-type="bibr" rid="RSOB180074C83">83</xref>].</p>
</sec>
<sec id="s5">
<label>5.</label>
<title>Is there a temporal niche for retrotransposition in the brain?</title>
<p>Retrotransposition in the brain could occur at any stage of life, from early brain development to brain maintenance and decline during adulthood, and also influence neural diversity and survival (<xref ref-type="fig" rid="RSOB180074F2">figure 2</xref><italic>a</italic>). Neural diversity arises during early embryogenesis through the spatial and temporal patterning of neuroblasts and neuronal progenitor cells. A complex network of gene expression determines a particular cell type-specific progenitor domain and fate [<xref ref-type="bibr" rid="RSOB180074C84">84</xref>]. Expression of pan-neuronal genes marks the beginning of neurogenesis and specific TFs are required for neuronal differentiation. Differentiating neurons migrate, grow axonal processes and later form synapses. Various signalling molecules, TFs and cell receptor molecules tightly control this development [<xref ref-type="bibr" rid="RSOB180074C85">85</xref>]. Although the bulk of neurons are generated during embryonic neurogenesis, neurons are also born in specific areas of the postnatal brain, such as hippocampus, olfactory system and amygdala [<xref ref-type="bibr" rid="RSOB180074C86">86</xref>,<xref ref-type="bibr" rid="RSOB180074C87">87</xref>]. An estimated 700 neurons are renewed in the human hippocampus daily [<xref ref-type="bibr" rid="RSOB180074C88">88</xref>]. Whether retrotransposition occurs during adult neurogenesis, or during embryonic development, in neuroblasts, committed neural progenitors, or in mature neural cells, determines the number of somatic L1 insertions harboured by a given cell. The spatio-temporal parameters of somatic L1 retrotransposition therefore will likely determine the number of cells that are mosaic for a particular insertion and, most importantly, will govern the overall impact an individual insertion may have on brain activity (<xref ref-type="fig" rid="RSOB180074F2">figure 2</xref><italic>b</italic>).
<fig id="RSOB180074F2" orientation="portrait" position="float"><label>Figure 2.</label><caption><p>Timeline of retrotransposition activity in the brain. (<italic>a</italic>) Retrotransposition can occur in the germline, during embryogenesis, as well as during nervous system development, and can involve neural stem cells (NSCs), NPCs and post-mitotic neurons. Retrotransposition events could accumulate over time and also, potentially, take place later in life as a consequence of the ageing process. (<italic>b</italic>) Depending on its timing and cell type, a single retrotransposition event can become clonally expanded in the neural cells of the adult brain, with potentially significant effects on brain physiology. When retrotransposition occurs later in brain development, or even in post-mitotic neural cells, new insertions are restricted to one cell, which can in turn be selected against during development or maintained in adults but with a lesser probability of affecting overall brain function.</p></caption><graphic xlink:href="rsob-8-180074-g2"></graphic></fig></p>
<sec id="s5a">
<label>5.1.</label>
<title>Retrotransposition in embryonic and adult neurogenesis</title>
<p>Over a decade ago, Muotri <italic>et al</italic>. [<xref ref-type="bibr" rid="RSOB180074C72">72</xref>] presented the first evidence that L1 retrotransposons can mobilize during neuronal differentiation. Using a human L1-EGFP reporter system, L1 expression was observed both <italic>in vitro</italic>, in rodent primary hippocampus-derived NPC cultures, and <italic>in vivo</italic>, in transgenic mice. L1 expression in transgenic mice was observed as early as embryonic day (E) 12.5, when the first waves of immature differentiated neurons appear in the brain [<xref ref-type="bibr" rid="RSOB180074C72">72</xref>]. These data were later corroborated and advanced by Coufal <italic>et al</italic>. [<xref ref-type="bibr" rid="RSOB180074C76">76</xref>] in a study reporting L1 reporter activity and endogenous L1 mRNA expression in human NPCs either isolated from fetal brain or derived from hESCs. The preference of retrotransposition for proliferating progenitor cells may be related to the cell cycle. Several studies reported an elevated rate of L1 retrotransposition in dividing cells which suggests that, although non-dividing cells can accommodate L1 retrotransposition [<xref ref-type="bibr" rid="RSOB180074C12">12</xref>,<xref ref-type="bibr" rid="RSOB180074C89">89</xref>], the cell cycle may promote efficient retrotransposition [<xref ref-type="bibr" rid="RSOB180074C90">90</xref>–<xref ref-type="bibr" rid="RSOB180074C92">92</xref>]. The mechanism through which the L1 RNP enters the nucleus is not well understood. However, live-cell imaging experiments tracking an L1 reporter construct during cell cycle progression indicate that L1 enters the nucleus as the cell starts to divide, presumably facilitated by nuclear envelope disassembly during mitosis [<xref ref-type="bibr" rid="RSOB180074C92">92</xref>].</p>
<p>Another explanation for L1 activity in proliferating NPCs may be a more relaxed chromatin state. A relaxed chromatin state is correlated with pluripotency and proliferation, and differentiated cells have more condensed chromatin than progenitor cells [<xref ref-type="bibr" rid="RSOB180074C93">93</xref>]. Open chromatin has been assumed to facilitate L1 activation. By using a transcription activator-like (TAL) effector to target different parts of a mouse L1, which was then fused with a transcriptional activator domain, a recent study demonstrated that L1 transcription directly impacts global chromatin accessibility in the early mouse embryo [<xref ref-type="bibr" rid="RSOB180074C94">94</xref>]. L1 transcriptional activity to maintain chromatin openness may be a prerequisite for normal development of the early embryo [<xref ref-type="bibr" rid="RSOB180074C94">94</xref>] and it will be interesting to further extend this study into later developmental stages and in the context of neurodevelopment.</p>
<p>Finally, TFs can stimulate L1 to retrotranspose during neuronal differentiation. Sex determining region Y-box 2 (SOX2), which is expressed in stem cells and neural progenitors, and is essential in maintaining a proliferative state, can bind to the 5' UTR of L1 and repress promoter activity [<xref ref-type="bibr" rid="RSOB180074C72">72</xref>]. During neuronal differentiation, when SOX2 is downregulated, L1 can become active [<xref ref-type="bibr" rid="RSOB180074C72">72</xref>]. Concomitantly, members of the Wnt signalling pathway such as wingless-related integration site family member 3a (WNT3a), which promotes neurogenesis, can also stimulate and increase L1 transcription, providing a window of opportunity for L1 mobilization to occur in differentiating neurons [<xref ref-type="bibr" rid="RSOB180074C73">73</xref>]. Hence, the shifting epigenetic and transcriptional landscapes of neurogenesis may provide a unique situation for somatic retrotransposition to occur in the brain.</p>
</sec>
<sec id="s5b">
<label>5.2.</label>
<title>Retrotransposition in postmitotic neurons</title>
<p>If we accept that endogenous L1 mobilization can occur during adult neurogenesis, can it also occur in postmitotic neurons? This is a fundamental question because the lifespan of mature neurons can be as long as a human lifespan, and therefore, any potential for somatic retrotransposition in this context may lead to the largest absolute accumulation of new L1 insertions found in the brain. Crucially, Kubo <italic>et al</italic>. [<xref ref-type="bibr" rid="RSOB180074C89">89</xref>] showed in 2006 that engineered L1 retrotransposition can occur in non-dividing human fibroblasts and hepatocytes and, much more recently, Macia <italic>et al</italic>. [<xref ref-type="bibr" rid="RSOB180074C12">12</xref>] confirmed that this was also true for postmitotic neurons. Macia <italic>et al</italic>. compared the retrotransposition of a hybrid adenoviral L1-EGFP vector in dividing versus non-dividing neural cells by infecting NPC cultures with the L1 reporter and concomitantly adding 5'-bromo-2'-deoxyuridine (BrdU), which labels dividing cells. Immunostainings of differentiated NPC cultures infected with L1-EGFP at 31 days post-NPC differentiation showed the presence of neurons expressing only EGFP but not the cycling marker, BrdU. When comparing the number of integrated L1-EGFP copies in cultures infected with the L1 reporter at day 0 (multi-potent NPC) versus day 31 of differentiation (in mature neurons), a sixfold increase in L1-EGFP copies was observed by qPCR against the EGFP splice junction in mature neurons, even when correcting for differences in proliferation rate [<xref ref-type="bibr" rid="RSOB180074C12">12</xref>]. This was an astonishing result, as it supports speculation that not only do mature neurons support retrotransposition, but also retrotransposition occurs at even higher rates in neurons than in proliferating neural progenitors. The study relied heavily on qPCR detection of EGFP copies, and used an <italic>in vitro</italic> assay to compare dividing versus non-dividing neural cells. Going forward, it will be interesting to address this question <italic>in vivo</italic>, perhaps by using an inducible knock-in reporter model. Furthermore, it would be very interesting to explore in detail the mechanisms through which retrotransposons escape epigenetic silencing and mobilize in postmitotic neurons.</p>
</sec>
</sec>
<sec id="s6">
<label>6.</label>
<title>Is retrotransposition necessary for healthy brain function?</title>
<p>It is not established whether retrotransposition in the neural genome is part of normal brain function. It is however plausible that, if retrotransposons did contribute to normal brain function, it would be via altered splicing and DNA methylation of genes, with these being routes to perturb the transcriptional output of cells. For example, pseudogene transcripts can carry microRNA (miRNA) recognition sites and facilitate degradation of their target miRNAs, acting as competitive miRNA targets to the miRNA targets of their parent genes [<xref ref-type="bibr" rid="RSOB180074C95">95</xref>]. Such pseudogenes carrying miRNA recognition sites are present in temporal lobe neurons, where they may play an important role in regulating the expression of miRNAs [<xref ref-type="bibr" rid="RSOB180074C96">96</xref>]. Somatic pseudogene insertions in the brain, if found, may therefore regulate gene regulation as miRNA ‘sponges’ [<xref ref-type="bibr" rid="RSOB180074C97">97</xref>]. In another example, experiments using L1-EGFP transgenic rodents, which were either sedentary or allowed to voluntarily run, demonstrated that exercise increased the total number of newborn hippocampal neurons, which correlated with an increase in engineered L1 retrotransposition [<xref ref-type="bibr" rid="RSOB180074C98">98</xref>]. However, it remains unclear whether the increase in GFP was due to a greater number of insertions in the running mice or an activation of GFP expression from previously silenced L1-EGFP insertions, due to changes in the epigenetic landscape. Nevertheless, as the hippocampus is an important area for brain structural plasticity, being involved in learning, memory as well as stress regulation, retrotransposition in hippocampal neurons could potentially contribute to neuronal plasticity. Whether retrotransposon insertions can actively contribute to neuronal physiology, and thus impact behaviour, is still debatable, as to date no functional analyses have been published in this area.</p>
</sec>
<sec id="s7">
<label>7.</label>
<title>Retrotransposition-induced genomic alterations in neuronal genes and their functional consequences</title>
<p>Retrotransposon insertions can significantly alter protein-coding and regulatory regions of the genome, and thereby affect gene expression and other cellular outputs [<xref ref-type="bibr" rid="RSOB180074C63">63</xref>,<xref ref-type="bibr" rid="RSOB180074C68">68</xref>,<xref ref-type="bibr" rid="RSOB180074C99">99</xref>–<xref ref-type="bibr" rid="RSOB180074C103">103</xref>]. L1 insertions can occur within neuronal genes, and therefore have the potential to change the structure of genes or how highly they are expressed [<xref ref-type="bibr" rid="RSOB180074C4">4</xref>,<xref ref-type="bibr" rid="RSOB180074C7">7</xref>,<xref ref-type="bibr" rid="RSOB180074C10">10</xref>,<xref ref-type="bibr" rid="RSOB180074C72">72</xref>,<xref ref-type="bibr" rid="RSOB180074C99">99</xref>]. The consequences of an intragenic L1 insertion for a cell depend on: (i) the characteristics of the insertion (full-length or 5' truncated L1, sense or antisense to the gene; internally inverted and deleted); (ii) the locus where it integrates; and (iii) the ability of the host cell to silence or compensate for the effects of the L1 insertion [<xref ref-type="bibr" rid="RSOB180074C104">104</xref>,<xref ref-type="bibr" rid="RSOB180074C105">105</xref>]. The various routes by which L1 insertions can lead to gene expression changes have been reviewed previously [<xref ref-type="bibr" rid="RSOB180074C106">106</xref>–<xref ref-type="bibr" rid="RSOB180074C108">108</xref>]. L1 insertions can delete sequences at the target site [<xref ref-type="bibr" rid="RSOB180074C52">52</xref>,<xref ref-type="bibr" rid="RSOB180074C109">109</xref>]. In some cases, these deletions can be quite large, such as the 46 kb deletion reported for the <italic>PDHX</italic> gene encoding pyruvate dehydrogenase, which results in pyruvate dehydrogenase deficiency, a neurodegenerative disorder [<xref ref-type="bibr" rid="RSOB180074C110">110</xref>]. Genomic sequences flanking the source L1 5' or 3' end can be transduced along with the L1 to the new integration site, potentially leading to exon shuffling and new genes [<xref ref-type="bibr" rid="RSOB180074C111">111</xref>]. Recombination can occur between retrotransposons, causing deletions, duplications or rearrangements in genes [<xref ref-type="bibr" rid="RSOB180074C112">112</xref>]. Transcriptional stop sites and polyadenylation signals can be introduced by new retrotransposon sequences, leading to premature transcriptional termination [<xref ref-type="bibr" rid="RSOB180074C99">99</xref>,<xref ref-type="bibr" rid="RSOB180074C113">113</xref>]. An antisense promoter located in the L1 5' UTR can also create new transcription start sites for genes upstream of the L1 [<xref ref-type="bibr" rid="RSOB180074C35">35</xref>,<xref ref-type="bibr" rid="RSOB180074C114">114</xref>–<xref ref-type="bibr" rid="RSOB180074C116">116</xref>], meaning that both intragenic and intergenic L1 insertions may alter gene expression.</p>
<p>New L1 insertions can lead to aberrant transcriptional splicing [<xref ref-type="bibr" rid="RSOB180074C117">117</xref>–<xref ref-type="bibr" rid="RSOB180074C121">121</xref>]. Two prominent examples of this are provided by mice bearing spontaneous mutations with neurological phenotypes: the Spastic and Orleans reeler mice. Firstly, the Spastic mouse harbours a germline full-length L1 insertion into a non-coding region of the glycine neurotransmitter receptor β (<italic>Glyrβ</italic>) gene which leads to aberrant splicing of the pre-mRNA by exon skipping, thus resulting in reduced intact subunit β expression in the brain [<xref ref-type="bibr" rid="RSOB180074C118">118</xref>,<xref ref-type="bibr" rid="RSOB180074C119">119</xref>]. As the β subunit is required for glycine receptor protein assembly, this insertion leads to a decrease in glycine receptors in the brain and a complex motor deficit phenotype. Secondly, the Orleans reeler mouse incorporates a full-length L1 insertion into a coding region of the Reelin (<italic>Reln</italic>) gene, which also leads to exon skipping and a frame shift, in this case generating a 220 bp deletion of the <italic>Reln</italic> mRNA, and leading to inefficient secretion of Reln truncated protein [<xref ref-type="bibr" rid="RSOB180074C120">120</xref>,<xref ref-type="bibr" rid="RSOB180074C122">122</xref>,<xref ref-type="bibr" rid="RSOB180074C123">123</xref>]. As Reln is essential for neuronal migration and cortical lamination, deficiency in its secretion leads to a severe impairment of neuronal migration and, as a consequence, cortical and cerebellar delamination. Subsequent neurological symptoms in <italic>Reln</italic> mutant mice recapitulate the phenotype seen in patients with lissencephaly caused by other <italic>Reln</italic> mutations [<xref ref-type="bibr" rid="RSOB180074C124">124</xref>]. Hence, de novo L1 insertions arising in the germline can alter genes expressed in the brain and cause a neurological phenotype, suggesting that similar mutations arising in neurons have the potential to generate a functional change.</p>
</sec>
<sec id="s8">
<label>8.</label>
<title>Retrotransposon regulation and environmental factors impacting retrotransposition</title>
<sec id="s8a">
<label>8.1.</label>
<title>Locus-specific regulation of long interspersed element 1 retrotransposition</title>
<p>Retrotransposition depends on a mobile element's intrinsic ability to ‘jump’, and its host cell's capacity to defeat this mobilization. Despite their significant presence in the genome, almost all human L1 copies are 5' truncated, or contain internal mutations and rearrangements, and are not able to mobilize. A few L1 copies are full length, remain transcriptionally active and have intact ORFs and therefore have the capacity to act as source, or donor, elements in a cycle of retrotransposition. An even smaller subset (approx. 6 L1s per individual genome) retrotranspose efficiently <italic>in vitro</italic> when tagged with a fluorescent or selectable marker [<xref ref-type="bibr" rid="RSOB180074C50">50</xref>,<xref ref-type="bibr" rid="RSOB180074C70">70</xref>] and are referred to as ‘hot’ donor L1s [<xref ref-type="bibr" rid="RSOB180074C41">41</xref>,<xref ref-type="bibr" rid="RSOB180074C42">42</xref>], although retrotransposition efficiency can vary significantly in different cell types. Hot L1s tend to be the most recently acquired L1 copies in the genome, have very low sequence divergence from the L1 consensus sequence and are polymorphic in the population (found in some individuals but absent in others) [<xref ref-type="bibr" rid="RSOB180074C41">41</xref>]. If a cell type supports a high L1 retrotransposition rate, is this due to the activity of a few hot donor L1s, or is it the result of L1 mRNAs being widely expressed in line with concerted, genome-wide dysregulation? To address this question, Philippe <italic>et al</italic>. [<xref ref-type="bibr" rid="RSOB180074C105">105</xref>] recently designed an assay that discriminated near-identical donor L1s by mapping the 5' and 3' genome junction sequences of all of the potentially active donor L1s in a set of somatic cell lines and intersecting these data with transcriptional and epigenetic signatures. The authors found that donor L1s were generally inactive, with a limited number active in each of the cell lines examined. These results suggested cell-type-specific activity of retrotransposition-competent L1s, presumably as only some L1s escaped silencing in each cell type. However, a previous study [<xref ref-type="bibr" rid="RSOB180074C125">125</xref>] identified a large number of L1s that were actively expressed in multiple hESC lines, suggesting that patterns of donor L1 activation may differ in pluripotent and differentiated cells, albeit with a different approach in each study.</p>
</sec>
<sec id="s8b">
<label>8.2.</label>
<title>Retrotransposon silencing mechanisms</title>
<p>As retrotransposition events can cause such large effects on gene expression, cell function and ultimately organism fitness, several mechanisms exist to limit and regulate L1 mobilization in germ and neural cells. These mechanisms have been reviewed comprehensively [<xref ref-type="bibr" rid="RSOB180074C126">126</xref>,<xref ref-type="bibr" rid="RSOB180074C127">127</xref>]. We will focus here on mechanisms thought to regulate retrotransposition during neural cell differentiation, a process that must be tightly regulated during critical stages of brain development, as differences have been observed in retrotransposition efficiency between proliferating NPCs and postmitotic neurons [<xref ref-type="bibr" rid="RSOB180074C12">12</xref>,<xref ref-type="bibr" rid="RSOB180074C76">76</xref>]. It is known that different DNA methylation patterns are present across neurodevelopmental stages [<xref ref-type="bibr" rid="RSOB180074C128">128</xref>]. Presumably, dynamic methylation during developmental processes, such as neuronal differentiation, can offer windows of opportunity for retrotransposition to occur [<xref ref-type="bibr" rid="RSOB180074C76">76</xref>]. Additionally, different neuronal subtypes (such as GABAergic interneurons and glutamatergic projection neurons from the prefrontal cortex (PFC)) are known to present differences in their methylation patterns [<xref ref-type="bibr" rid="RSOB180074C129">129</xref>]. A recent study investigating methylation of the L1 5' UTR, which is a critical predictor of L1 promotor activity [<xref ref-type="bibr" rid="RSOB180074C76">76</xref>,<xref ref-type="bibr" rid="RSOB180074C130">130</xref>], found no differences in the levels of methyl-cytosine and 5-hydroxy-methyl-cytosine across frontal cortex, hippocampus, cerebellum and basal ganglia regions in the adult mouse brain [<xref ref-type="bibr" rid="RSOB180074C131">131</xref>]. Nevertheless, subtle differences in L1 methylation state across neuronal types and brain areas could potentially be missed when analysing bulk tissue samples.</p>
<p>Several epigenetic factors are known to repress L1. For example, methyl-CpG-binding protein 2 (MeCP2) is present ubiquitously in the body and in higher abundance in mature neurons. MeCP2 binds 5-methyl-cytosine residues in CpG dinucleotides and interacts with histone deacetylase protein (HDAC) and transcriptional SIN3A corepressor complexes to repress transcription [<xref ref-type="bibr" rid="RSOB180074C132">132</xref>–<xref ref-type="bibr" rid="RSOB180074C134">134</xref>]. MeCP2 knockout mice show an increase in L1 promoter activity consistent with MeCP2 functioning as an L1 repressor [<xref ref-type="bibr" rid="RSOB180074C74">74</xref>,<xref ref-type="bibr" rid="RSOB180074C135">135</xref>]. Valproic acid inhibition of HDAC1 enhances the transcriptional activity of L1 [<xref ref-type="bibr" rid="RSOB180074C136">136</xref>], indicating that HDAC1 is also involved in L1 repression. Another deacetylase suggested to inhibit L1 is mono-ADP ribosyltransferase enzyme, or Sirtuin 6 (SIRT6), that was shown to localize to the L1 promoter [<xref ref-type="bibr" rid="RSOB180074C137">137</xref>]. SIRT6 is expressed in neurons and appears to be displaced in oxidative stress conditions and during ageing [<xref ref-type="bibr" rid="RSOB180074C138">138</xref>]. Although L1 is repressed by these epigenetic mechanisms, the brain appears to exhibit lower L1 methylation than found for other tissues, such as skin [<xref ref-type="bibr" rid="RSOB180074C76">76</xref>].</p>
<p>In addition to epigenetic regulation, retrotransposon activity can be regulated by specific TFs, such as yin yang 1 (YY1), runt-related transcription factor 3 (RUNX3), SOX2 and tumour protein p53 (p53). YY1 is a zinc finger protein expressed ubiquitously in the brain. It is critical for regional patterning of the brain and neuronal differentiation, as it regulates genes including Otx2 and Engrailed 2 [<xref ref-type="bibr" rid="RSOB180074C139">139</xref>–<xref ref-type="bibr" rid="RSOB180074C141">141</xref>]. YY1 positively regulates L1 by directing the RNA polymerase II complex to its proper binding site [<xref ref-type="bibr" rid="RSOB180074C142">142</xref>,<xref ref-type="bibr" rid="RSOB180074C143">143</xref>]. RUNX3, which is involved in neurogenesis, development and survival of proprioceptive neurons, also positively regulates the L1 promoter [<xref ref-type="bibr" rid="RSOB180074C144">144</xref>–<xref ref-type="bibr" rid="RSOB180074C146">146</xref>]. Conversely, the TF SOX2, involved in the maintenance of the multi-potent state of neural stem cells (NSCs), has been shown to inhibit L1 transcription [<xref ref-type="bibr" rid="RSOB180074C72">72</xref>,<xref ref-type="bibr" rid="RSOB180074C73">73</xref>,<xref ref-type="bibr" rid="RSOB180074C76">76</xref>,<xref ref-type="bibr" rid="RSOB180074C147">147</xref>–<xref ref-type="bibr" rid="RSOB180074C149">149</xref>]. This is also the case for p53, a master regulator of cell cycling that is involved in neural proliferation and differentiation (reviewed in [<xref ref-type="bibr" rid="RSOB180074C150">150</xref>]). p53 may suppress L1 retrotransposition through its involvement in H3K9 trimethylation (H3K9me3), a silencing marker, at the L1 5' UTR [<xref ref-type="bibr" rid="RSOB180074C151">151</xref>,<xref ref-type="bibr" rid="RSOB180074C152">152</xref>]<italic>.</italic> As new L1 insertions carry TF binding sites and potentially attract epigenetic suppression [<xref ref-type="bibr" rid="RSOB180074C153">153</xref>], the integration of an L1 into an intron or an intergenic region immediately upstream of a protein-coding gene can alter the expression pattern of that gene. L1 insertions are thought to be particularly harmful if oriented in sense to the gene, based on a depletion of these insertions from the human population [<xref ref-type="bibr" rid="RSOB180074C99">99</xref>,<xref ref-type="bibr" rid="RSOB180074C154">154</xref>], and also the length of the insertion may influence its impact [<xref ref-type="bibr" rid="RSOB180074C99">99</xref>]. Host factors, such as apolipoprotein B mRNA editing enzyme catalytic subunit 3A (APOBEC3A) [<xref ref-type="bibr" rid="RSOB180074C155">155</xref>], or DNA repair factors such as ATM [<xref ref-type="bibr" rid="RSOB180074C54">54</xref>], can therefore counteract the impact of L1 at the insertion site by limiting the length of L1 insertions [<xref ref-type="bibr" rid="RSOB180074C156">156</xref>]. Hence, even if the host cell fails to prevent the integration of a new L1 copy, it may mitigate the potential consequences that L1 insertion has upon the genome.</p>
</sec>
<sec id="s8c">
<label>8.3.</label>
<title>Environmental factors impacting retrotransposition</title>
<p>Numerous studies have proposed that environmental factors may trigger hyperactivation of L1 and other retrotransposons. However, most of these studies are preliminary and the experiments have been largely performed on cell lines. For instance, heavy metals such as mercury, nickel and cadmium seem to increase L1 retrotransposition in HeLa and neuroblastoma cells [<xref ref-type="bibr" rid="RSOB180074C157">157</xref>–<xref ref-type="bibr" rid="RSOB180074C159">159</xref>], and so does oxidative stress [<xref ref-type="bibr" rid="RSOB180074C160">160</xref>]. Pollutants such as benzo[a]pyrene (BaP), a polycyclic aromatic hydrocarbon ubiquitously found in grilled meats, tobacco smoke, vehicle exhaust, domestic wood and coal fires, have also been found to be involved in L1 retrotransposition [<xref ref-type="bibr" rid="RSOB180074C161">161</xref>]. Similarly, an L1-lacZ retrotransposition assay showed that UV light and heat-shock induces an increase in β-galactosidase activity in tumour cell lines [<xref ref-type="bibr" rid="RSOB180074C162">162</xref>]. The increase in L1 activity as a result of environmental insults may occur via an indirect pathway, for example, L1 retrotransposon may leverage the DNA double-stranded breaks induced by heavy metal toxicity to mobilize and insert at new genomic locations. Indeed, Morrish <italic>et al</italic>. [<xref ref-type="bibr" rid="RSOB180074C163">163</xref>] described an endonuclease-deficient engineered L1 that could readily retrotranspose in cell lines lacking DNA repair mechanisms. However, Farkash <italic>et al</italic>. [<xref ref-type="bibr" rid="RSOB180074C164">164</xref>] reported no increase in retrotransposition of an endonuclease-deficient L1 after application of gamma radiation, which is known to induce DNA double-strand breaks. It therefore remains unclear whether L1 can easily integrate, through an endonuclease-independent mechanism, at preformed DNA double-strand breaks. Alternatively, the cellular machinery could use L1 to induce apoptosis or repair DNA damage through a compensatory mechanism [<xref ref-type="bibr" rid="RSOB180074C161">161</xref>,<xref ref-type="bibr" rid="RSOB180074C163">163</xref>,<xref ref-type="bibr" rid="RSOB180074C165">165</xref>]. Although these environmental insults are known to impact neurogenesis and brain function, a link between these factors and an increase in retrotransposition in neurons or brain tissue has not been formally demonstrated <italic>in vivo</italic>.</p>
</sec>
</sec>
<sec id="s9">
<label>9.</label>
<title>Retrotransposition in neurological disease</title>
<p>Retrotransposition in the early embryo and committed germline can result in heritable mutations that cause genetic disease [<xref ref-type="bibr" rid="RSOB180074C11">11</xref>,<xref ref-type="bibr" rid="RSOB180074C63">63</xref>]. Several retrotransposon insertions involved in genetic neurologic diseases have been reported to date (<xref ref-type="table" rid="RSOB180074TB1">table 1</xref>). As stress-responsive elements, retrotransposons could be activated by an abnormal neural cell environment, and thereby generate somatic insertions with the potential to influence neurological diseases of developmental and degenerative origin. Early developmental stress factors, as well as environmental insults occurring later in life, are major risk factors for developing neuropsychiatric and neurodegenerative disorders [<xref ref-type="bibr" rid="RSOB180074C208">208</xref>]. Although many studies report elevated retrotransposon copy numbers, mRNA levels or retroviral markers in neurological diseases, to date there are essentially no confirmed causative links established between any neurological condition and somatic retrotransposition. Here, we present an overview of the most relevant findings in this area from L1 and <italic>Alu</italic> data. The implication of HERVs in neurological disease, such as multiple sclerosis, schizophrenia and bipolar disorder, has been recently reviewed [<xref ref-type="bibr" rid="RSOB180074C178">178</xref>,<xref ref-type="bibr" rid="RSOB180074C209">209</xref>,<xref ref-type="bibr" rid="RSOB180074C210">210</xref>]. The involvement of SVA retrotransposons in neurological disease has also been recently reviewed [<xref ref-type="bibr" rid="RSOB180074C211">211</xref>,<xref ref-type="bibr" rid="RSOB180074C212">212</xref>]. Processed pseudogenes in the context of neuropathology have not been studied extensively, to our knowledge.
<table-wrap id="RSOB180074TB1" orientation="portrait" position="float"><label>Table 1.</label><caption><p>Studies associating retrotransposons with neurological disease. Here, we consider association as a study having shown that a retrotransposon insertion, or insertions, may cause a disease, or the study having reported elevation of retrotransposon copy number or mRNA level in the brain tissue of affected individuals when compared with healthy individuals.</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/></colgroup><thead valign="bottom"><tr><th align="left" colspan="1" rowspan="2">retrotransposon</th><th align="left" colspan="2" rowspan="1">neurological disease<hr/></th></tr><tr><th align="left" colspan="1" rowspan="1">insertions</th><th align="left" colspan="1" rowspan="1">activity (mRNA levels, CNV, biomarkers)</th></tr></thead><tbody><tr><td colspan="1" rowspan="1">HERV</td><td colspan="1" rowspan="1">multiple sclerosis [<xref ref-type="bibr" rid="RSOB180074C166">166</xref>–<xref ref-type="bibr" rid="RSOB180074C168">168</xref>]<break></break>3q13.31 microdeletion syndrome [<xref ref-type="bibr" rid="RSOB180074C169">169</xref>]</td><td colspan="1" rowspan="1">amyotrophic lateral sclerosis [<xref ref-type="bibr" rid="RSOB180074C170">170</xref>,<xref ref-type="bibr" rid="RSOB180074C171">171</xref>]<break></break>multiple sclerosis [<xref ref-type="bibr" rid="RSOB180074C166">166</xref>–<xref ref-type="bibr" rid="RSOB180074C168">168</xref>,<xref ref-type="bibr" rid="RSOB180074C172">172</xref>]<break></break>schizophrenia [<xref ref-type="bibr" rid="RSOB180074C173">173</xref>–<xref ref-type="bibr" rid="RSOB180074C176">176</xref>]<break></break>bipolar disorder [<xref ref-type="bibr" rid="RSOB180074C173">173</xref>,<xref ref-type="bibr" rid="RSOB180074C175">175</xref>,<xref ref-type="bibr" rid="RSOB180074C177">177</xref>]<break></break>HIV-associated dementia [<xref ref-type="bibr" rid="RSOB180074C178">178</xref>]<break></break>major depression [<xref ref-type="bibr" rid="RSOB180074C177">177</xref>]<break></break>autism [<xref ref-type="bibr" rid="RSOB180074C179">179</xref>]<break></break>ADHD [<xref ref-type="bibr" rid="RSOB180074C180">180</xref>]</td></tr><tr><td colspan="1" rowspan="1">L1</td><td colspan="1" rowspan="1">pyruvate dehydrogenase complex deficiency [<xref ref-type="bibr" rid="RSOB180074C110">110</xref>]<break></break>Fukuyama-type congenital muscular dystrophy [<xref ref-type="bibr" rid="RSOB180074C181">181</xref>]<break></break>neurofibromatosis type I [<xref ref-type="bibr" rid="RSOB180074C182">182</xref>]<break></break>ataxia with oculomotor apraxia 2 [<xref ref-type="bibr" rid="RSOB180074C183">183</xref>]<break></break>glioblastoma [<xref ref-type="bibr" rid="RSOB180074C184">184</xref>,<xref ref-type="bibr" rid="RSOB180074C185">185</xref>]<break></break>schizophrenia [<xref ref-type="bibr" rid="RSOB180074C176">176</xref>]<break></break>ataxia telangiectasia [<xref ref-type="bibr" rid="RSOB180074C54">54</xref>]<break></break>Coffin Lowry syndrome [<xref ref-type="bibr" rid="RSOB180074C186">186</xref>]</td><td colspan="1" rowspan="1">major depression [<xref ref-type="bibr" rid="RSOB180074C187">187</xref>,<xref ref-type="bibr" rid="RSOB180074C188">188</xref>]<break></break>schizophrenia [<xref ref-type="bibr" rid="RSOB180074C187">187</xref>–<xref ref-type="bibr" rid="RSOB180074C189">189</xref>]<break></break>Rett syndrome [<xref ref-type="bibr" rid="RSOB180074C74">74</xref>]<break></break>autism [<xref ref-type="bibr" rid="RSOB180074C190">190</xref>]<break></break>cocaine addiction [<xref ref-type="bibr" rid="RSOB180074C191">191</xref>]<break></break>post-traumatic stress disorder [<xref ref-type="bibr" rid="RSOB180074C192">192</xref>]</td></tr><tr><td colspan="1" rowspan="1"><italic>Alu</italic></td><td colspan="1" rowspan="1">autosomal dominant optic atrophy [<xref ref-type="bibr" rid="RSOB180074C193">193</xref>]<break></break>adrenoleukodystrophy [<xref ref-type="bibr" rid="RSOB180074C194">194</xref>]<break></break>neurofibromatosis type I [<xref ref-type="bibr" rid="RSOB180074C182">182</xref>,<xref ref-type="bibr" rid="RSOB180074C195">195</xref>]<break></break>lipoprotein lipase deficiency [<xref ref-type="bibr" rid="RSOB180074C196">196</xref>]<break></break>spastic paraplegia [<xref ref-type="bibr" rid="RSOB180074C197">197</xref>,<xref ref-type="bibr" rid="RSOB180074C198">198</xref>]<break></break>Hunter disease [<xref ref-type="bibr" rid="RSOB180074C199">199</xref>]<break></break>Menkes disease [<xref ref-type="bibr" rid="RSOB180074C200">200</xref>]<break></break>Walker–Warburg syndrome [<xref ref-type="bibr" rid="RSOB180074C201">201</xref>]<break></break>Lesch–Nyhan disease [<xref ref-type="bibr" rid="RSOB180074C202">202</xref>]<break></break>glycogen storage disease type II [<xref ref-type="bibr" rid="RSOB180074C203">203</xref>]</td><td colspan="1" rowspan="1">post-traumatic stress disorder [<xref ref-type="bibr" rid="RSOB180074C192">192</xref>]</td></tr><tr><td colspan="1" rowspan="1">SVA</td><td colspan="1" rowspan="1">neurofibromatosis type I [<xref ref-type="bibr" rid="RSOB180074C204">204</xref>]<break></break>X-linked dystonia-parkinsonism [<xref ref-type="bibr" rid="RSOB180074C101">101</xref>–<xref ref-type="bibr" rid="RSOB180074C103">103</xref>,<xref ref-type="bibr" rid="RSOB180074C205">205</xref>]<break></break>Fukuyama muscular dystrophy [<xref ref-type="bibr" rid="RSOB180074C206">206</xref>]</td><td colspan="1" rowspan="1">n.a.</td></tr><tr><td colspan="1" rowspan="1">processed pseudogenes</td><td colspan="1" rowspan="1">spinal muscular atrophy [<xref ref-type="bibr" rid="RSOB180074C207">207</xref>]</td><td colspan="1" rowspan="1">n.a.</td></tr></tbody></table></table-wrap></p>
<sec id="s9a">
<label>9.1.</label>
<title>Neurodevelopmental and psychiatric disease</title>
<p>A prominent example of a neurodevelopmental disorder that has been linked to retrotransposon activity is Rett syndrome (RTT). RTT is a progressive, severe neurodevelopmental disease associated with a mutation in the <italic>MeCP2</italic> gene [<xref ref-type="bibr" rid="RSOB180074C213">213</xref>]. MeCP2 globally regulates methylated DNA and, as mentioned above, has been shown to repress L1 transcription and retrotransposition [<xref ref-type="bibr" rid="RSOB180074C74">74</xref>,<xref ref-type="bibr" rid="RSOB180074C135">135</xref>]. Mice lacking functional MeCP2 exhibit elevated L1 mRNA expression and L1 copy number in brain [<xref ref-type="bibr" rid="RSOB180074C74">74</xref>]. Increased retrotransposition of the L1-EGFP reporter has been observed in <italic>MeCP2</italic> mutant rat NSC cultures and transgenic mice [<xref ref-type="bibr" rid="RSOB180074C74">74</xref>]. Elevated L1 mRNA abundance and L1-EGFP reporter activity were also found in NPCs differentiated from induced pluripotent stem cells (iPSCs) derived from RTT patient fibroblasts [<xref ref-type="bibr" rid="RSOB180074C74">74</xref>]. However, it remains unclear whether susceptibility to increased L1 retrotransposition in RTT patients can act as a driving force for disease phenotype or progression, or is a peripheral outcome of <italic>MeCP2</italic> mutation.</p>
<p>Psychiatric diseases, such as autism, schizophrenia and bipolar disorder, have also been linked with retrotransposon activity [<xref ref-type="bibr" rid="RSOB180074C177">177</xref>,<xref ref-type="bibr" rid="RSOB180074C179">179</xref>,<xref ref-type="bibr" rid="RSOB180074C187">187</xref>,<xref ref-type="bibr" rid="RSOB180074C188">188</xref>,<xref ref-type="bibr" rid="RSOB180074C190">190</xref>–<xref ref-type="bibr" rid="RSOB180074C192">192</xref>]. The aetiology of these disorders involves polygenic and environmental risk factors. Recreational drugs that cause addiction, such as methamphetamines (METH) and cocaine, are major risk factors for the development of psychiatric disorders [<xref ref-type="bibr" rid="RSOB180074C214">214</xref>,<xref ref-type="bibr" rid="RSOB180074C215">215</xref>] and have been reported to affect L1 retrotransposition in cell lines and rodent brains [<xref ref-type="bibr" rid="RSOB180074C216">216</xref>,<xref ref-type="bibr" rid="RSOB180074C217">217</xref>]. One study reported elevated L1 mRNA and ORF2p levels after METH exposure in rat neurogenic areas [<xref ref-type="bibr" rid="RSOB180074C217">217</xref>]. Both METH and cocaine can induce L1 retrotransposition in cultured neuroblastoma cell lines, as determined by L1-EGFP [<xref ref-type="bibr" rid="RSOB180074C217">217</xref>] and L1-neomycin reporter assays [<xref ref-type="bibr" rid="RSOB180074C216">216</xref>]. In cell culture, METH and cocaine do not induce DNA breaks, as revealed by the absence of gamma H2A histone family X (H2AX) phosphorylation at serine 139, a marker for double-strand DNA breaks [<xref ref-type="bibr" rid="RSOB180074C216">216</xref>]. Instead, L1 mobilization in response to METH and cocaine treatment may occur via the cyclic AMP response element-binding protein pathway mediating ORF1p access to chromatin [<xref ref-type="bibr" rid="RSOB180074C216">216</xref>]. In a recent study, Doyle <italic>et al</italic>. [<xref ref-type="bibr" rid="RSOB180074C191">191</xref>] sought to further test the potential link between L1 insertions and cocaine in brain tissue of cocaine addicts and controls. The authors employed a TaqMan ddPCR assay and found no significant increase in the L1 mRNA transcript levels in the cocaine group [<xref ref-type="bibr" rid="RSOB180074C191">191</xref>]. WGS performed on pools of neuronal and non-neuronal nuclei, as well as blood samples from cases and controls, revealed no significant increase in the number of L1 insertions in cocaine samples compared with controls [<xref ref-type="bibr" rid="RSOB180074C191">191</xref>]. The authors reported gene ontology terms, potentially important for cocaine signalling pathways, to be enriched for genes harbouring L1 insertions found in the cocaine group and not observed in the control. However, the study had several caveats which could be addressed in future research. Samples were pooled across control or case individuals, relying on a ddPCR assay to determine the allele frequency of insertions in each individual. Furthermore, insertions were detected based only on the 3' end of L1 and 100 nt single-end Illumina reads, and therefore were not fully resolved and characterized. How and whether these new insertions ultimately contribute to addiction is still very much unclear. The relevant studies have to date not incorporated single-cell genomic analysis with full characterization of candidate somatic insertions.</p>
<p>Increased retrotransposon copy number and mRNA levels have been reported in schizophrenia and depression [<xref ref-type="bibr" rid="RSOB180074C187">187</xref>,<xref ref-type="bibr" rid="RSOB180074C192">192</xref>]. Bundo <italic>et al</italic>. [<xref ref-type="bibr" rid="RSOB180074C187">187</xref>] revealed a significant increase in L1 ORF2 copy number in neurons isolated from schizophrenia PFC when compared with matched control neurons. This result was replicated in iPSC-derived neurons from patients affected by 22q11 deletion, a mutation found in a number of schizophrenia patients and considered a high genetic risk factor [<xref ref-type="bibr" rid="RSOB180074C218">218</xref>]. A consistent increase in L1 copy number was also observed in the PFC tissue of two established schizophrenia animal models (i.e. maternal immune activation induced by polyinosinic : polycytidylic acid (PolyI : C) and epidermal growth factor (EGF)) [<xref ref-type="bibr" rid="RSOB180074C187">187</xref>]. WGS performed on neuronal nuclei and liver samples revealed no increase in L1 insertion number in patients when compared with controls. The authors reported that the L1 insertions in schizophrenia patients were more frequently present in genes important for synaptic function and schizophrenia-related genes [<xref ref-type="bibr" rid="RSOB180074C187">187</xref>]. However, the insertions were not validated and characterized. Moreover, many of the brain-specific insertions appeared from inactive, old L1 subfamilies, which could not have accounted for de novo retrotransposition. Another study reported significant L1 promotor hypomethylation in the PolyI : C model of maternal immune activation, which could explain elevated L1 transcription [<xref ref-type="bibr" rid="RSOB180074C219">219</xref>]. Very recently, Bedrosian <italic>et al</italic>. [<xref ref-type="bibr" rid="RSOB180074C79">79</xref>] proposed that low maternal care, another risk factor for schizophrenia and other psychiatric disorders, may elevate L1 retrotransposition in the hippocampus. This study, based largely on a qPCR L1 CNV assay, estimated higher L1 copy number and transcript levels in mice after low maternal care when compared with those reared in high maternal care conditions. The authors reported no change in neurogenesis between the two groups. However, the elevated L1 transcript levels correlated with hypomethylation of L1 at a YY1 TF binding site [<xref ref-type="bibr" rid="RSOB180074C79">79</xref>]. As a qPCR assay cannot prove L1 integration, it remains unclear whether the difference in L1 copy number and transcript abundance was reflected by an increase in retrotransposition. Consistent L1 upregulation across various schizophrenia experimental systems indicates a strong association between disease phenotype and L1 activity, although it remains unclear whether L1 is a driver or a passenger with respect to neuropathology and, again, single-cell genomic analyses supporting elevated L1 mobilization, as opposed to L1 CNV, have yet to be published.</p>
<p>Even if elevated somatic retrotransposition ultimately is not found to occur in a given neurological condition, a molecular signature of L1 regulatory disruption may indicate a wider landscape of epigenome abnormality, and prove useful as a diagnostic tool. For example, altered L1 and <italic>Alu</italic> epigenetic regulation has been reported in post-traumatic stress disorder (PTSD), an anxiety condition characterized by persistent re-experiences of a past traumatic event or events [<xref ref-type="bibr" rid="RSOB180074C192">192</xref>]. PTSD patients within a cohort of military personnel assessed post-deployment showed hypermethylation of L1 and <italic>Alu</italic> in serum when compared with healthy individuals [<xref ref-type="bibr" rid="RSOB180074C192">192</xref>]. Non-PTSD post-deployment individuals also exhibited a hypermethylation pattern when compared with the same individuals pre-deployment. These two observations are intriguing and might suggest an adaptive stress response mediated by retrotransposon repression or pre-existing methylation in PTSD cases compared with controls [<xref ref-type="bibr" rid="RSOB180074C220">220</xref>]. These findings could be buttressed by experiments performed using animal models where L1 methylation and CNV could be analysed in brain tissue. Overall, a theme has emerged of L1 activation in a wide range of neurological disorders. More research is required in this area to understand whether there is a functional consequence of L1 mobilization in schizophrenia and other psychiatric disorders.</p>
</sec>
<sec id="s9b">
<label>9.2.</label>
<title>Neurodegeneration</title>
<p>Neurodegenerative conditions, such as Parkinson's disease, Huntington's disease and Alzheimer's disease, represent a group of nervous system disorders characterized by the selective death of neuronal subsets in particular brain regions [<xref ref-type="bibr" rid="RSOB180074C221">221</xref>]. Experimental data showing somatic retrotransposition, or even the broad involvement of retrotransposons, in neurodegeneration are quite scarce. To speculate, dysfunctional epigenetic silencing, deficient DNA repair and oxidative stress could all lead to retrotransposon activation associated with neuronal degeneration or to the progression of degenerative processes. As an instructive example, L1 copy number was found via a qPCR-based assay to be elevated in hippocampal neurons from ataxia telangiectasia patients [<xref ref-type="bibr" rid="RSOB180074C54">54</xref>]. These patients presented a loss of function mutation in the <italic>ATM</italic> gene encoding a serine/threonine kinase [<xref ref-type="bibr" rid="RSOB180074C222">222</xref>], which leads to neuronal degeneration [<xref ref-type="bibr" rid="RSOB180074C223">223</xref>]. ATM responds to double-stranded DNA breaks by phosphorylating downstream factors and activating DNA damage checkpoints, thus leading to cell cycle arrest and to the repair of damaged DNA or p53-mediated apoptosis [<xref ref-type="bibr" rid="RSOB180074C223">223</xref>]. <italic>ATM</italic> mutation in cultured human NPCs and <italic>ATM</italic> knockout in L1-EGFP mice significantly increased L1-EGFP retrotransposition, measured by the number of GFP-positive cells, without affecting L1 promoter activity or endogenous ORF1p levels, and with no change in cell division rates or survival [<xref ref-type="bibr" rid="RSOB180074C54">54</xref>]. Notably, longer L1 insertions appeared to occur in <italic>ATM</italic> mutant cells [<xref ref-type="bibr" rid="RSOB180074C54">54</xref>], potentially owing to the role of ATM in cellular DNA repair, which may interfere with host defences against L1 retrotransposition under wild-type conditions. Further analysis, preferably <italic>in vivo</italic>, is required to corroborate these results, and identify the role of ATM in controlling L1 integration.</p>
<p>As many neurodegenerative conditions are associated with ageing, retrotransposition in neurodegenerative conditions may, in general, reflect conditions encountered in senescent cells. Accumulation of oxidative DNA damage and unrepaired DNA, as well as changes in methylation patterns commonly associated with ageing, might lead to reduced silencing of retrotransposition in the brain. As an example of this, TAR DNA-binding protein 43 (TDP-43) is a nucleic acid binding protein involved in transcriptional repression and RNA metabolism during stress response. Mutant TDP-43 is usually associated with neurodegenerative disorders, but it can also be present in healthy elderly people [<xref ref-type="bibr" rid="RSOB180074C224">224</xref>]. Accumulation of TDP-43 in tau-negative and ubiquitin-positive cytoplasmic inclusions is a neuropathological hallmark in neurodegenerative conditions, such as amyotrophic lateral sclerosis (ALS) and frontotemporal lobar dementia (FTLD) [<xref ref-type="bibr" rid="RSOB180074C225">225</xref>]. Transcriptomic analyses performed on brain tissue obtained from TDP-43 mutant mice and mice expressing human mutant TDP-43 showed an overall increase in retrotransposon expression [<xref ref-type="bibr" rid="RSOB180074C226">226</xref>]. Moreover, surveys of protein–RNA interactions and gene expression performed on FTLD brain samples versus matched controls found a significantly reduced association of mutant TDP-43 at its target retrotransposons in patients [<xref ref-type="bibr" rid="RSOB180074C226">226</xref>]. Another recent study, wherein human TDP-43 was expressed in <italic>Drosophila</italic> brains, recapitulated these results from patients and mouse models, demonstrating that TDP-43 dysfunction results in de-repression of retrotransposons [<xref ref-type="bibr" rid="RSOB180074C227">227</xref>]. Interestingly, the expression of human TDP-43 specifically in fly glial cells led to an early and significant increase in <italic>gypsy</italic> ERV transcript levels as previously reported to be elevated in ageing flies [<xref ref-type="bibr" rid="RSOB180074C228">228</xref>]. Human TDP-43 in the fly glia resulted in a high number of apoptotic nuclei, very significant motor impairment and shortened lifespan. Knockdown of <italic>gypsy</italic> ameliorated this phenotype, suggesting that <italic>gypsy</italic> may be involved in cell death, potentially by mediating DNA damage [<xref ref-type="bibr" rid="RSOB180074C227">227</xref>].</p>
<p>Many neurodegenerative disorders are strongly linked with mitochondrial dysfunction. In intriguing recent work, Larsen <italic>et al</italic>. [<xref ref-type="bibr" rid="RSOB180074C229">229</xref>] put forward the hypothesis that retrotransposons were involved in mitochondrial gene dysfunction observed in neurodegeneration. Analysis of the retrotransposon sequence content in over a thousand mitochondrial genes, in conjunction with randomly selected protein-coding genes, showed an enrichment for <italic>Alu</italic> within and adjacent to mitochondrial genes [<xref ref-type="bibr" rid="RSOB180074C229">229</xref>]. Previous studies have identified L1 and <italic>Alu</italic> retrotransposon insertions in a number of translocase of outer mitochondrial membrane genes [<xref ref-type="bibr" rid="RSOB180074C4">4</xref>,<xref ref-type="bibr" rid="RSOB180074C230">230</xref>,<xref ref-type="bibr" rid="RSOB180074C231">231</xref>]. Moreover, <italic>Alu</italic> insertions in two genes involved in mitochondria stabilization and function led to disorders with a neurodegenerative component [<xref ref-type="bibr" rid="RSOB180074C193">193</xref>,<xref ref-type="bibr" rid="RSOB180074C194">194</xref>]. More studies, in cell culture and animal models, are required to test if <italic>Alu</italic> activity can preferentially insert into and induce mitochondrial gene disruption.</p>
</sec>
</sec>
<sec id="s10">
<label>10.</label>
<title>Concluding remarks</title>
<p>It is now well established that retrotransposon-driven mosaicism can occur in the mammalian brain. Dynamism in TF activity, and that of other regulatory mechanisms described to act during embryonic and adult neurogenesis, provides a temporal and spatial niche amenable to retrotransposition. Additionally, retrotransposition may not be limited to NPCs; it may also take place in postmitotic neurons. Further proof is required to be certain that this can occur <italic>in vivo</italic>, and the regulatory mechanisms involved in allowing L1 retrotransposition in mature neurons require further investigation. Environmental stress, as well as genetic dysfunction in L1 silencing factors, can result in high retrotransposition levels, and possibly lead to neurological disease. This also requires extensive investigation, as we lack even basic understanding of the pathways on which stress factors or dysfunction in silencing factors can act to impact retrotransposition in neural cells. Our understanding of retrotransposition in the brain is still very much in its infancy.</p>
<p>Further advances in single-cell genomics (and perhaps taking Eric Kandel's reductionist approach of ‘one cell at a time’ to focus on very well-defined neuronal subtypes [<xref ref-type="bibr" rid="RSOB180074C232">232</xref>]) to understand the precise timing of retrotransposition, and its regulation, are required at this point, and will also advance our knowledge of which neuronal types and contexts best support endogenous L1 retrotransposition. Genome-editing tools, such as the CRISPR–Cas9 system [<xref ref-type="bibr" rid="RSOB180074C233">233</xref>], may be employed in the near future to resolve L1 insertions identified in patient samples and introduce these faithfully into neuronal cultures or animal models, to evaluate their impact on gene expression and, potentially, neurobiological phenotype. This approach may prove to be a viable alternative to the current transgenic approaches used to study engineered L1 mobilization in the brain, and would bring us closer to understanding whether endogenous retrotransposition has an impact upon neurobiology and neurological disease.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgements</title>
<p>We thank Dr Sandra Richardson, Dr Adam Ewing and Dr Liviu-Gabriel Bodea for critical reading of the manuscript and comments. We thank Dr Sandra Richardson and Dr Francisco Jose Sanchez-Luque for constructive comments on the figures.</p>
</ack>
<sec id="s11">
<title>Data accessibility</title>
<p>This article has no additional data.</p>
</sec>
<sec id="s12">
<title>Authors' contributions</title>
<p>G.O.B., E.G.Z.M. and G.J.F. read the literature and drafted the text. E.G.Z.M. and G.O.B. drafted table 1. G.O.B. drafted the figures. All authors approved the final manuscript.</p>
</sec>
<sec id="s13" sec-type="COI-statement">
<title>Competing interests</title>
<p>We declare we have no competing interests.</p>
</sec>
<sec id="s14">
<title>Funding</title>
<p>We acknowledge the support of an NHMRC-ARC Research Fellowship (GNT1108258) to G.O.B. and a CSL Centenary Fellowship to G.J.F.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="RSOB180074C1">
<label>1</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>DeFelipe</surname><given-names>J</given-names></name></person-group>
<year>1993</year>
<article-title>Neocortical neuronal diversity: chemical heterogeneity revealed by colocalization studies of classic neurotransmitters, neuropeptides, calcium-binding proteins, and cell surface molecules</article-title>. <source/>Cereb. Cortex
<volume>3</volume>, <fpage>273</fpage>–<lpage>289</lpage>. (<pub-id pub-id-type="doi">10.1093/cercor/3.4.273</pub-id>)<pub-id pub-id-type="pmid">8104567</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C2">
<label>2</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nelson</surname><given-names>SB</given-names></name>, <name name-style="western"><surname>Sugino</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Hempel</surname><given-names>CM</given-names></name></person-group>
<year>2006</year>
<article-title>The problem of neuronal cell types: a physiological genomics approach</article-title>. <source/>Trends Neurosci.
<volume>29</volume>, <fpage>339</fpage>–<lpage>345</lpage>. (<pub-id pub-id-type="doi">10.1016/j.tins.2006.05.004</pub-id>)<pub-id pub-id-type="pmid">16714064</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C3">
<label>3</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tognini</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Napoli</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Pizzorusso</surname><given-names>T</given-names></name></person-group>
<year>2015</year>
<article-title>Dynamic DNA methylation in the brain: a new epigenetic mark for experience-dependent plasticity</article-title>. <source/>Front. Cell. Neurosci.
<volume>9</volume>, <fpage>331</fpage> (<pub-id pub-id-type="doi">10.3389/fncel.2015.00331</pub-id>)<pub-id pub-id-type="pmid">26379502</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C4">
<label>4</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baillie</surname><given-names>JK</given-names></name><etal>et al.</etal></person-group>
<year>2011</year>
<article-title>Somatic retrotransposition alters the genetic landscape of the human brain</article-title>. <source/>Nature
<volume>479</volume>, <fpage>534</fpage>–<lpage>537</lpage>. (<pub-id pub-id-type="doi">10.1038/nature10531</pub-id>)<pub-id pub-id-type="pmid">22037309</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C5">
<label>5</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Evrony</surname><given-names>GD</given-names></name><etal>et al.</etal></person-group>
<year>2012</year>
<article-title>Single-neuron sequencing analysis of L1 retrotransposition and somatic mutation in the human brain</article-title>. <source/>Cell
<volume>151</volume>, <fpage>483</fpage>–<lpage>496</lpage>. (<pub-id pub-id-type="doi">10.1016/j.cell.2012.09.035</pub-id>)<pub-id pub-id-type="pmid">23101622</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C6">
<label>6</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Evrony</surname><given-names>GD</given-names></name><etal>et al.</etal></person-group>
<year>2015</year>
<article-title>Cell lineage analysis in human brain using endogenous retroelements</article-title>. <source/>Neuron
<volume>85</volume>, <fpage>49</fpage>–<lpage>60</lpage>. (<pub-id pub-id-type="doi">10.1016/j.neuron.2014.12.028</pub-id>)<pub-id pub-id-type="pmid">25569347</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C7">
<label>7</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Erwin</surname><given-names>JA</given-names></name><etal>et al.</etal></person-group>
<year>2016</year>
<article-title>L1-associated genomic regions are deleted in somatic cells of the healthy human brain</article-title>. <source/>Nat. Neurosci.
<volume>19</volume>, <fpage>1583</fpage>–<lpage>1591</lpage>. (<pub-id pub-id-type="doi">10.1038/nn.4388</pub-id>)<pub-id pub-id-type="pmid">27618310</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C8">
<label>8</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McConnell</surname><given-names>MJ</given-names></name><etal>et al.</etal></person-group>
<year>2013</year>
<article-title>Mosaic copy number variation in human neurons</article-title>. <source/>Science
<volume>342</volume>, <fpage>632</fpage>–<lpage>637</lpage>. (<pub-id pub-id-type="doi">10.1126/science.1243472</pub-id>)<pub-id pub-id-type="pmid">24179226</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C9">
<label>9</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lodato</surname><given-names>MA</given-names></name><etal>et al.</etal></person-group>
<year>2015</year>
<article-title>Somatic mutation in single human neurons tracks developmental and transcriptional history</article-title>. <source/>Science
<volume>350</volume>, <fpage>94</fpage>–<lpage>98</lpage>. (<pub-id pub-id-type="doi">10.1126/science.aab1785</pub-id>)<pub-id pub-id-type="pmid">26430121</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C10">
<label>10</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Upton</surname><given-names>KR</given-names></name><etal>et al.</etal></person-group>
<year>2015</year>
<article-title>Ubiquitous L1 mosaicism in hippocampal neurons</article-title>. <source/>Cell
<volume>161</volume>, <fpage>228</fpage>–<lpage>239</lpage>. (<pub-id pub-id-type="doi">10.1016/j.cell.2015.03.026</pub-id>)<pub-id pub-id-type="pmid">25860606</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C11">
<label>11</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Richardson</surname><given-names>SR</given-names></name><etal>et al.</etal></person-group>
<year>2017</year>
<article-title>Heritable L1 retrotransposition in the mouse primordial germline and early embryo</article-title>. <source/>Genome Res.
<volume>27</volume>, <fpage>1395</fpage>–<lpage>1405</lpage>. (<pub-id pub-id-type="doi">10.1101/gr.219022.116</pub-id>)<pub-id pub-id-type="pmid">28483779</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C12">
<label>12</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Macia</surname><given-names>A</given-names></name><etal>et al.</etal></person-group>
<year>2017</year>
<article-title>Engineered LINE-1 retrotransposition in nondividing human neurons</article-title>. <source/>Genome Res.
<volume>27</volume>, <fpage>335</fpage>–<lpage>348</lpage>. (<pub-id pub-id-type="doi">10.1101/gr.206805.116</pub-id>)<pub-id pub-id-type="pmid">27965292</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C13">
<label>13</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gleeson</surname><given-names>JG</given-names></name>, <name name-style="western"><surname>Minnerath</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Kuzniecky</surname><given-names>RI</given-names></name>, <name name-style="western"><surname>Dobyns</surname><given-names>WB</given-names></name>, <name name-style="western"><surname>Young</surname><given-names>ID</given-names></name>, <name name-style="western"><surname>Ross</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>Walsh</surname><given-names>CA</given-names></name></person-group>
<year>2000</year>
<article-title>Somatic and germline mosaic mutations in the doublecortin gene are associated with variable phenotypes</article-title>. <source/>Am. J. Hum. Genet.
<volume>67</volume>, <fpage>574</fpage>–<lpage>581</lpage>. (<pub-id pub-id-type="doi">10.1086/303043</pub-id>)<pub-id pub-id-type="pmid">10915612</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C14">
<label>14</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hazen</surname><given-names>JL</given-names></name><etal>et al.</etal></person-group>
<year>2016</year>
<article-title>The complete genome sequences, unique mutational spectra, and developmental potency of adult neurons revealed by cloning</article-title>. <source/>Neuron
<volume>89</volume>, <fpage>1223</fpage>–<lpage>1236</lpage>. (<pub-id pub-id-type="doi">10.1016/j.neuron.2016.02.004</pub-id>)<pub-id pub-id-type="pmid">26948891</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C15">
<label>15</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>de Koning</surname><given-names>APJ</given-names></name>, <name name-style="western"><surname>Gu</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Castoe</surname><given-names>TA</given-names></name>, <name name-style="western"><surname>Batzer</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Pollock</surname><given-names>DD</given-names></name></person-group>
<year>2011</year>
<article-title>Repetitive elements may comprise over two-thirds of the human genome</article-title>. <source/>PLoS Genet.
<volume>7</volume>, <fpage>e1002384</fpage> (<pub-id pub-id-type="doi">10.1371/journal.pgen.1002384</pub-id>)<pub-id pub-id-type="pmid">22144907</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C16">
<label>16</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mills</surname><given-names>RE</given-names></name>, <name name-style="western"><surname>Bennett</surname><given-names>EA</given-names></name>, <name name-style="western"><surname>Iskow</surname><given-names>RC</given-names></name>, <name name-style="western"><surname>Devine</surname><given-names>SE</given-names></name></person-group>
<year>2007</year>
<article-title>Which transposable elements are active in the human genome?</article-title>
<source/>Trends Genet.
<volume>23</volume>, <fpage>183</fpage>–<lpage>191</lpage>. (<pub-id pub-id-type="doi">10.1016/j.tig.2007.02.006</pub-id>)<pub-id pub-id-type="pmid">17331616</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C17">
<label>17</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Singer</surname><given-names>T</given-names></name>, <name name-style="western"><surname>McConnell</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Marchetto</surname><given-names>MCN</given-names></name>, <name name-style="western"><surname>Coufal</surname><given-names>NG</given-names></name>, <name name-style="western"><surname>Gage</surname><given-names>FH</given-names></name></person-group>
<year>2010</year>
<article-title>LINE-1 retrotransposons: mediators of somatic variation in neuronal genomes?</article-title>
<source/>Trends Neurosci.
<volume>33</volume>, <fpage>345</fpage>–<lpage>354</lpage>. (<pub-id pub-id-type="doi">10.1016/j.tins.2010.04.001</pub-id>)<pub-id pub-id-type="pmid">20471112</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C18">
<label>18</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Erwin</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Marchetto</surname><given-names>MC</given-names></name>, <name name-style="western"><surname>Gage</surname><given-names>FH</given-names></name></person-group>
<year>2014</year>
<article-title>Mobile DNA elements in the generation of diversity and complexity in the brain</article-title>. <source/>Nat. Rev. Neurosci.
<volume>15</volume>, <fpage>497</fpage>–<lpage>506</lpage>. (<pub-id pub-id-type="doi">10.1038/nrn3730</pub-id>)<pub-id pub-id-type="pmid">25005482</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C19">
<label>19</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lander</surname><given-names>ES</given-names></name><etal>et al.</etal></person-group>
<year>2001</year>
<article-title>Initial sequencing and analysis of the human genome</article-title>. <source/>Nature
<volume>409</volume>, <fpage>860</fpage>–<lpage>921</lpage>. (<pub-id pub-id-type="doi">10.1038/35057062</pub-id>)<pub-id pub-id-type="pmid">11237011</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C20">
<label>20</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weiss</surname><given-names>RA</given-names></name></person-group>
<year>2016</year>
<article-title>Human endogenous retroviruses: friend or foe?</article-title>
<source/>APMIS
<volume>124</volume>, <fpage>4</fpage>–<lpage>10</lpage>. (<pub-id pub-id-type="doi">10.1111/apm.12476</pub-id>)<pub-id pub-id-type="pmid">26818257</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C21">
<label>21</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dewannieux</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Esnault</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Heidmann</surname><given-names>T</given-names></name></person-group>
<year>2003</year>
<article-title>LINE-mediated retrotransposition of marked Alu sequences</article-title>. <source/>Nat. Genet.
<volume>35</volume>, <fpage>41</fpage>–<lpage>48</lpage>. (<pub-id pub-id-type="doi">10.1038/ng1223</pub-id>)<pub-id pub-id-type="pmid">12897783</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C22">
<label>22</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dewannieux</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Heidmann</surname><given-names>T</given-names></name></person-group>
<year>2005</year>
<article-title>L1-mediated retrotransposition of murine B1 and B2 SINEs recapitulated in cultured cells</article-title>. <source/>J. Mol. Biol.
<volume>349</volume>, <fpage>241</fpage>–<lpage>247</lpage>. (<pub-id pub-id-type="doi">10.1016/j.jmb.2005.03.068</pub-id>)<pub-id pub-id-type="pmid">15890192</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C23">
<label>23</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Raiz</surname><given-names>J</given-names></name><etal>et al.</etal></person-group>
<year>2012</year>
<article-title>The non-autonomous retrotransposon SVA is trans-mobilized by the human LINE-1 protein machinery</article-title>. <source/>Nucleic Acids Res.
<volume>40</volume>, <fpage>1666</fpage>–<lpage>1683</lpage>. (<pub-id pub-id-type="doi">10.1093/nar/gkr863</pub-id>)<pub-id pub-id-type="pmid">22053090</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C24">
<label>24</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hancks</surname><given-names>DC</given-names></name>, <name name-style="western"><surname>Goodier</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Mandal</surname><given-names>PK</given-names></name>, <name name-style="western"><surname>Cheung</surname><given-names>LE</given-names></name>, <name name-style="western"><surname>Kazazian</surname><given-names>HH</given-names></name></person-group>
<year>2011</year>
<article-title>Retrotransposition of marked SVA elements by human L1s in cultured cells</article-title>. <source/>Hum. Mol. Genet.
<volume>20</volume>, <fpage>3386</fpage>–<lpage>3400</lpage>. (<pub-id pub-id-type="doi">10.1093/hmg/ddr245</pub-id>)<pub-id pub-id-type="pmid">21636526</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C25">
<label>25</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Esnault</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Maestre</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Heidmann</surname><given-names>T</given-names></name></person-group>
<year>2000</year>
<article-title>Human LINE retrotransposons generate processed pseudogenes</article-title>. <source/>Nat. Genet.
<volume>24</volume>, <fpage>363</fpage>–<lpage>367</lpage>. (<pub-id pub-id-type="doi">10.1038/74184</pub-id>)<pub-id pub-id-type="pmid">10742098</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C26">
<label>26</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ullu</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Tschudi</surname><given-names>C</given-names></name></person-group>
<year>1984</year>
<article-title>Alu sequences are processed 7SL RNA genes</article-title>. <source/>Nature
<volume>312</volume>, <fpage>171</fpage>–<lpage>172</lpage>. (<pub-id pub-id-type="doi">10.1038/312171a0</pub-id>)<pub-id pub-id-type="pmid">6209580</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C27">
<label>27</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Deininger</surname><given-names>PL</given-names></name>, <name name-style="western"><surname>Jolly</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Rubin</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Friedmann</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Schmid</surname><given-names>CW</given-names></name></person-group>
<year>1981</year>
<article-title>Base sequence studies of 300 nucleotide renatured repeated human DNA clones</article-title>. <source/>J. Mol. Biol.
<volume>151</volume>, <fpage>17</fpage>–<lpage>33</lpage>. (<pub-id pub-id-type="doi">10.1016/0022-2836(81)90219-9</pub-id>)<pub-id pub-id-type="pmid">6276559</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C28">
<label>28</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ostertag</surname><given-names>EM</given-names></name>, <name name-style="western"><surname>Goodier</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Kazazian</surname><given-names>HH</given-names></name></person-group>
<year>2003</year>
<article-title>SVA elements are nonautonomous retrotransposons that cause disease in humans</article-title>. <source/>Am. J. Hum. Genet.
<volume>73</volume>, <fpage>1444</fpage>–<lpage>1451</lpage>. (<pub-id pub-id-type="doi">10.1086/380207</pub-id>)<pub-id pub-id-type="pmid">14628287</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C29">
<label>29</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Xing</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Grover</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Hedges</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Han</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Walker</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Batzer</surname><given-names>MA</given-names></name></person-group>
<year>2005</year>
<article-title>SVA elements: a hominid-specific retroposon family</article-title>. <source/>J. Mol. Biol.
<volume>354</volume>, <fpage>994</fpage>–<lpage>1007</lpage>. (<pub-id pub-id-type="doi">10.1016/j.jmb.2005.09.085</pub-id>)<pub-id pub-id-type="pmid">16288912</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C30">
<label>30</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hancks</surname><given-names>DC</given-names></name>, <name name-style="western"><surname>Kazazian</surname><given-names>HH</given-names></name></person-group>
<year>2010</year>
<article-title>SVA retrotransposons: evolution and genetic instability</article-title>. <source/>Semin. Cancer Biol.
<volume>20</volume>, <fpage>234</fpage>–<lpage>245</lpage>. (<pub-id pub-id-type="doi">10.1016/j.semcancer.2010.04.001</pub-id>)<pub-id pub-id-type="pmid">20416380</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C31">
<label>31</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Holmes</surname><given-names>SE</given-names></name>, <name name-style="western"><surname>Singer</surname><given-names>MF</given-names></name>, <name name-style="western"><surname>Swergold</surname><given-names>GD</given-names></name></person-group>
<year>1992</year>
<article-title>Studies on p40, the leucine zipper motif-containing protein encoded by the first open reading frame of an active human LINE-1 transposable element</article-title>. <source/>J. Biol. Chem.
<volume>267</volume>, <fpage>19 765</fpage>–<lpage>19 768</lpage>.</mixed-citation>
</ref>
<ref id="RSOB180074C32">
<label>32</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hohjoh</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Singer</surname><given-names>MF</given-names></name></person-group>
<year>1996</year>
<article-title>Cytoplasmic ribonucleoprotein complexes containing human LINE-1 protein and RNA</article-title>. <source/>EMBO J.
<volume>15</volume>, <fpage>630</fpage>–<lpage>639</lpage>. (<pub-id pub-id-type="doi">10.1002/j.1460-2075.1996.tb00395.x</pub-id>)<pub-id pub-id-type="pmid">8599946</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C33">
<label>33</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Feng</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Moran</surname><given-names>JV</given-names></name>, <name name-style="western"><surname>Kazazian</surname><given-names>HH</given-names></name>, <name name-style="western"><surname>Boeke</surname><given-names>JD</given-names></name></person-group>
<year>1996</year>
<article-title>Human L1 retrotransposon encodes a conserved endonuclease required for retrotransposition</article-title>. <source/>Cell
<volume>87</volume>, <fpage>905</fpage>–<lpage>916</lpage>. (<pub-id pub-id-type="doi">10.1016/S0092-8674(00)81997-2</pub-id>)<pub-id pub-id-type="pmid">8945517</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C34">
<label>34</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mathias</surname><given-names>SL</given-names></name>, <name name-style="western"><surname>Scott</surname><given-names>AF</given-names></name>, <name name-style="western"><surname>Kazazian</surname><given-names>HH</given-names></name>, <name name-style="western"><surname>Boeke</surname><given-names>JD</given-names></name>, <name name-style="western"><surname>Gabriel</surname><given-names>A</given-names></name></person-group>
<year>1991</year>
<article-title>Reverse transcriptase encoded by a human transposable element</article-title>. <source/>Science
<volume>254</volume>, <fpage>1808</fpage>–<lpage>1810</lpage>. (<pub-id pub-id-type="doi">10.1126/science.1722352</pub-id>)<pub-id pub-id-type="pmid">1722352</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C35">
<label>35</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Denli</surname><given-names>AM</given-names></name><etal>et al.</etal></person-group>
<year>2015</year>
<article-title>Primate-specific ORF0 contributes to retrotransposon-mediated diversity</article-title>. <source/>Cell
<volume>163</volume>, <fpage>583</fpage>–<lpage>893</lpage>. (<pub-id pub-id-type="doi">10.1016/j.cell.2015.09.025</pub-id>)<pub-id pub-id-type="pmid">26496605</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C36">
<label>36</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Luan</surname><given-names>DD</given-names></name>, <name name-style="western"><surname>Korman</surname><given-names>MH</given-names></name>, <name name-style="western"><surname>Jakubczak</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Eickbush</surname><given-names>TH</given-names></name></person-group>
<year>1993</year>
<article-title>Reverse transcription of R2Bm RNA is primed by a nick at the chromosomal target site: a mechanism for non-LTR retrotransposition</article-title>. <source/>Cell
<volume>72</volume>, <fpage>595</fpage>–<lpage>605</lpage>. (<pub-id pub-id-type="doi">10.1016/0092-8674(93)90078-5</pub-id>)<pub-id pub-id-type="pmid">7679954</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C37">
<label>37</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cost</surname><given-names>GJ</given-names></name></person-group>
<year>2002</year>
<article-title>Human L1 element target-primed reverse transcription in vitro</article-title>. <source/>EMBO J.
<volume>21</volume>, <fpage>5899</fpage>–<lpage>5910</lpage>. (<pub-id pub-id-type="doi">10.1093/emboj/cdf592</pub-id>)<pub-id pub-id-type="pmid">12411507</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C38">
<label>38</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Skowronski</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Fanning</surname><given-names>TG</given-names></name>, <name name-style="western"><surname>Singer</surname><given-names>MF</given-names></name></person-group>
<year>1988</year>
<article-title>Unit-length line-1 transcripts in human teratocarcinoma cells</article-title>. <source/>Mol. Cell. Biol.
<volume>8</volume>, <fpage>1385</fpage>–<lpage>1397</lpage>. (<pub-id pub-id-type="doi">10.1128/MCB.8.4.1385</pub-id>)<pub-id pub-id-type="pmid">2454389</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C39">
<label>39</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smit</surname><given-names>AF</given-names></name>, <name name-style="western"><surname>Tóth</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Riggs</surname><given-names>AD</given-names></name>, <name name-style="western"><surname>Jurka</surname><given-names>J</given-names></name></person-group>
<year>1995</year>
<article-title>Ancestral, mammalian-wide subfamilies of LINE-1 repetitive sequences</article-title>. <source/>J. Mol. Biol.
<volume>246</volume>, <fpage>401</fpage>–<lpage>417</lpage>. (<pub-id pub-id-type="doi">10.1006/jmbi.1994.0095</pub-id>)<pub-id pub-id-type="pmid">7877164</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C40">
<label>40</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boissinot</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Chevret</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Furano</surname><given-names>AV</given-names></name></person-group>
<year>2000</year>
<article-title>L1 (LINE-1) retrotransposon evolution and amplification in recent human history</article-title>. <source/>Mol. Biol. Evol.
<volume>17</volume>, <fpage>915</fpage>–<lpage>928</lpage>. (<pub-id pub-id-type="doi">10.1093/oxfordjournals.molbev.a026372</pub-id>)<pub-id pub-id-type="pmid">10833198</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C41">
<label>41</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Beck</surname><given-names>CR</given-names></name>, <name name-style="western"><surname>Collier</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Macfarlane</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Malig</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Kidd</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Eichler</surname><given-names>EE</given-names></name>, <name name-style="western"><surname>Badge</surname><given-names>RM</given-names></name>, <name name-style="western"><surname>Moran</surname><given-names>JV</given-names></name></person-group>
<year>2010</year>
<article-title>LINE-1 retrotransposition activity in human genomes</article-title>. <source/>Cell
<volume>141</volume>, <fpage>1159</fpage>–<lpage>1170</lpage>. (<pub-id pub-id-type="doi">10.1016/j.cell.2010.05.021</pub-id>)<pub-id pub-id-type="pmid">20602998</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C42">
<label>42</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brouha</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Schustak</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Badge</surname><given-names>RM</given-names></name>, <name name-style="western"><surname>Lutz-Prigge</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Farley</surname><given-names>AH</given-names></name>, <name name-style="western"><surname>Moran</surname><given-names>JV</given-names></name>, <name name-style="western"><surname>Kazazian</surname><given-names>HH</given-names></name></person-group>
<year>2003</year>
<article-title>Hot L1s account for the bulk of retrotransposition in the human population</article-title>. <source/>Proc. Natl Acad. Sci. USA
<volume>100</volume>, <fpage>5280</fpage>–<lpage>5285</lpage>. (<pub-id pub-id-type="doi">10.1073/pnas.0831042100</pub-id>)<pub-id pub-id-type="pmid">12682288</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C43">
<label>43</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Konkel</surname><given-names>MK</given-names></name>, <name name-style="western"><surname>Walker</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Hotard</surname><given-names>AB</given-names></name>, <name name-style="western"><surname>Ranck</surname><given-names>MC</given-names></name>, <name name-style="western"><surname>Fontenot</surname><given-names>CC</given-names></name>, <name name-style="western"><surname>Storer</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Stewart</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Marth</surname><given-names>GT</given-names></name>, <name name-style="western"><surname>Batzer</surname><given-names>MA</given-names></name></person-group>
<year>2015</year>
<article-title>Sequence analysis and characterization of active human <italic>Alu</italic> subfamilies based on the 1000 Genomes pilot project</article-title>. <source/>Genome Biol. Evol.
<volume>7</volume>, <fpage>2608</fpage>–<lpage>2622</lpage>. (<pub-id pub-id-type="doi">10.1093/gbe/evv167</pub-id>)<pub-id pub-id-type="pmid">26319576</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C44">
<label>44</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wildschutte</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Williams</surname><given-names>ZH</given-names></name>, <name name-style="western"><surname>Montesion</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Subramanian</surname><given-names>RP</given-names></name>, <name name-style="western"><surname>Kidd</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Coffin</surname><given-names>JM</given-names></name></person-group>
<year>2016</year>
<article-title>Discovery of unfixed endogenous retrovirus insertions in diverse human populations</article-title>. <source/>Proc. Natl Acad. Sci. USA
<volume>113</volume>, <fpage>E2326</fpage>–<lpage>E2334</lpage>. (<pub-id pub-id-type="doi">10.1073/pnas.1602336113</pub-id>)<pub-id pub-id-type="pmid">27001843</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C45">
<label>45</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boeke</surname><given-names>JD</given-names></name>, <name name-style="western"><surname>Garfinkel</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Styles</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Fink</surname><given-names>GR</given-names></name></person-group>
<year>1985</year>
<article-title>Ty elements transpose through an RNA intermediate</article-title>. <source/>Cell
<volume>40</volume>, <fpage>491</fpage>–<lpage>500</lpage>. (<pub-id pub-id-type="doi">10.1016/0092-8674(85)90197-7</pub-id>)<pub-id pub-id-type="pmid">2982495</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C46">
<label>46</label>
<mixed-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Boeke</surname><given-names>JD</given-names></name>, <name name-style="western"><surname>Voytas</surname><given-names>DF</given-names></name></person-group>
<year>2002</year>
<article-title>Ty1 and Ty5 of <italic>Saccharomyces cerevisiae</italic></article-title>. In <source/>Mobile DNA II (eds <person-group person-group-type="editor"><name name-style="western"><surname>Craig</surname><given-names>NL</given-names></name>, <name name-style="western"><surname>Craigie</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Gellert</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Lambowitz</surname><given-names>AM</given-names></name></person-group>), pp. <fpage>631</fpage>–<lpage>662</lpage>. <publisher-loc>Washington, DC</publisher-loc>: <publisher-name>American Society of Microbiology</publisher-name> (<pub-id pub-id-type="doi">10.1128/9781555817954.ch26</pub-id>)</mixed-citation>
</ref>
<ref id="RSOB180074C47">
<label>47</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wei</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Gilbert</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Ooi</surname><given-names>SL</given-names></name>, <name name-style="western"><surname>Lawler</surname><given-names>JF</given-names></name>, <name name-style="western"><surname>Ostertag</surname><given-names>EM</given-names></name>, <name name-style="western"><surname>Kazazian</surname><given-names>HH</given-names></name>, <name name-style="western"><surname>Boeke</surname><given-names>JD</given-names></name>, <name name-style="western"><surname>Moran</surname><given-names>JV</given-names></name></person-group>
<year>2001</year>
<article-title>Human L1 retrotransposition: <italic>cis</italic> preference versus <italic>trans</italic> complementation</article-title>. <source/>Mol. Cell. Biol.
<volume>21</volume>, <fpage>1429</fpage>–<lpage>1439</lpage>. (<pub-id pub-id-type="doi">10.1128/MCB.21.4.1429-1439.2001</pub-id>)<pub-id pub-id-type="pmid">11158327</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C48">
<label>48</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Doucet</surname><given-names>AJ</given-names></name><etal>et al.</etal></person-group>
<year>2010</year>
<article-title>Characterization of LINE-1 ribonucleoprotein particles</article-title>. <source/>PLoS Genet.
<volume>6</volume>, <fpage>1</fpage>–<lpage>19</lpage>. (<pub-id pub-id-type="doi">10.1371/journal.pgen.1001150</pub-id>)</mixed-citation>
</ref>
<ref id="RSOB180074C49">
<label>49</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Goodier</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Vetter</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Kazazian</surname><given-names>HH</given-names></name></person-group>
<year>2007</year>
<article-title>LINE-1 ORF1 protein localizes in stress granules with other RNA-binding proteins, including components of RNA interference RNA-induced silencing complex</article-title>. <source/>Mol. Cell. Biol.
<volume>27</volume>, <fpage>6469</fpage>–<lpage>6483</lpage>. (<pub-id pub-id-type="doi">10.1128/MCB.00332-07</pub-id>)<pub-id pub-id-type="pmid">17562864</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C50">
<label>50</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moran</surname><given-names>JVJ</given-names></name>, <name name-style="western"><surname>Holmes</surname><given-names>SES</given-names></name>, <name name-style="western"><surname>Naas</surname><given-names>TPT</given-names></name>, <name name-style="western"><surname>DeBerardinis</surname><given-names>RJ</given-names></name>, <name name-style="western"><surname>Boeke</surname><given-names>JD</given-names></name>, <name name-style="western"><surname>Kazazian</surname><given-names>HH</given-names></name></person-group>
<year>1996</year>
<article-title>High frequency retrotransposition in cultured mammalian cells</article-title>. <source/>Cell
<volume>87</volume>, <fpage>917</fpage>–<lpage>927</lpage>. (<pub-id pub-id-type="doi">10.1016/S0092-8674(00)81998-4</pub-id>)<pub-id pub-id-type="pmid">8945518</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C51">
<label>51</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jurka</surname><given-names>J</given-names></name></person-group>
<year>1997</year>
<article-title>Sequence patterns indicate an enzymatic involvement in integration of mammalian retroposons</article-title>. <source/>Proc. Natl Acad. Sci. USA
<volume>94</volume>, <fpage>1872</fpage>–<lpage>1877</lpage>. (<pub-id pub-id-type="doi">10.1073/pnas.94.5.1872</pub-id>)<pub-id pub-id-type="pmid">9050872</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C52">
<label>52</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gilbert</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Lutz</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Morrish</surname><given-names>TA</given-names></name>, <name name-style="western"><surname>Moran</surname><given-names>JV</given-names></name></person-group>
<year>2005</year>
<article-title>Multiple fates of L1 retrotransposition intermediates in cultured human cells</article-title>. <source/>Mol. Cell. Biol.
<volume>25</volume>, <fpage>7780</fpage>–<lpage>7795</lpage>. (<pub-id pub-id-type="doi">10.1128/MCB.25.17.7780-7795.2005</pub-id>)<pub-id pub-id-type="pmid">16107723</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C53">
<label>53</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Myers</surname><given-names>JS</given-names></name><etal>et al.</etal></person-group>
<year>2002</year>
<article-title>A comprehensive analysis of recently integrated human Ta L1 elements</article-title>. <source/>Am. J. Hum. Genet.
<volume>71</volume>, <fpage>312</fpage>–<lpage>326</lpage>. (<pub-id pub-id-type="doi">10.1086/341718</pub-id>)<pub-id pub-id-type="pmid">12070800</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C54">
<label>54</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Coufal</surname><given-names>NG</given-names></name><etal>et al.</etal></person-group>
<year>2011</year>
<article-title>Ataxia telangiectasia mutated (ATM) modulates long interspersed element-1 (L1) retrotransposition in human neural stem cells</article-title>. <source/>Proc. Natl Acad. Sci. USA
<volume>108</volume>, <fpage>20 382</fpage>–<lpage>20 387</lpage>. (<pub-id pub-id-type="doi">10.1073/pnas.1100273108</pub-id>)</mixed-citation>
</ref>
<ref id="RSOB180074C55">
<label>55</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ostertag</surname><given-names>EM</given-names></name>, <name name-style="western"><surname>Kazazian</surname><given-names>H.H. J</given-names></name></person-group>
<year>2001</year>
<article-title>Twin priming: a proposed mechanism for the creation of inversions in L1 retrotransposition</article-title>. <source/>Genome Res.
<volume>11</volume>, <fpage>2059</fpage>–<lpage>2065</lpage>. (<pub-id pub-id-type="doi">10.1101/gr.205701</pub-id>)<pub-id pub-id-type="pmid">11731496</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C56">
<label>56</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lutz</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Vincent</surname><given-names>BJ</given-names></name>, <name name-style="western"><surname>Kazazian</surname><given-names>HH</given-names></name>, <name name-style="western"><surname>Batzer</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Moran</surname><given-names>JV</given-names></name></person-group>
<year>2003</year>
<article-title>Allelic heterogeneity in LINE-1 retrotransposition activity</article-title>. <source/>Am. J. Hum. Genet.
<volume>73</volume>, <fpage>1431</fpage>–<lpage>1437</lpage>. (<pub-id pub-id-type="doi">10.1086/379744</pub-id>)<pub-id pub-id-type="pmid">14610717</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C57">
<label>57</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Seleme</surname><given-names>MdC</given-names></name>, <name name-style="western"><surname>Vetter</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Cordaux</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Bastone</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Batzer</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Kazazian</surname><given-names>HH</given-names></name></person-group>
<year>2006</year>
<article-title>Extensive individual variation in L1 retrotransposition capability contributes to human genetic diversity</article-title>. <source/>Proc. Natl Acad. Sci. USA
<volume>103</volume>, <fpage>6611</fpage>–<lpage>6616</lpage>. (<pub-id pub-id-type="doi">10.1073/pnas.0601324103</pub-id>)<pub-id pub-id-type="pmid">16618923</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C58">
<label>58</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sassaman</surname><given-names>DM</given-names></name>, <name name-style="western"><surname>Dombroski</surname><given-names>BA</given-names></name>, <name name-style="western"><surname>Moran</surname><given-names>JV</given-names></name>, <name name-style="western"><surname>Kimberland</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Naas</surname><given-names>TP</given-names></name>, <name name-style="western"><surname>DeBerardinis</surname><given-names>RJ</given-names></name>, <name name-style="western"><surname>Gabriel</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Swergold</surname><given-names>GD</given-names></name>, <name name-style="western"><surname>Kazazian</surname><given-names>HH</given-names></name></person-group>
<year>1997</year>
<article-title>Many human L1 elements are capable of retrotransposition</article-title>. <source/>Nat. Genet.
<volume>16</volume>, <fpage>37</fpage>–<lpage>43</lpage>. (<pub-id pub-id-type="doi">10.1038/ng0597-37</pub-id>)<pub-id pub-id-type="pmid">9140393</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C59">
<label>59</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ewing</surname><given-names>AD</given-names></name>, <name name-style="western"><surname>Kazazian</surname><given-names>HH</given-names></name></person-group>
<year>2010</year>
<article-title>High-throughput sequencing reveals extensive variation in human-specific L1 content in individual human genomes</article-title>. <source/>Genome Res.
<volume>20</volume>, <fpage>1262</fpage>–<lpage>1270</lpage>. (<pub-id pub-id-type="doi">10.1101/gr.106419.110</pub-id>)<pub-id pub-id-type="pmid">20488934</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C60">
<label>60</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Goodier</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Ostertag</surname><given-names>EM</given-names></name>, <name name-style="western"><surname>Du</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Kazazian</surname><given-names>HH</given-names><suffix>Jr</suffix></name></person-group>
<year>2001</year>
<article-title>A novel active L1 retrotransposon subfamily in the mouse</article-title>. <source/>Genome Res.
<volume>11</volume>, <fpage>1677</fpage>–<lpage>1685</lpage>. (<pub-id pub-id-type="doi">10.1101/gr.198301</pub-id>)<pub-id pub-id-type="pmid">11591644</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C61">
<label>61</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McClintock</surname><given-names>B</given-names></name></person-group>
<year>1956</year>
<article-title>Controlling elements and the gene</article-title>. <source/>Cold Spring Harb. Symp. Quant. Biol.
<volume>21</volume>, <fpage>197</fpage>–<lpage>216</lpage>. (<pub-id pub-id-type="doi">10.1101/SQB.1956.021.01.017</pub-id>)<pub-id pub-id-type="pmid">13433592</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C62">
<label>62</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McClintock</surname><given-names>B</given-names></name></person-group>
<year>1950</year>
<article-title>The origin and behavior of mutable loci in maize</article-title>. <source/>Proc. Natl Acad. Sci. USA
<volume>36</volume>, <fpage>344</fpage>–<lpage>355</lpage>. (<pub-id pub-id-type="doi">10.1073/pnas.36.6.344</pub-id>)<pub-id pub-id-type="pmid">15430309</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C63">
<label>63</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kazazian</surname><given-names>HH</given-names></name>, <name name-style="western"><surname>Wong</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Youssoufian</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Scott</surname><given-names>AF</given-names></name>, <name name-style="western"><surname>Phillips</surname><given-names>DG</given-names></name>, <name name-style="western"><surname>Antonarakis</surname><given-names>SE</given-names></name></person-group>
<year>1988</year>
<article-title>Haemophilia A resulting from de novo insertion of L1 sequences represents a novel mechanism for mutation in man</article-title>. <source/>Nature
<volume>332</volume>, <fpage>164</fpage>–<lpage>166</lpage>. (<pub-id pub-id-type="doi">10.1038/332164a0</pub-id>)<pub-id pub-id-type="pmid">2831458</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C64">
<label>64</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kano</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Godoy</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Courtney</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Vetter</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Gerton</surname><given-names>GL</given-names></name>, <name name-style="western"><surname>Ostertag</surname><given-names>EM</given-names></name>, <name name-style="western"><surname>Kazazian</surname><given-names>HH</given-names></name></person-group>
<year>2009</year>
<article-title>L1 retrotransposition occurs mainly in embryogenesis and creates somatic mosaicism</article-title>. <source/>Genes Dev.
<volume>23</volume>, <fpage>1303</fpage>–<lpage>1312</lpage>. (<pub-id pub-id-type="doi">10.1101/gad.1803909</pub-id>)<pub-id pub-id-type="pmid">19487571</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C65">
<label>65</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Iskow</surname><given-names>RC</given-names></name>, <name name-style="western"><surname>McCabe</surname><given-names>MT</given-names></name>, <name name-style="western"><surname>Mills</surname><given-names>RE</given-names></name>, <name name-style="western"><surname>Torene</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Pittard</surname><given-names>WS</given-names></name>, <name name-style="western"><surname>Neuwald</surname><given-names>AF</given-names></name>, <name name-style="western"><surname>Van Meir</surname><given-names>EG</given-names></name>, <name name-style="western"><surname>Vertino</surname><given-names>PM</given-names></name>, <name name-style="western"><surname>Devine</surname><given-names>SE</given-names></name></person-group>
<year>2010</year>
<article-title>Natural mutagenesis of human genomes by endogenous retrotransposons</article-title>. <source/>Cell
<volume>141</volume>, <fpage>1253</fpage>–<lpage>1261</lpage>. (<pub-id pub-id-type="doi">10.1016/j.cell.2010.05.020</pub-id>)<pub-id pub-id-type="pmid">20603005</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C66">
<label>66</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Scott</surname><given-names>EC</given-names></name>, <name name-style="western"><surname>Devine</surname><given-names>SE</given-names></name></person-group>
<year>2017</year>
<article-title>The role of somatic L1 retrotransposition in human cancers</article-title>. <source/>Viruses
<volume>9</volume>, <fpage>131</fpage> (<pub-id pub-id-type="doi">10.3390/v9060131</pub-id>)</mixed-citation>
</ref>
<ref id="RSOB180074C67">
<label>67</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van den Hurk</surname><given-names>JAJM</given-names></name><etal>et al.</etal></person-group>
<year>2007</year>
<article-title>L1 retrotransposition can occur early in human embryonic development</article-title>. <source/>Hum. Mol. Genet.
<volume>16</volume>, <fpage>1587</fpage>–<lpage>1592</lpage>. (<pub-id pub-id-type="doi">10.1093/hmg/ddm108</pub-id>)<pub-id pub-id-type="pmid">17483097</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C68">
<label>68</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Miki</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Nishisho</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Horii</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Miyoshi</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Utsunomiya</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Kinzler</surname><given-names>KW</given-names></name>, <name name-style="western"><surname>Vogelstein</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Nakamura</surname><given-names>Y</given-names></name></person-group>
<year>1992</year>
<article-title>Disruption of the APC gene by a retrotransposal insertion of L1 sequence in a colon cancer</article-title>. <source/>Cancer Res.
<volume>52</volume>, <fpage>643</fpage>–<lpage>645</lpage>.<pub-id pub-id-type="pmid">1310068</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C69">
<label>69</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brouha</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Meischl</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Ostertag</surname><given-names>E</given-names></name>, <name name-style="western"><surname>de Boer</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Neijens</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Roos</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Kazazian</surname><given-names>HH</given-names></name></person-group>
<year>2002</year>
<article-title>Evidence consistent with human L1 retrotransposition in maternal meiosis I</article-title>. <source/>Am. J. Hum. Genet.
<volume>71</volume>, <fpage>327</fpage>–<lpage>336</lpage>. (<pub-id pub-id-type="doi">10.1086/341722</pub-id>)<pub-id pub-id-type="pmid">12094329</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C70">
<label>70</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ostertag</surname><given-names>EM</given-names></name>, <name name-style="western"><surname>Prak</surname><given-names>ET</given-names></name>, <name name-style="western"><surname>DeBerardinis</surname><given-names>RJ</given-names></name>, <name name-style="western"><surname>Moran</surname><given-names>JV</given-names></name>, <name name-style="western"><surname>Kazazian</surname><given-names>HH</given-names></name></person-group>
<year>2000</year>
<article-title>Determination of L1 retrotransposition kinetics in cultured cells</article-title>. <source/>Nucleic Acids Res.
<volume>28</volume>, <fpage>1418</fpage>–<lpage>1423</lpage>. (<pub-id pub-id-type="doi">10.1093/nar/28.6.1418</pub-id>)<pub-id pub-id-type="pmid">10684937</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C71">
<label>71</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ostertag</surname><given-names>EM</given-names></name>, <name name-style="western"><surname>DeBerardinis</surname><given-names>RJ</given-names></name>, <name name-style="western"><surname>Goodier</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Gerton</surname><given-names>GL</given-names></name>, <name name-style="western"><surname>Kazazian</surname><given-names>HH</given-names></name></person-group>
<year>2002</year>
<article-title>A mouse model of human L1 retrotransposition</article-title>. <source/>Nat. Genet.
<volume>32</volume>, <fpage>655</fpage>–<lpage>660</lpage>. (<pub-id pub-id-type="doi">10.1038/ng1022</pub-id>)<pub-id pub-id-type="pmid">12415270</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C72">
<label>72</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Muotri</surname><given-names>AR</given-names></name>, <name name-style="western"><surname>Chu</surname><given-names>VT</given-names></name>, <name name-style="western"><surname>Marchetto</surname><given-names>MCN</given-names></name>, <name name-style="western"><surname>Deng</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Moran</surname><given-names>JV</given-names></name>, <name name-style="western"><surname>Gage</surname><given-names>FH</given-names></name></person-group>
<year>2005</year>
<article-title>Somatic mosaicism in neuronal precursor cells mediated by L1 retrotransposition</article-title>. <source/>Nature
<volume>435</volume>, <fpage>903</fpage>–<lpage>910</lpage>. (<pub-id pub-id-type="doi">10.1038/nature03663</pub-id>)<pub-id pub-id-type="pmid">15959507</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C73">
<label>73</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kuwabara</surname><given-names>T</given-names></name><etal>et al.</etal></person-group>
<year>2009</year>
<article-title>Wnt-mediated activation of NeuroD1 and retro-elements during adult neurogenesis</article-title>. <source/>Nat. Neurosci.
<volume>12</volume>, <fpage>1097</fpage>–<lpage>1105</lpage>. (<pub-id pub-id-type="doi">10.1038/nn.2360</pub-id>)<pub-id pub-id-type="pmid">19701198</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C74">
<label>74</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Muotri</surname><given-names>AR</given-names></name>, <name name-style="western"><surname>Marchetto</surname><given-names>MCN</given-names></name>, <name name-style="western"><surname>Coufal</surname><given-names>NG</given-names></name>, <name name-style="western"><surname>Oefner</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Yeo</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Nakashima</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Gage</surname><given-names>FH</given-names></name></person-group>
<year>2010</year>
<article-title>L1 retrotransposition in neurons is modulated by MeCP2</article-title>. <source/>Nature
<volume>468</volume>, <fpage>443</fpage>–<lpage>446</lpage>. (<pub-id pub-id-type="doi">10.1038/nature09544</pub-id>)<pub-id pub-id-type="pmid">21085180</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C75">
<label>75</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Savell</surname><given-names>KE</given-names></name>, <name name-style="western"><surname>Day</surname><given-names>JJ</given-names></name></person-group>
<year>2017</year>
<article-title>Applications of CRISPR/Cas9 in the mammalian central nervous system</article-title>. <source/>Yale J. Biol. Med.
<volume>90</volume>, <fpage>567</fpage>–<lpage>581</lpage>.<pub-id pub-id-type="pmid">29259522</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C76">
<label>76</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Coufal</surname><given-names>NG</given-names></name><etal>et al.</etal></person-group>
<year>2009</year>
<article-title>L1 retrotransposition in human neural progenitor cells</article-title>. <source/>Nature
<volume>460</volume>, <fpage>1127</fpage>–<lpage>1158</lpage>. (<pub-id pub-id-type="doi">10.1038/nature08248</pub-id>)<pub-id pub-id-type="pmid">19657334</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C77">
<label>77</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Goodier</surname><given-names>JL</given-names></name></person-group>
<year>2014</year>
<article-title>Retrotransposition in tumors and brains</article-title>. <source/>Mob. DNA
<volume>5</volume>, <fpage>11</fpage> (<pub-id pub-id-type="doi">10.1186/1759-8753-5-11</pub-id>)<pub-id pub-id-type="pmid">24708615</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C78">
<label>78</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Newkirk</surname><given-names>SJ</given-names></name><etal>et al.</etal></person-group>
<year>2017</year>
<article-title>Intact piRNA pathway prevents L1 mobilization in male meiosis</article-title>. <source/>Proc. Natl Acad. Sci. USA
<volume>114</volume>, <fpage>E5635</fpage>–<lpage>E5644</lpage>. (<pub-id pub-id-type="doi">10.1073/pnas.1701069114</pub-id>)<pub-id pub-id-type="pmid">28630288</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C79">
<label>79</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bedrosian</surname><given-names>TA</given-names></name>, <name name-style="western"><surname>Quayle</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Novaresi</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Gage</surname><given-names>FH</given-names></name></person-group>
<year>2018</year>
<article-title>Early life experience drives structural variation of neural genomes in mice</article-title>. <source/>Science
<volume>359</volume>, <fpage>1395</fpage>–<lpage>1399</lpage>. (<pub-id pub-id-type="doi">10.1126/science.aah3378</pub-id>)<pub-id pub-id-type="pmid">29567711</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C80">
<label>80</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kurnosov</surname><given-names>AA</given-names></name><etal>et al.</etal></person-group>
<year>2015</year>
<article-title>The evidence for increased L1 activity in the site of human adult brain neurogenesis</article-title>. <source/>PLoS ONE
<volume>10</volume>, <fpage>e0117854</fpage> (<pub-id pub-id-type="doi">10.1371/journal.pone.0117854</pub-id>)<pub-id pub-id-type="pmid">25689626</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C81">
<label>81</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sanchez-Luque</surname><given-names>FJ</given-names></name>, <name name-style="western"><surname>Richardson</surname><given-names>SR</given-names></name>, <name name-style="western"><surname>Faulkner</surname><given-names>GJ</given-names></name></person-group>
<year>2016</year>
<article-title>Retrotransposon capture sequencing (RC-Seq): a targeted, high-throughput approach to resolve somatic L1 retrotransposition in humans</article-title>. <source/>Methods Mol. Biol.
<volume>1400</volume>, <fpage>47</fpage>–<lpage>77</lpage>. (<pub-id pub-id-type="doi">10.1007/978-1-4939-3372-3_4</pub-id>)<pub-id pub-id-type="pmid">26895046</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C82">
<label>82</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Richardson</surname><given-names>SR</given-names></name>, <name name-style="western"><surname>Morell</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Faulkner</surname><given-names>GJ</given-names></name></person-group>
<year>2014</year>
<article-title>L1 Retrotransposons and somatic mosaicism in the brain</article-title>. <source/>Annu. Rev. Genet.
<volume>48</volume>, <fpage>1</fpage>–<lpage>27</lpage>. (<pub-id pub-id-type="doi">10.1146/annurev-genet-120213-092412</pub-id>)<pub-id pub-id-type="pmid">25036377</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C83">
<label>83</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Faulkner</surname><given-names>GJ</given-names></name>, <name name-style="western"><surname>Garcia-Perez</surname><given-names>JL</given-names></name></person-group>
<year>2017</year>
<article-title>L1 mosaicism in mammals: extent, effects, and evolution</article-title>. <source/>Trends Genet.
<volume>33</volume>, <fpage>802</fpage>–<lpage>816</lpage>. (<pub-id pub-id-type="doi">10.1016/j.tig.2017.07.004</pub-id>)<pub-id pub-id-type="pmid">28797643</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C84">
<label>84</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Azzarelli</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Hardwick</surname><given-names>LJA</given-names></name>, <name name-style="western"><surname>Philpott</surname><given-names>A</given-names></name></person-group>
<year>2015</year>
<article-title>Emergence of neuronal diversity from patterning of telencephalic progenitors</article-title>. <source/>Wiley Interdiscip. Rev. Dev. Biol.
<volume>4</volume>, <fpage>197</fpage>–<lpage>214</lpage>. (<pub-id pub-id-type="doi">10.1002/wdev.174</pub-id>)<pub-id pub-id-type="pmid">25619507</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C85">
<label>85</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gao</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Sultan</surname><given-names>KT</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>XJ</given-names></name>, <name name-style="western"><surname>Shi</surname><given-names>SH</given-names></name></person-group>
<year>2013</year>
<article-title>Lineage-dependent circuit assembly in the neocortex</article-title>. <source/>Development
<volume>140</volume>, <fpage>2645</fpage>–<lpage>2655</lpage>. (<pub-id pub-id-type="doi">10.1242/dev.087668</pub-id>)<pub-id pub-id-type="pmid">23757410</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C86">
<label>86</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Eriksson</surname><given-names>PS</given-names></name>, <name name-style="western"><surname>Perfilieva</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Björk-Eriksson</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Alborn</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Nordborg</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Peterson</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Gage</surname><given-names>FH</given-names></name></person-group>
<year>1998</year>
<article-title>Neurogenesis in the adult human hippocampus</article-title>. <source/>Nat. Med.
<volume>4</volume>, <fpage>1313</fpage>–<lpage>1317</lpage>. (<pub-id pub-id-type="doi">10.1038/3305</pub-id>)<pub-id pub-id-type="pmid">9809557</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C87">
<label>87</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jhaveri</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Tedoldi</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Hunt</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Sullivan</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Watts</surname><given-names>NR</given-names></name>, <name name-style="western"><surname>Power</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Bartlett</surname><given-names>PF</given-names></name>, <name name-style="western"><surname>Sah</surname><given-names>P</given-names></name></person-group>
<year>2018</year>
<article-title>Evidence for newly generated interneurons in the basolateral amygdala of adult mice</article-title>. <source/>Mol. Psychiatry
<volume>23</volume>, <fpage>521</fpage>–<lpage>532</lpage>. (<pub-id pub-id-type="doi">10.1038/mp.2017.134</pub-id>)<pub-id pub-id-type="pmid">28809399</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C88">
<label>88</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Spalding</surname><given-names>KL</given-names></name><etal>et al.</etal></person-group>
<year>2013</year>
<article-title>Dynamics of hippocampal neurogenesis in adult humans</article-title>. <source/>Cell
<volume>153</volume>, <fpage>1219</fpage>–<lpage>1227</lpage>. (<pub-id pub-id-type="doi">10.1016/j.cell.2013.05.002</pub-id>)<pub-id pub-id-type="pmid">23746839</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C89">
<label>89</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kubo</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Seleme</surname><given-names>MDC</given-names></name>, <name name-style="western"><surname>Soifer</surname><given-names>HS</given-names></name>, <name name-style="western"><surname>Perez</surname><given-names>JLG</given-names></name>, <name name-style="western"><surname>Moran</surname><given-names>JV</given-names></name>, <name name-style="western"><surname>Kazazian</surname><given-names>HH</given-names></name>, <name name-style="western"><surname>Kasahara</surname><given-names>N</given-names></name></person-group>
<year>2006</year>
<article-title>L1 retrotransposition in nondividing and primary human somatic cells</article-title>. <source/>Proc. Natl Acad. Sci. USA
<volume>103</volume>, <fpage>8036</fpage>–<lpage>8041</lpage>. (<pub-id pub-id-type="doi">10.1073/pnas.0601954103</pub-id>)<pub-id pub-id-type="pmid">16698926</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C90">
<label>90</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shi</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Seluanov</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Gorbunova</surname><given-names>V</given-names></name></person-group>
<year>2007</year>
<article-title>Cell divisions are required for L1 retrotransposition</article-title>. <source/>Mol. Cell. Biol.
<volume>27</volume>, <fpage>1264</fpage>–<lpage>1270</lpage>. (<pub-id pub-id-type="doi">10.1128/MCB.01888-06</pub-id>)<pub-id pub-id-type="pmid">17145770</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C91">
<label>91</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xie</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Mates</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Ivics</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Izsvák</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Martin</surname><given-names>SL</given-names></name>, <name name-style="western"><surname>An</surname><given-names>W</given-names></name></person-group>
<year>2013</year>
<article-title>Cell division promotes efficient retrotransposition in a stable L1 reporter cell line</article-title>. <source/>Mob. DNA
<volume>4</volume>, <fpage>10</fpage> (<pub-id pub-id-type="doi">10.1186/1759-8753-4-10</pub-id>)<pub-id pub-id-type="pmid">23497436</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C92">
<label>92</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mita</surname><given-names>P</given-names></name><etal>et al.</etal></person-group>
<year>2018</year>
<article-title>LINE-1 protein localization and functional dynamics during the cell cycle</article-title>. <source/>Elife
<volume>7</volume>, <fpage>e30058</fpage> (<pub-id pub-id-type="doi">10.7554/eLife.30058</pub-id>)<pub-id pub-id-type="pmid">29309036</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C93">
<label>93</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gaspar-Maia</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Alajem</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Meshorer</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Ramalho-Santos</surname><given-names>M</given-names></name></person-group>
<year>2011</year>
<article-title>Open chromatin in pluripotency and reprogramming</article-title>. <source/>Nat. Rev. Mol. Cell Biol.
<volume>12</volume>, <fpage>36</fpage>–<lpage>47</lpage>. (<pub-id pub-id-type="doi">10.1038/nrm3036</pub-id>)<pub-id pub-id-type="pmid">21179060</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C94">
<label>94</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jachowicz</surname><given-names>JW</given-names></name>, <name name-style="western"><surname>Bing</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Pontabry</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Bošković</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Rando</surname><given-names>OJ</given-names></name>, <name name-style="western"><surname>Torres-Padilla</surname><given-names>M-E</given-names></name></person-group>
<year>2017</year>
<article-title>LINE-1 activation after fertilization regulates global chromatin accessibility in the early mouse embryo</article-title>. <source/>Nat. Genet.
<volume>49</volume>, <fpage>1502</fpage>–<lpage>1510</lpage>. (<pub-id pub-id-type="doi">10.1038/ng.3945</pub-id>)<pub-id pub-id-type="pmid">28846101</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C95">
<label>95</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sen</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Ghosal</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Das</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Balti</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Chakrabarti</surname><given-names>J</given-names></name></person-group>
<year>2014</year>
<article-title>Competing endogenous RNA: the key to posttranscriptional regulation</article-title>. <source/>Sci. World J.
<volume>2014</volume>, <fpage>896206</fpage> (<pub-id pub-id-type="doi">10.1155/2014/896206</pub-id>)</mixed-citation>
</ref>
<ref id="RSOB180074C96">
<label>96</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barbash</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Simchovitz</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Buchman</surname><given-names>AS</given-names></name>, <name name-style="western"><surname>Bennett</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Shifman</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Soreq</surname><given-names>H</given-names></name></person-group>
<year>2017</year>
<article-title>Neuronal-expressed microRNA-targeted pseudogenes compete with coding genes in the human brain</article-title>. <source/>Transl. Psychiatry
<volume>7</volume>, <fpage>e1199</fpage> (<pub-id pub-id-type="doi">10.1038/tp.2017.163</pub-id>)<pub-id pub-id-type="pmid">28786976</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C97">
<label>97</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chan</surname><given-names>W-L</given-names></name>, <name name-style="western"><surname>Chang</surname><given-names>J-G</given-names></name></person-group>
<year>2014</year>
<article-title>Pseudogene-derived endogenous siRNAs and their function</article-title>. <source/>Methods Mol. Biol.
<volume>1167</volume>, <fpage>227</fpage>–<lpage>239</lpage>. (<pub-id pub-id-type="doi">10.1007/978-1-4939-0835-6_15</pub-id>)<pub-id pub-id-type="pmid">24823781</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C98">
<label>98</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Muotri</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Marchetto</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Gage</surname><given-names>F</given-names></name></person-group>
<year>2009</year>
<article-title>Environmental influence on L1 retrotransposon in the adult hippocampus</article-title>. <source/>Hippocampus
<volume>19</volume>, <fpage>1002</fpage>–<lpage>1007</lpage>. (<pub-id pub-id-type="doi">10.1002/hipo.20564</pub-id>)<pub-id pub-id-type="pmid">19771587</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C99">
<label>99</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Han</surname><given-names>JS</given-names></name>, <name name-style="western"><surname>Szak</surname><given-names>ST</given-names></name>, <name name-style="western"><surname>Boeke</surname><given-names>JD</given-names></name></person-group>
<year>2004</year>
<article-title>Transcriptional disruption by the L1 retrotransposon and implications for mammalian transcriptomes</article-title>. <source/>Nature
<volume>429</volume>, <fpage>268</fpage>–<lpage>274</lpage>. (<pub-id pub-id-type="doi">10.1038/nature02536</pub-id>)<pub-id pub-id-type="pmid">15152245</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C100">
<label>100</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shukla</surname><given-names>R</given-names></name><etal>et al.</etal></person-group>
<year>2013</year>
<article-title>Endogenous retrotransposition activates oncogenic pathways in hepatocellular carcinoma</article-title>. <source/>Cell
<volume>153</volume>, <fpage>101</fpage>–<lpage>111</lpage>. (<pub-id pub-id-type="doi">10.1016/j.cell.2013.02.032</pub-id>)<pub-id pub-id-type="pmid">23540693</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C101">
<label>101</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aneichyk</surname><given-names>T</given-names></name><etal>et al.</etal></person-group>
<year>2018</year>
<article-title>Dissecting the causal mechanism of X-Linked dystonia-parkinsonism by integrating genome and transcriptome assembly</article-title>. <source/>Cell
<volume>172</volume>, <fpage>897</fpage>–<lpage>909.e21</lpage>. (<pub-id pub-id-type="doi">10.1016/j.cell.2018.02.011</pub-id>)<pub-id pub-id-type="pmid">29474918</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C102">
<label>102</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bragg</surname><given-names>DC</given-names></name><etal>et al.</etal></person-group>
<year>2017</year>
<article-title>Disease onset in X-linked dystonia-parkinsonism correlates with expansion of a hexameric repeat within an SVA retrotransposon in TAF1</article-title>. <source/>Proc. Natl Acad. Sci. USA
<volume>114</volume>, <fpage>E11020</fpage>–<lpage>E11028</lpage>. (<pub-id pub-id-type="doi">10.1073/pnas.1712526114</pub-id>)<pub-id pub-id-type="pmid">29229810</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C103">
<label>103</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ito</surname><given-names>N</given-names></name><etal>et al.</etal></person-group>
<year>2016</year>
<article-title>Decreased N-TAF1 expression in X-linked dystonia-parkinsonism patient-specific neural stem cells</article-title>. <source/>Dis. Model. Mech.
<volume>9</volume>, <fpage>451</fpage>–<lpage>462</lpage>. (<pub-id pub-id-type="doi">10.1242/dmm.022590</pub-id>)<pub-id pub-id-type="pmid">26769797</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C104">
<label>104</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lavie</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Maldener</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Brouha</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Meese</surname><given-names>EU</given-names></name>, <name name-style="western"><surname>Mayer</surname><given-names>J</given-names></name></person-group>
<year>2004</year>
<article-title>The human L1 promoter: variable transcription initiation sites and a major impact of upstream flanking sequence on promoter activity</article-title>. <source/>Genome Res.
<volume>14</volume>, <fpage>2253</fpage>–<lpage>2260</lpage>. (<pub-id pub-id-type="doi">10.1101/gr.2745804</pub-id>)<pub-id pub-id-type="pmid">15520289</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C105">
<label>105</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Philippe</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Vargas-Landin</surname><given-names>DB</given-names></name>, <name name-style="western"><surname>Doucet</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>van Essen</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Vera-Otarola</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Kuciak</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Corbin</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Nigumann</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Cristofari</surname><given-names>G</given-names></name></person-group>
<year>2016</year>
<article-title>Activation of individual L1 retrotransposon instances is restricted to cell-type dependent permissive loci</article-title>. <source/>Elife
<volume>5</volume>, e13926. (<pub-id pub-id-type="doi">10.7554/eLife.13926</pub-id>)</mixed-citation>
</ref>
<ref id="RSOB180074C106">
<label>106</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hancks</surname><given-names>DC</given-names></name>, <name name-style="western"><surname>Kazazian</surname><given-names>HH</given-names></name></person-group>
<year>2016</year>
<article-title>Roles for retrotransposon insertions in human disease</article-title>. <source/>Mob. DNA
<volume>7</volume>, <fpage>9</fpage> (<pub-id pub-id-type="doi">10.1186/s13100-016-0065-9</pub-id>)<pub-id pub-id-type="pmid">27158268</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C107">
<label>107</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chuong</surname><given-names>EB</given-names></name>, <name name-style="western"><surname>Elde</surname><given-names>NC</given-names></name>, <name name-style="western"><surname>Feschotte</surname><given-names>C</given-names></name></person-group>
<year>2017</year>
<article-title>Regulatory activities of transposable elements: from conflicts to benefits</article-title>. <source/>Nat. Rev. Genet.
<volume>18</volume>, <fpage>71</fpage>–<lpage>86</lpage>. (<pub-id pub-id-type="doi">10.1038/nrg.2016.139</pub-id>)<pub-id pub-id-type="pmid">27867194</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C108">
<label>108</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Levin</surname><given-names>HL</given-names></name>, <name name-style="western"><surname>Moran</surname><given-names>JV</given-names></name></person-group>
<year>2011</year>
<article-title>Dynamic interactions between transposable elements and their hosts</article-title>. <source/>Nat. Rev. Genet.
<volume>12</volume>, <fpage>615</fpage>–<lpage>627</lpage>. (<pub-id pub-id-type="doi">10.1038/nrg3030</pub-id>)<pub-id pub-id-type="pmid">21850042</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C109">
<label>109</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gilbert</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Lutz-Prigge</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Moran</surname><given-names>JV</given-names></name></person-group>
<year>2002</year>
<article-title>Genomic deletions created upon LINE-1 retrotransposition</article-title>. <source/>Cell
<volume>110</volume>, <fpage>315</fpage>–<lpage>325</lpage>. (<pub-id pub-id-type="doi">10.1055/s-2008-1033461</pub-id>)<pub-id pub-id-type="pmid">12176319</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C110">
<label>110</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Miné</surname><given-names>M</given-names></name><etal>et al.</etal></person-group>
<year>2007</year>
<article-title>A large genomic deletion in the PDHX gene caused by the retrotranspositional insertion of a full-length LINE-1 element</article-title>. <source/>Hum. Mutat.
<volume>28</volume>, <fpage>137</fpage>–<lpage>142</lpage>. (<pub-id pub-id-type="doi">10.1002/humu.20449</pub-id>)<pub-id pub-id-type="pmid">17152059</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C111">
<label>111</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moran</surname><given-names>JV</given-names></name>, <name name-style="western"><surname>DeBerardinis</surname><given-names>RJ</given-names></name>, <name name-style="western"><surname>Kazazian</surname><given-names>HH</given-names></name></person-group>
<year>1999</year>
<article-title>Exon shuffling by L1 retrotransposition</article-title>. <source/>Science
<volume>283</volume>, <fpage>1530</fpage>–<lpage>1534</lpage>. (<pub-id pub-id-type="doi">10.1126/science.283.5407.1530</pub-id>)<pub-id pub-id-type="pmid">10066175</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C112">
<label>112</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xing</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Witherspoon</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Ray</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Batzer</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Jorde</surname><given-names>LB</given-names></name></person-group>
<year>2007</year>
<article-title>Mobile DNA elements in primate and human evolution</article-title>. <source/>Am. J. Phys. Anthropol.
<volume>134</volume>, <fpage>2</fpage>–<lpage>19</lpage>. (<pub-id pub-id-type="doi">10.1002/ajpa.20722</pub-id>)</mixed-citation>
</ref>
<ref id="RSOB180074C113">
<label>113</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Perepelitsa-Belancio</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Deininger</surname><given-names>P</given-names></name></person-group>
<year>2003</year>
<article-title>RNA truncation by premature polyadenylation attenuates human mobile element activity</article-title>. <source/>Nat. Genet.
<volume>35</volume>, <fpage>363</fpage>–<lpage>366</lpage>. (<pub-id pub-id-type="doi">10.1038/ng1269</pub-id>)<pub-id pub-id-type="pmid">14625551</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C114">
<label>114</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mätlik</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Redik</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Speek</surname><given-names>M</given-names></name></person-group>
<year>2006</year>
<article-title>L1 antisense promoter drives tissue-specific transcription of human genes</article-title>. <source/>J. Biomed. Biotechnol.
<volume>2006</volume>, <fpage>71753</fpage> (<pub-id pub-id-type="doi">10.1155/JBB/2006/71753</pub-id>)<pub-id pub-id-type="pmid">16877819</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C115">
<label>115</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Faulkner</surname><given-names>GJ</given-names></name><etal>et al.</etal></person-group>
<year>2009</year>
<article-title>The regulated retrotransposon transcriptome of mammalian cells</article-title>. <source/>Nat. Genet.
<volume>41</volume>, <fpage>563</fpage>–<lpage>571</lpage>. (<pub-id pub-id-type="doi">10.1038/ng.368</pub-id>)<pub-id pub-id-type="pmid">19377475</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C116">
<label>116</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Speek</surname><given-names>M</given-names></name></person-group>
<year>2001</year>
<article-title>Antisense promoter of human L1 retrotransposon drives transcription of adjacent cellular genes</article-title>. <source/>Mol. Cell. Biol.
<volume>21</volume>, <fpage>1973</fpage>–<lpage>1985</lpage>. (<pub-id pub-id-type="doi">10.1128/MCB.21.6.1973-1985.2001</pub-id>)<pub-id pub-id-type="pmid">11238933</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C117">
<label>117</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Narita</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Nishio</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Kitoh</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Ishikawa</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Ishikawa</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Minami</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Nakamura</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Matsuo</surname><given-names>M</given-names></name></person-group>
<year>1993</year>
<article-title>Insertion of a 5′ truncated L1 element into the 3′ end of exon 44 of the dystrophin gene resulted in skipping of the exon during splicing in a case of Duchenne muscular dystrophy</article-title>. <source/>J. Clin. Invest.
<volume>91</volume>, <fpage>1862</fpage>–<lpage>1867</lpage>. (<pub-id pub-id-type="doi">10.1172/JCI116402</pub-id>)<pub-id pub-id-type="pmid">8387534</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C118">
<label>118</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mülhardt</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Fischer</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Gass</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Simon-Chazottes</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Guenet</surname><given-names>J-L</given-names></name>, <name name-style="western"><surname>Kuhse</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Betz</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Becker</surname><given-names>C-M</given-names></name></person-group>
<year>1994</year>
<article-title>The spastic mouse: aberrant splicing of glycine receptor <italic>β</italic> subunit mRNA caused by intronic insertion of Ll element</article-title>. <source/>Neuron
<volume>13</volume>, <fpage>1003</fpage>–<lpage>1015</lpage>. (<pub-id pub-id-type="doi">10.1016/0896-6273(94)90265-8</pub-id>)<pub-id pub-id-type="pmid">7946325</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C119">
<label>119</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kingsmore</surname><given-names>SF</given-names></name>, <name name-style="western"><surname>Giros</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Suh</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Bieniarz</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Caron</surname><given-names>MG</given-names></name>, <name name-style="western"><surname>Seldin</surname><given-names>MF</given-names></name></person-group>
<year>1994</year>
<article-title>Glycine receptor beta-subunit gene mutation in spastic mouse associated with LINE-1 element insertion</article-title>. <source/>Nat. Genet.
<volume>7</volume>, <fpage>136</fpage>–<lpage>141</lpage>. (<pub-id pub-id-type="doi">10.1038/ng0694-136</pub-id>)<pub-id pub-id-type="pmid">7920630</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C120">
<label>120</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Takahara</surname><given-names>T</given-names></name><etal>et al.</etal></person-group>
<year>1996</year>
<article-title>Dysfunction of the Orleans reeler gene arising from exon skipping due to transposition of a full-length copy of an active L1 sequence into the skipped exon</article-title>. <source/>Hum. Mol. Genet.
<volume>5</volume>, <fpage>989</fpage>–<lpage>993</lpage>. (<pub-id pub-id-type="doi">10.1093/hmg/5.7.989</pub-id>)<pub-id pub-id-type="pmid">8817336</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C121">
<label>121</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kohrman</surname><given-names>DC</given-names></name>, <name name-style="western"><surname>Harris</surname><given-names>JB</given-names></name>, <name name-style="western"><surname>Meisler</surname><given-names>MH</given-names></name></person-group>
<year>1996</year>
<article-title>Mutation detection in the med and medJ alleles of the sodium channel Scn8a. Unusual splicing due to a minor class AT-AC intron</article-title>. <source/>J. Biol. Chem.
<volume>271</volume>, <fpage>17 576</fpage>–<lpage>17 581</lpage>. (<pub-id pub-id-type="doi">10.1074/jbc.271.29.17576</pub-id>)<pub-id pub-id-type="pmid">8550554</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C122">
<label>122</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>de Bergeyck</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Nakajima</surname><given-names>K</given-names></name>, <name name-style="western"><surname>de Rouvroit</surname><given-names>CL</given-names></name>, <name name-style="western"><surname>Naerhuyzen</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Goffinet</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Miyata</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Ogawa</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Mikoshiba</surname><given-names>K</given-names></name></person-group>
<year>1997</year>
<article-title>A truncated Reelin protein is produced but not secreted in the ‘Orleans’ reeler mutation (Relnrl-Orl)</article-title>. <source/>Mol. Brain Res.
<volume>50</volume>, <fpage>85</fpage>–<lpage>90</lpage>. (<pub-id pub-id-type="doi">10.1016/S0169-328X(97)00166-6</pub-id>)<pub-id pub-id-type="pmid">9406921</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C123">
<label>123</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>D'Arcangelo</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Miao</surname><given-names>GG</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>SC</given-names></name>, <name name-style="western"><surname>Soares</surname><given-names>HD</given-names></name>, <name name-style="western"><surname>Morgan</surname><given-names>JI</given-names></name>, <name name-style="western"><surname>Curran</surname><given-names>T</given-names></name></person-group>
<year>1995</year>
<article-title>A protein related to extracellular matrix proteins deleted in the mouse mutant reeler</article-title>. <source/>Nature
<volume>374</volume>, <fpage>719</fpage>–<lpage>723</lpage>. (<pub-id pub-id-type="doi">10.1038/374719a0</pub-id>)<pub-id pub-id-type="pmid">7715726</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C124">
<label>124</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chang</surname><given-names>BS</given-names></name><etal>et al.</etal></person-group>
<year>2007</year>
<article-title>The role of RELN in lissencephaly and neuropsychiatric disease</article-title>. <source/>Am. J. Med. Genet. B Neuropsychiatr. Genet.
<volume>144B</volume>, <fpage>58</fpage>–<lpage>63</lpage>. (<pub-id pub-id-type="doi">10.1002/ajmg.b.30392</pub-id>)<pub-id pub-id-type="pmid">16958033</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C125">
<label>125</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Macia</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Munoz-Lopez</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Cortes</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Hastings</surname><given-names>RK</given-names></name>, <name name-style="western"><surname>Morell</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Lucena-Aguilar</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Marchal</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Badge</surname><given-names>RM</given-names></name>, <name name-style="western"><surname>Garcia-Perez</surname><given-names>JL</given-names></name></person-group>
<year>2011</year>
<article-title>Epigenetic control of retrotransposon expression in human embryonic stem cells</article-title>. <source/>Mol. Cell. Biol.
<volume>31</volume>, <fpage>300</fpage>–<lpage>316</lpage>. (<pub-id pub-id-type="doi">10.1128/MCB.00561-10</pub-id>)<pub-id pub-id-type="pmid">21041477</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C126">
<label>126</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Goodier</surname><given-names>JL</given-names></name></person-group>
<year>2016</year>
<article-title>Restricting retrotransposons: a review</article-title>. <source/>Mob. DNA
<volume>7</volume>, <fpage>16</fpage> (<pub-id pub-id-type="doi">10.1186/s13100-016-0070-z</pub-id>)<pub-id pub-id-type="pmid">27525044</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C127">
<label>127</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mortelmans</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Wang-Johanning</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Johanning</surname><given-names>GL</given-names></name></person-group>
<year>2016</year>
<article-title>The role of human endogenous retroviruses in brain development and function</article-title>. <source/>APMIS
<volume>124</volume>, <fpage>105</fpage>–<lpage>115</lpage>. (<pub-id pub-id-type="doi">10.1111/apm.12495</pub-id>)<pub-id pub-id-type="pmid">26818265</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C128">
<label>128</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jang</surname><given-names>HS</given-names></name>, <name name-style="western"><surname>Shin</surname><given-names>WJ</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Do</surname><given-names>JT</given-names></name></person-group>
<year>2017</year>
<article-title>CpG and non-CpG methylation in epigenetic gene regulation and brain function</article-title>. <source/>Genes
<volume>8</volume>, <fpage>148</fpage> (<pub-id pub-id-type="doi">10.3390/genes8060148</pub-id>)</mixed-citation>
</ref>
<ref id="RSOB180074C129">
<label>129</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kozlenkov</surname><given-names>A</given-names></name><etal>et al.</etal></person-group>
<year>2016</year>
<article-title>Substantial DNA methylation differences between two major neuronal subtypes in human brain</article-title>. <source/>Nucleic Acids Res.
<volume>44</volume>, <fpage>2593</fpage>–<lpage>2612</lpage>. (<pub-id pub-id-type="doi">10.1093/nar/gkv1304</pub-id>)<pub-id pub-id-type="pmid">26612861</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C130">
<label>130</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hata</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Sakaki</surname><given-names>Y</given-names></name></person-group>
<year>1997</year>
<article-title>Identification of critical CpG sites for repression of L1 transcription by DNA methylation</article-title>. <source/>Gene
<volume>189</volume>, <fpage>227</fpage>–<lpage>234</lpage>. (<pub-id pub-id-type="doi">10.1016/S0378-1119(96)00856-6</pub-id>)<pub-id pub-id-type="pmid">9168132</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C131">
<label>131</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Murata</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Bundo</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Ueda</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Kubota-Sakashita</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Kasai</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Kato</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Iwamoto</surname><given-names>K</given-names></name></person-group>
<year>2017</year>
<article-title>DNA methylation and hydroxymethylation analyses of the active LINE-1 subfamilies in mice</article-title>. <source/>Sci. Rep.
<volume>7</volume>, <fpage>13624</fpage> (<pub-id pub-id-type="doi">10.1038/s41598-017-14165-7</pub-id>)<pub-id pub-id-type="pmid">29051587</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C132">
<label>132</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fuks</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Hurd</surname><given-names>PJ</given-names></name>, <name name-style="western"><surname>Wolf</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Nan</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Bird</surname><given-names>AP</given-names></name>, <name name-style="western"><surname>Kouzarides</surname><given-names>T</given-names></name></person-group>
<year>2003</year>
<article-title>The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation</article-title>. <source/>J. Biol. Chem.
<volume>278</volume>, <fpage>4035</fpage>–<lpage>4040</lpage>. (<pub-id pub-id-type="doi">10.1074/jbc.M210256200</pub-id>)<pub-id pub-id-type="pmid">12427740</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C133">
<label>133</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nan</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Ng</surname><given-names>HH</given-names></name>, <name name-style="western"><surname>Johnson</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Laherty</surname><given-names>CD</given-names></name>, <name name-style="western"><surname>Turner</surname><given-names>BM</given-names></name>, <name name-style="western"><surname>Eisenman</surname><given-names>RN</given-names></name>, <name name-style="western"><surname>Bird</surname><given-names>A</given-names></name></person-group>
<year>1998</year>
<article-title>Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex</article-title>. <source/>Nature
<volume>393</volume>, <fpage>386</fpage>–<lpage>389</lpage>. (<pub-id pub-id-type="doi">10.1038/30764</pub-id>)<pub-id pub-id-type="pmid">9620804</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C134">
<label>134</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lewis</surname><given-names>JD</given-names></name>, <name name-style="western"><surname>Meehan</surname><given-names>RR</given-names></name>, <name name-style="western"><surname>Henzel</surname><given-names>WJ</given-names></name>, <name name-style="western"><surname>Maurer-Fogy</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Jeppesen</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Klein</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Bird</surname><given-names>A</given-names></name></person-group>
<year>1992</year>
<article-title>Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA</article-title>. <source/>Cell
<volume>69</volume>, <fpage>905</fpage>–<lpage>914</lpage>. (<pub-id pub-id-type="doi">10.1016/0092-8674(92)90610-O</pub-id>)<pub-id pub-id-type="pmid">1606614</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C135">
<label>135</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Zingler</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Schumann</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Strätling</surname><given-names>WH</given-names></name></person-group>
<year>2001</year>
<article-title>Methyl-CpG-binding protein 2 represses LINE-1 expression and retrotransposition but not Alu transcription</article-title>. <source/>Nucleic Acids Res.
<volume>29</volume>, <fpage>4493</fpage>–<lpage>4501</lpage>. (<pub-id pub-id-type="doi">10.1093/nar/29.21.4493</pub-id>)<pub-id pub-id-type="pmid">11691937</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C136">
<label>136</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lennartsson</surname><given-names>A</given-names></name><etal>et al.</etal></person-group>
<year>2015</year>
<article-title>Remodeling of retrotransposon elements during epigenetic induction of adult visual cortical plasticity by HDAC inhibitors</article-title>. <source/>Epigenetics Chromatin
<volume>8</volume>, <fpage>55</fpage> (<pub-id pub-id-type="doi">10.1186/s13072-015-0043-3</pub-id>)<pub-id pub-id-type="pmid">26673794</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C137">
<label>137</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Van Meter</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Kashyap</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Rezazadeh</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Geneva</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Morello</surname><given-names>TD</given-names></name>, <name name-style="western"><surname>Seluanov</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Gorbunova</surname><given-names>V</given-names></name></person-group>
<year>2014</year>
<article-title>SIRT6 represses LINE1 retrotransposons by ribosylating KAP1 but this repression fails with stress and age</article-title>. <source/>Nat. Commun.
<volume>5</volume>, <fpage>5011</fpage> (<pub-id pub-id-type="doi">10.1038/ncomms6011</pub-id>)<pub-id pub-id-type="pmid">25247314</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C138">
<label>138</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liao</surname><given-names>C-Y</given-names></name>, <name name-style="western"><surname>Kennedy</surname><given-names>BK</given-names></name></person-group>
<year>2016</year>
<article-title>SIRT6, oxidative stress and aging</article-title>. <source/>Cell Res.
<volume>26</volume>, <fpage>143</fpage>–<lpage>144</lpage>. (<pub-id pub-id-type="doi">10.1038/cr.2016.8</pub-id>)<pub-id pub-id-type="pmid">26780861</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C139">
<label>139</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Takasaki</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Kurokawa</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Nakayama</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Nakayama</surname><given-names>J-I</given-names></name>, <name name-style="western"><surname>Aizawa</surname><given-names>S</given-names></name></person-group>
<year>2007</year>
<article-title>Acetylated YY1 regulates Otx2 expression in anterior neuroectoderm at two cis-sites 90 kb apart</article-title>. <source/>EMBO J.
<volume>26</volume>, <fpage>1649</fpage>–<lpage>1659</lpage>. (<pub-id pub-id-type="doi">10.1038/sj.emboj.7601619</pub-id>)<pub-id pub-id-type="pmid">17332747</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C140">
<label>140</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kwon</surname><given-names>H-J</given-names></name>, <name name-style="western"><surname>Chung</surname><given-names>H-M</given-names></name></person-group>
<year>2003</year>
<article-title>Yin Yang 1, a vertebrate polycomb group gene, regulates antero-posterior neural patterning</article-title>. <source/>Biochem. Biophys. Res. Commun.
<volume>306</volume>, <fpage>1008</fpage>–<lpage>1013</lpage>. (<pub-id pub-id-type="doi">10.1016/S0006-291X(03)01071-4</pub-id>)<pub-id pub-id-type="pmid">12821143</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C141">
<label>141</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rylski</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Amborska</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Zybura</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Konopacki</surname><given-names>FA</given-names></name>, <name name-style="western"><surname>Wilczynski</surname><given-names>GM</given-names></name>, <name name-style="western"><surname>Kaczmarek</surname><given-names>L</given-names></name></person-group>
<year>2008</year>
<article-title>Yin Yang 1 expression in the adult rodent brain</article-title>. <source/>Neurochem. Res.
<volume>33</volume>, <fpage>2556</fpage>–<lpage>2564</lpage>. (<pub-id pub-id-type="doi">10.1007/s11064-008-9757-y</pub-id>)<pub-id pub-id-type="pmid">18584324</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C142">
<label>142</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Becker</surname><given-names>KG</given-names></name>, <name name-style="western"><surname>Swergold</surname><given-names>GD</given-names></name>, <name name-style="western"><surname>Ozato</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Thayer</surname><given-names>RE</given-names></name></person-group>
<year>1993</year>
<article-title>Binding of the ubiquitous nuclear transcription factor YY1 to a cis regulatory sequence in the human LINE-1 transposable element</article-title>. <source/>Hum. Mol. Genet.
<volume>2</volume>, <fpage>1697</fpage>–<lpage>1702</lpage>. (<pub-id pub-id-type="doi">10.1093/hmg/2.10.1697</pub-id>)<pub-id pub-id-type="pmid">8268924</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C143">
<label>143</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Athanikar</surname><given-names>JN</given-names></name>, <name name-style="western"><surname>Badge</surname><given-names>RM</given-names></name>, <name name-style="western"><surname>Moran</surname><given-names>JV</given-names></name></person-group>
<year>2004</year>
<article-title>A YY1-binding site is required for accurate human LINE-1 transcription initiation</article-title>. <source/>Nucleic Acids Res.
<volume>32</volume>, <fpage>3846</fpage>–<lpage>3855</lpage>. (<pub-id pub-id-type="doi">10.1093/nar/gkh698</pub-id>)<pub-id pub-id-type="pmid">15272086</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C144">
<label>144</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Kazazian</surname><given-names>HH</given-names></name></person-group>
<year>2003</year>
<article-title>An important role for RUNX3 in human L1 transcription and retrotransposition</article-title>. <source/>Nucleic Acids Res.
<volume>31</volume>, <fpage>4929</fpage>–<lpage>4940</lpage>. (<pub-id pub-id-type="doi">10.1093/nar/gkg663</pub-id>)<pub-id pub-id-type="pmid">12907736</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C145">
<label>145</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Inoue</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Shiga</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Ito</surname><given-names>Y</given-names></name></person-group>
<year>2008</year>
<article-title>Runx transcription factors in neuronal development</article-title>. <source/>Neural Dev.
<volume>3</volume>, <fpage>20</fpage> (<pub-id pub-id-type="doi">10.1186/1749-8104-3-20</pub-id>)<pub-id pub-id-type="pmid">18727821</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C146">
<label>146</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lallemend</surname><given-names>F</given-names></name><etal>et al.</etal></person-group>
<year>2012</year>
<article-title>Positional differences of axon growth rates between sensory neurons encoded by Runx3</article-title>. <source/>EMBO J.
<volume>31</volume>, <fpage>3718</fpage>–<lpage>3729</lpage>. (<pub-id pub-id-type="doi">10.1038/emboj.2012.228</pub-id>)<pub-id pub-id-type="pmid">22903063</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C147">
<label>147</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Graham</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Khudyakov</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Ellis</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Pevny</surname><given-names>L</given-names></name></person-group>
<year>2003</year>
<article-title>SOX2 functions to maintain neural progenitor identity</article-title>. <source/>Neuron
<volume>39</volume>, <fpage>749</fpage>–<lpage>765</lpage>. (<pub-id pub-id-type="doi">10.1016/S0896-6273(03)00497-5</pub-id>)<pub-id pub-id-type="pmid">12948443</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C148">
<label>148</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ring</surname><given-names>KL</given-names></name><etal>et al.</etal></person-group>
<year>2012</year>
<article-title>Direct reprogramming of mouse and human fibroblasts into multipotent neural stem cells with a single factor</article-title>. <source/>Cell Stem Cell
<volume>11</volume>, <fpage>100</fpage>–<lpage>109</lpage>. (<pub-id pub-id-type="doi">10.1016/j.stem.2012.05.018</pub-id>)<pub-id pub-id-type="pmid">22683203</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C149">
<label>149</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Heinrich</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Bergami</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Gascón</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Lepier</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Viganò</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Dimou</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Sutor</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Berninger</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Götz</surname><given-names>M</given-names></name></person-group>
<year>2014</year>
<article-title>Sox2-mediated conversion of NG2 glia into induced neurons in the injured adult cerebral cortex</article-title>. <source/>Stem Cell Rep.
<volume>3</volume>, <fpage>1000</fpage>–<lpage>1014</lpage>. (<pub-id pub-id-type="doi">10.1016/j.stemcr.2014.10.007</pub-id>)</mixed-citation>
</ref>
<ref id="RSOB180074C150">
<label>150</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tedeschi</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Di Giovanni</surname><given-names>S</given-names></name></person-group>
<year>2009</year>
<article-title>The non-apoptotic role of p53 in neuronal biology: enlightening the dark side of the moon</article-title>. <source/>EMBO Rep.
<volume>10</volume>, <fpage>576</fpage>–<lpage>583</lpage>. (<pub-id pub-id-type="doi">10.1038/embor.2009.89</pub-id>)<pub-id pub-id-type="pmid">19424293</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C151">
<label>151</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wylie</surname><given-names>A</given-names></name><etal>et al.</etal></person-group>
<year>2015</year>
<article-title>p53 genes function to restrain mobile elements</article-title>. <source/>Genes Dev.
<volume>30</volume>, <fpage>64</fpage>–<lpage>77</lpage>. (<pub-id pub-id-type="doi">10.1101/gad.266098.115</pub-id>)<pub-id pub-id-type="pmid">26701264</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C152">
<label>152</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Harris</surname><given-names>CR</given-names></name>, <name name-style="western"><surname>Dewan</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Zupnick</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Normart</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Gabriel</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Prives</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Levine</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Hoh</surname><given-names>J</given-names></name></person-group>
<year>2009</year>
<article-title>p53 responsive elements in human retrotransposons</article-title>. <source/>Oncogene
<volume>28</volume>, <fpage>3857</fpage>–<lpage>3865</lpage>. (<pub-id pub-id-type="doi">10.1038/onc.2009.246</pub-id>)<pub-id pub-id-type="pmid">19718052</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C153">
<label>153</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Garcia-Perez</surname><given-names>JL</given-names></name><etal>et al.</etal></person-group>
<year>2010</year>
<article-title>Epigenetic silencing of engineered L1 retrotransposition events in human embryonic carcinoma cells</article-title>. <source/>Nature
<volume>466</volume>, <fpage>769</fpage>–<lpage>773</lpage>. (<pub-id pub-id-type="doi">10.1038/nature09209</pub-id>)<pub-id pub-id-type="pmid">20686575</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C154">
<label>154</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ewing</surname><given-names>AD</given-names></name>, <name name-style="western"><surname>Kazazian</surname><given-names>HH</given-names></name></person-group>
<year>2011</year>
<article-title>Whole-genome resequencing allows detection of many rare LINE-1 insertion alleles in humans</article-title>. <source/>Genome Res.
<volume>21</volume>, <fpage>985</fpage>–<lpage>990</lpage>. (<pub-id pub-id-type="doi">10.1101/gr.114777.110</pub-id>)<pub-id pub-id-type="pmid">20980553</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C155">
<label>155</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Richardson</surname><given-names>SR</given-names></name>, <name name-style="western"><surname>Narvaiza</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Planegger</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Weitzman</surname><given-names>MD</given-names></name>, <name name-style="western"><surname>Moran</surname><given-names>JV</given-names></name></person-group>
<year>2014</year>
<article-title>APOBEC3A deaminates transiently exposed single-strand DNA during LINE-1 retrotransposition</article-title>. <source/>Elife
<volume>3</volume>, <fpage>e02008</fpage> (<pub-id pub-id-type="doi">10.7554/eLife.02008</pub-id>)<pub-id pub-id-type="pmid">24843014</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C156">
<label>156</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Buckley</surname><given-names>RM</given-names></name>, <name name-style="western"><surname>Kortschak</surname><given-names>RD</given-names></name>, <name name-style="western"><surname>Raison</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Adelson</surname><given-names>DL</given-names></name></person-group>
<year>2017</year>
<article-title>Similar evolutionary trajectories for retrotransposon accumulation in mammals</article-title>. <source/>Genome Biol. Evol.
<volume>9</volume>, <fpage>2336</fpage>–<lpage>2353</lpage>. (<pub-id pub-id-type="doi">10.1093/gbe/evx179</pub-id>)<pub-id pub-id-type="pmid">28945883</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C157">
<label>157</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>El-Sawy</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Kale</surname><given-names>SP</given-names></name>, <name name-style="western"><surname>Dugan</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Nguyen</surname><given-names>TQ</given-names></name>, <name name-style="western"><surname>Belancio</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Bruch</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Roy-Engel</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Deininger</surname><given-names>PL</given-names></name></person-group>
<year>2005</year>
<article-title>Nickel stimulates L1 retrotransposition by a post-transcriptional mechanism</article-title>. <source/>J. Mol. Biol.
<volume>354</volume>, <fpage>246</fpage>–<lpage>257</lpage>. (<pub-id pub-id-type="doi">10.1016/j.jmb.2005.09.050</pub-id>)<pub-id pub-id-type="pmid">16249005</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C158">
<label>158</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kale</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Carmichael</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Harris</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Roy-Engel</surname><given-names>A</given-names></name></person-group>
<year>2006</year>
<article-title>The L1 retrotranspositional stimulation by particulate and soluble cadmium exposure is independent of the generation of DNA breaks</article-title>. <source/>Int. J. Environ. Res. Public Health
<volume>3</volume>, <fpage>121</fpage>–<lpage>128</lpage>. (<pub-id pub-id-type="doi">10.3390/ijerph2006030015</pub-id>)<pub-id pub-id-type="pmid">16823085</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C159">
<label>159</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kale</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Moore</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Deininger</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Roy-Engel</surname><given-names>A</given-names></name></person-group>
<year>2005</year>
<article-title>Heavy metals stimulate human LINE-1 retrotransposition</article-title>. <source/>Int. J. Environ. Res. Public Health
<volume>2</volume>, <fpage>14</fpage>–<lpage>23</lpage>. (<pub-id pub-id-type="doi">10.3390/ijerph2005010014</pub-id>)<pub-id pub-id-type="pmid">16705797</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C160">
<label>160</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Giorgi</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Marcantonio</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Del Re</surname><given-names>B</given-names></name></person-group>
<year>2011</year>
<article-title>LINE-1 retrotransposition in human neuroblastoma cells is affected by oxidative stress</article-title>. <source/>Cell Tissue Res.
<volume>346</volume>, <fpage>383</fpage>–<lpage>391</lpage>. (<pub-id pub-id-type="doi">10.1007/s00441-011-1289-0</pub-id>)<pub-id pub-id-type="pmid">22160459</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C161">
<label>161</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stribinskis</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Ramos</surname><given-names>KS</given-names></name></person-group>
<year>2006</year>
<article-title>Activation of human long interspersed nuclear element 1 retrotransposition by benzo(a)pyrene, an ubiquitous environmental carcinogen</article-title>. <source/>Cancer Res.
<volume>66</volume>, <fpage>2616</fpage>–<lpage>2620</lpage>. (<pub-id pub-id-type="doi">10.1158/0008-5472.CAN-05-3478</pub-id>)<pub-id pub-id-type="pmid">16510580</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C162">
<label>162</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Morales</surname><given-names>JF</given-names></name>, <name name-style="western"><surname>Snow</surname><given-names>ET</given-names></name>, <name name-style="western"><surname>Murnane</surname><given-names>JP</given-names></name></person-group>
<year>2003</year>
<article-title>Environmental factors affecting transcription of the human L1 retrotransposon. II. Stressors</article-title>. <source/>Mutagenesis
<volume>18</volume>, <fpage>151</fpage>–<lpage>158</lpage>. (<pub-id pub-id-type="doi">10.1093/mutage/18.2.151</pub-id>)<pub-id pub-id-type="pmid">12621071</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C163">
<label>163</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Morrish</surname><given-names>TA</given-names></name>, <name name-style="western"><surname>Gilbert</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Myers</surname><given-names>JS</given-names></name>, <name name-style="western"><surname>Vincent</surname><given-names>BJ</given-names></name>, <name name-style="western"><surname>Stamato</surname><given-names>TD</given-names></name>, <name name-style="western"><surname>Taccioli</surname><given-names>GE</given-names></name>, <name name-style="western"><surname>Batzer</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Moran</surname><given-names>JV</given-names></name></person-group>
<year>2002</year>
<article-title>DNA repair mediated by endonuclease-independent LINE-1 retrotransposition</article-title>. <source/>Nat. Genet.
<volume>31</volume>, <fpage>159</fpage>–<lpage>165</lpage>. (<pub-id pub-id-type="doi">10.1038/ng898</pub-id>)<pub-id pub-id-type="pmid">12006980</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C164">
<label>164</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Farkash</surname><given-names>EA</given-names></name>, <name name-style="western"><surname>Kao</surname><given-names>GD</given-names></name>, <name name-style="western"><surname>Horman</surname><given-names>SR</given-names></name>, <name name-style="western"><surname>Prak</surname><given-names>ETL</given-names></name></person-group>
<year>2006</year>
<article-title>Gamma radiation increases endonuclease-dependent L1 retrotransposition in a cultured cell assay</article-title>. <source/>Nucleic Acids Res.
<volume>34</volume>, <fpage>1196</fpage>–<lpage>1204</lpage>. (<pub-id pub-id-type="doi">10.1093/nar/gkj522</pub-id>)<pub-id pub-id-type="pmid">16507671</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C165">
<label>165</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Teng</surname><given-names>SC</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Gabriel</surname><given-names>A</given-names></name></person-group>
<year>1996</year>
<article-title>Retrotransposon reverse-transcriptase-mediated repair of chromosomal breaks</article-title>. <source/>Nature
<volume>383</volume>, <fpage>641</fpage>–<lpage>644</lpage>. (<pub-id pub-id-type="doi">10.1038/383641a0</pub-id>)<pub-id pub-id-type="pmid">8857543</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C166">
<label>166</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Perron</surname><given-names>H</given-names></name><etal>et al.</etal></person-group>
<year>2012</year>
<article-title>Human endogenous retrovirus type W envelope expression in blood and brain cells provides new insights into multiple sclerosis disease</article-title>. <source/>Mult. Scler.
<volume>18</volume>, <fpage>1721</fpage>–<lpage>1736</lpage>. (<pub-id pub-id-type="doi">10.1177/1352458512441381</pub-id>)<pub-id pub-id-type="pmid">22457345</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C167">
<label>167</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van Horssen</surname><given-names>J</given-names></name>, <name name-style="western"><surname>van der Pol</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Nijland</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Amor</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Perron</surname><given-names>H</given-names></name></person-group>
<year>2016</year>
<article-title>Human endogenous retrovirus W in brain lesions: rationale for targeted therapy in multiple sclerosis</article-title>. <source/>Mult. Scler. Relat. Disord.
<volume>8</volume>, <fpage>11</fpage>–<lpage>18</lpage>. (<pub-id pub-id-type="doi">10.1016/j.msard.2016.04.006</pub-id>)<pub-id pub-id-type="pmid">27456869</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C168">
<label>168</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Antony</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Deslauriers</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Bhat</surname><given-names>RK</given-names></name>, <name name-style="western"><surname>Ellestad</surname><given-names>KK</given-names></name>, <name name-style="western"><surname>Power</surname><given-names>C</given-names></name></person-group>
<year>2011</year>
<article-title>Human endogenous retroviruses and multiple sclerosis: innocent bystanders or disease determinants?</article-title>
<source/>Biochim. Biophys. Acta
<volume>1812</volume>, <fpage>162</fpage>–<lpage>176</lpage>. (<pub-id pub-id-type="doi">10.1016/j.bbadis.2010.07.016</pub-id>)<pub-id pub-id-type="pmid">20696240</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C169">
<label>169</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shuvarikov</surname><given-names>A</given-names></name><etal>et al.</etal></person-group>
<year>2013</year>
<article-title>Recurrent HERV-H-mediated 3q13.2–q13.31 deletions cause a syndrome of hypotonia and motor, language, and cognitive delays</article-title>. <source/>Hum. Mutat.
<volume>34</volume>, <fpage>1415</fpage>–<lpage>1423</lpage>. (<pub-id pub-id-type="doi">10.1002/humu.22384</pub-id>)<pub-id pub-id-type="pmid">23878096</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C170">
<label>170</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Douville</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Rothstein</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Nath</surname><given-names>A</given-names></name></person-group>
<year>2011</year>
<article-title>Identification of active loci of a human endogenous retrovirus in neurons of patients with amyotrophic lateral sclerosis</article-title>. <source/>Ann. Neurol.
<volume>69</volume>, <fpage>141</fpage>–<lpage>151</lpage>. (<pub-id pub-id-type="doi">10.1002/ana.22149</pub-id>)<pub-id pub-id-type="pmid">21280084</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C171">
<label>171</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>W</given-names></name><etal>et al.</etal></person-group>
<year>2015</year>
<article-title>Human endogenous retrovirus-K contributes to motor neuron disease</article-title>. <source/>Sci. Transl. Med.
<volume>7</volume>, <fpage>307ra153</fpage> (<pub-id pub-id-type="doi">10.1126/scitranslmed.aac8201</pub-id>)</mixed-citation>
</ref>
<ref id="RSOB180074C172">
<label>172</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Laska</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Brudek</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Nissen</surname><given-names>KK</given-names></name>, <name name-style="western"><surname>Christensen</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Møller-Larsen</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Petersen</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Nexø</surname><given-names>BA</given-names></name></person-group>
<year>2012</year>
<article-title>Expression of HERV-Fc1, a human endogenous retrovirus, is increased in patients with active multiple sclerosis</article-title>. <source/>J. Virol.
<volume>86</volume>, <fpage>3713</fpage>–<lpage>3722</lpage>. (<pub-id pub-id-type="doi">10.1128/JVI.06723-11</pub-id>)<pub-id pub-id-type="pmid">22278236</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C173">
<label>173</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Frank</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Giehl</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Zheng</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Hehlmann</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Leib-Mösch</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Seifarth</surname><given-names>W</given-names></name></person-group>
<year>2005</year>
<article-title>Human endogenous retrovirus expression profiles in samples from brains of patients with schizophrenia and bipolar disorders</article-title>. <source/>J. Virol.
<volume>79</volume>, <fpage>10 890</fpage>–<lpage>10 901</lpage>. (<pub-id pub-id-type="doi">10.1128/JVI.79.17.10890-10901.2005</pub-id>)</mixed-citation>
</ref>
<ref id="RSOB180074C174">
<label>174</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Karlsson</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Bachmann</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Schröder</surname><given-names>J</given-names></name>, <name name-style="western"><surname>McArthur</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Torrey</surname><given-names>EF</given-names></name>, <name name-style="western"><surname>Yolken</surname><given-names>RH</given-names></name></person-group>
<year>2001</year>
<article-title>Retroviral RNA identified in the cerebrospinal fluids and brains of individuals with schizophrenia</article-title>. <source/>Proc. Natl Acad. Sci. USA
<volume>98</volume>, <fpage>4634</fpage>–<lpage>4639</lpage>. (<pub-id pub-id-type="doi">10.1073/pnas.061021998</pub-id>)<pub-id pub-id-type="pmid">11296294</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C175">
<label>175</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Perron</surname><given-names>H</given-names></name><etal>et al.</etal></person-group>
<year>2012</year>
<article-title>Molecular characteristics of human endogenous retrovirus type-W in schizophrenia and bipolar disorder</article-title>. <source/>Transl. Psychiatry
<volume>2</volume>, <fpage>e201</fpage> (<pub-id pub-id-type="doi">10.1038/tp.2012.125</pub-id>)<pub-id pub-id-type="pmid">23212585</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C176">
<label>176</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guffanti</surname><given-names>G</given-names></name><etal>et al.</etal></person-group>
<year>2016</year>
<article-title>LINE1 insertions as a genomic risk factor for schizophrenia: preliminary evidence from an affected family</article-title>. <source/>Am. J. Med. Genet. B Neuropsychiatr. Genet.
<volume>171</volume>, <fpage>534</fpage>–<lpage>545</lpage>. (<pub-id pub-id-type="doi">10.1002/ajmg.b.32437</pub-id>)<pub-id pub-id-type="pmid">26990047</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C177">
<label>177</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weis</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Llenos</surname><given-names>IC</given-names></name>, <name name-style="western"><surname>Sabunciyan</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Dulay</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Isler</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Yolken</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Perron</surname><given-names>H</given-names></name></person-group>
<year>2007</year>
<article-title>Reduced expression of human endogenous retrovirus (HERV)-W GAG protein in the cingulate gyrus and hippocampus in schizophrenia, bipolar disorder, and depression</article-title>. <source/>J. Neural Transm.
<volume>114</volume>, <fpage>645</fpage>–<lpage>655</lpage>. (<pub-id pub-id-type="doi">10.1007/s00702-006-0599-y</pub-id>)<pub-id pub-id-type="pmid">17219017</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C178">
<label>178</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Christensen</surname><given-names>T</given-names></name></person-group>
<year>2016</year>
<article-title>Human endogenous retroviruses in neurologic disease</article-title>. <source/>APMIS
<volume>124</volume>, <fpage>116</fpage>–<lpage>126</lpage>. (<pub-id pub-id-type="doi">10.1111/apm.12486</pub-id>)<pub-id pub-id-type="pmid">26818266</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C179">
<label>179</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Balestrieri</surname><given-names>E</given-names></name><etal>et al.</etal></person-group>
<year>2012</year>
<article-title>HERVs expression in autism spectrum disorders</article-title>. <source/>PLoS ONE
<volume>7</volume>, <fpage>e48831</fpage> (<pub-id pub-id-type="doi">10.1371/journal.pone.0048831</pub-id>)<pub-id pub-id-type="pmid">23155411</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C180">
<label>180</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Balestrieri</surname><given-names>E</given-names></name><etal>et al.</etal></person-group>
<year>2014</year>
<article-title>Human endogenous retroviruses and ADHD</article-title>. <source/>World J. Biol. Psychiatry
<volume>15</volume>, <fpage>499</fpage>–<lpage>504</lpage>. (<pub-id pub-id-type="doi">10.3109/15622975.2013.862345</pub-id>)<pub-id pub-id-type="pmid">24286278</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C181">
<label>181</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kondo-Iida</surname><given-names>E</given-names></name><etal>et al.</etal></person-group>
<year>1999</year>
<article-title>Novel mutations and genotype–phenotype relationships in 107 families with Fukuyama-type congenital muscular dystrophy (FCMD)</article-title>. <source/>Hum. Mol. Genet. <volume>8</volume>, <fpage>2303</fpage>–<lpage>2309</lpage>. (<pub-id pub-id-type="doi">10.1093/hmg/8.12.2303</pub-id>)<pub-id pub-id-type="pmid">10545611</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C182">
<label>182</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wimmer</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Callens</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Wernstedt</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Messiaen</surname><given-names>L</given-names></name></person-group>
<year>2011</year>
<article-title>The NF1 gene contains hotspots for L1 endonuclease-dependent de novo insertion</article-title>. <source/>PLoS Genet.
<volume>7</volume>, <fpage>e1002371</fpage> (<pub-id pub-id-type="doi">10.1371/journal.pgen.1002371</pub-id>)<pub-id pub-id-type="pmid">22125493</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C183">
<label>183</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bernard</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Minnerop</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Bürk</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Kreuz</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Gillessen-Kaesbach</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Zühlke</surname><given-names>C</given-names></name></person-group>
<year>2009</year>
<article-title>Exon deletions and intragenic insertions are not rare in ataxia with oculomotor apraxia 2</article-title>. <source/>BMC Med. Genet.
<volume>10</volume>, <fpage>87</fpage> (<pub-id pub-id-type="doi">10.1186/1471-2350-10-87</pub-id>)<pub-id pub-id-type="pmid">19744353</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C184">
<label>184</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carreira</surname><given-names>PE</given-names></name><etal>et al.</etal></person-group>
<year>2016</year>
<article-title>Evidence for L1-associated DNA rearrangements and negligible L1 retrotransposition in glioblastoma multiforme</article-title>. <source/>Mob. DNA
<volume>7</volume>, <fpage>21</fpage> (<pub-id pub-id-type="doi">10.1186/s13100-016-0076-6</pub-id>)<pub-id pub-id-type="pmid">27843499</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C185">
<label>185</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Achanta</surname><given-names>P</given-names></name><etal>et al.</etal></person-group>
<year>2016</year>
<article-title>Somatic retrotransposition is infrequent in glioblastomas</article-title>. <source/>Mob. DNA
<volume>7</volume>, <fpage>22</fpage> (<pub-id pub-id-type="doi">10.1186/s13100-016-0077-5</pub-id>)<pub-id pub-id-type="pmid">27843500</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C186">
<label>186</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Martínez-Garay</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Ballesta</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Oltra</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Orellana</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Palomeque</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Moltó</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Prieto</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Martínez</surname><given-names>F</given-names></name></person-group>
<year>2003</year>
<article-title>Intronic L1 insertion and F268S, novel mutations in RPS6KA3 (RSK2) causing Coffin–Lowry syndrome</article-title>. <source/>Clin. Genet.
<volume>64</volume>, <fpage>491</fpage>–<lpage>496</lpage>. (<pub-id pub-id-type="doi">10.1046/j.1399-0004.2003.00166.x</pub-id>)<pub-id pub-id-type="pmid">14986828</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C187">
<label>187</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bundo</surname><given-names>M</given-names></name><etal>et al.</etal></person-group>
<year>2014</year>
<article-title>Increased L1 retrotransposition in the neuronal genome in schizophrenia</article-title>. <source/>Neuron
<volume>81</volume>, <fpage>306</fpage>–<lpage>313</lpage>. (<pub-id pub-id-type="doi">10.1016/j.neuron.2013.10.053</pub-id>)<pub-id pub-id-type="pmid">24389010</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C188">
<label>188</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Du</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Shen</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Xiu</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>Q</given-names></name></person-group>
<year>2016</year>
<article-title>Inverse changes in L1 retrotransposons between blood and brain in major depressive disorder</article-title>. <source/>Sci. Rep.
<volume>6</volume>, <fpage>37530</fpage> (<pub-id pub-id-type="doi">10.1038/srep37530</pub-id>)<pub-id pub-id-type="pmid">27874048</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C189">
<label>189</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Doyle</surname><given-names>GA</given-names></name>, <name name-style="western"><surname>Crist</surname><given-names>RC</given-names></name>, <name name-style="western"><surname>Karatas</surname><given-names>ET</given-names></name>, <name name-style="western"><surname>Hammond</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Ewing</surname><given-names>AD</given-names></name>, <name name-style="western"><surname>Ferraro</surname><given-names>TN</given-names></name>, <name name-style="western"><surname>Hahn</surname><given-names>C-G</given-names></name>, <name name-style="western"><surname>Berrettini</surname><given-names>WH</given-names></name></person-group>
<year>2017</year>
<article-title>Analysis of LINE-1 elements in DNA from postmortem brains of individuals with schizophrenia</article-title>. <source/>Neuropsychopharmacology
<volume>42</volume>, <fpage>2602</fpage>–<lpage>2611</lpage>. (<pub-id pub-id-type="doi">10.1038/npp.2017.115</pub-id>)<pub-id pub-id-type="pmid">28585566</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C190">
<label>190</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shpyleva</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Melnyk</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Pavliv</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Pogribny</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Jill James</surname><given-names>S</given-names></name></person-group>
<year>2017</year>
<article-title>Overexpression of LINE-1 retrotransposons in autism brain</article-title>. <source/>Mol. Neurobiol.
<volume>55</volume>, <fpage>1740</fpage>–<lpage>1749</lpage>. (<pub-id pub-id-type="doi">10.1007/s12035-017-0421-x</pub-id>)<pub-id pub-id-type="pmid">28220356</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C191">
<label>191</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Doyle</surname><given-names>GA</given-names></name>, <name name-style="western"><surname>Doucet-O'Hare</surname><given-names>TT</given-names></name>, <name name-style="western"><surname>Hammond</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Crist</surname><given-names>RC</given-names></name>, <name name-style="western"><surname>Ewing</surname><given-names>AD</given-names></name>, <name name-style="western"><surname>Ferraro</surname><given-names>TN</given-names></name>, <name name-style="western"><surname>Mash</surname><given-names>DC</given-names></name>, <name name-style="western"><surname>Kazazian</surname><given-names>HH</given-names></name>, <name name-style="western"><surname>Berrettini</surname><given-names>WH</given-names></name></person-group>
<year>2017</year>
<article-title>Reading LINEs within the cocaine addicted brain</article-title>. <source/>Brain Behav.
<volume>7</volume>, <fpage>1</fpage>–<lpage>12</lpage>. (<pub-id pub-id-type="doi">10.1002/brb3.678</pub-id>)</mixed-citation>
</ref>
<ref id="RSOB180074C192">
<label>192</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rusiecki</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Srikantan</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Yan</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Polin</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Baccarelli</surname><given-names>A</given-names></name></person-group>
<year>2012</year>
<article-title>DNA methylation in repetitive elements and post-traumatic stress disorder: a case–control study of US military service members</article-title>. <source/>Epigenomics
<volume>4</volume>, <fpage>29</fpage>–<lpage>40</lpage>. (<pub-id pub-id-type="doi">10.2217/epi.11.116</pub-id>)<pub-id pub-id-type="pmid">22332656</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C193">
<label>193</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gallus</surname><given-names>GN</given-names></name><etal>et al.</etal></person-group>
<year>2010</year>
<article-title>Alu-element insertion in an OPA1 intron sequence associated with autosomal dominant optic atrophy</article-title>. <source/>Mol. Vis.
<volume>16</volume>, <fpage>178</fpage>–<lpage>183</lpage>.<pub-id pub-id-type="pmid">20157369</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C194">
<label>194</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kutsche</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Ressler</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Katzera</surname><given-names>H-G</given-names></name>, <name name-style="western"><surname>Orth</surname><given-names>U</given-names></name>, <name name-style="western"><surname>Gillessen-Kaesbach</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Morlot</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Schwinger</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Gal</surname><given-names>A</given-names></name></person-group>
<year>2002</year>
<article-title>Characterization of breakpoint sequences of five rearrangements in L1CAM and ABCD1 (ALD) genes</article-title>. <source/>Hum. Mutat.
<volume>19</volume>, <fpage>526</fpage>–<lpage>535</lpage>. (<pub-id pub-id-type="doi">10.1002/humu.10072</pub-id>)<pub-id pub-id-type="pmid">11968085</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C195">
<label>195</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wallace</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Andersen</surname><given-names>LB</given-names></name>, <name name-style="western"><surname>Saulino</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Gregory</surname><given-names>PE</given-names></name>, <name name-style="western"><surname>Glover</surname><given-names>TW</given-names></name>, <name name-style="western"><surname>Collins</surname><given-names>FS</given-names></name></person-group>
<year>1991</year>
<article-title>A de novo Alu insertion results in neurofibromatosis type 1</article-title>. <source/>Nature
<volume>353</volume>, <fpage>864</fpage>–<lpage>866</lpage>. (<pub-id pub-id-type="doi">10.1038/353864a0</pub-id>)<pub-id pub-id-type="pmid">1719426</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C196">
<label>196</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Okubo</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Horinishi</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Saito</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Ebara</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Endo</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Kaku</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Murase</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Eto</surname><given-names>M</given-names></name></person-group>
<year>2007</year>
<article-title>A novel complex deletion-insertion mutation mediated by Alu repetitive elements leads to lipoprotein lipase deficiency</article-title>. <source/>Mol. Genet. Metab.
<volume>92</volume>, <fpage>229</fpage>–<lpage>233</lpage>. (<pub-id pub-id-type="doi">10.1016/j.ymgme.2007.06.018</pub-id>)<pub-id pub-id-type="pmid">17706445</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C197">
<label>197</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Conceição Pereira</surname><given-names>M</given-names></name><etal>et al.</etal></person-group>
<year>2012</year>
<article-title>Alu elements mediate large SPG11 gene rearrangements: further spatacsin mutations</article-title>. <source/>Genet. Med.
<volume>14</volume>, <fpage>143</fpage>–<lpage>151</lpage>. (<pub-id pub-id-type="doi">10.1038/gim.2011.7</pub-id>)<pub-id pub-id-type="pmid">22237444</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C198">
<label>198</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boone</surname><given-names>PM</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Carvalho</surname><given-names>CMB</given-names></name>, <name name-style="western"><surname>Towne</surname><given-names>CF</given-names></name>, <name name-style="western"><surname>Batish</surname><given-names>SD</given-names></name>, <name name-style="western"><surname>Lupski</surname><given-names>JR</given-names></name></person-group>
<year>2011</year>
<article-title>Alu-specific microhomology-mediated deletion of the final exon of SPAST in three unrelated subjects with hereditary spastic paraplegia</article-title>. <source/>Genet. Med.
<volume>13</volume>, <fpage>582</fpage>–<lpage>592</lpage>. (<pub-id pub-id-type="doi">10.1097/GIM.0b013e3182106775</pub-id>)<pub-id pub-id-type="pmid">21659953</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C199">
<label>199</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ricci</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Regis</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Di Duca</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Filocamo</surname><given-names>M</given-names></name></person-group>
<year>2003</year>
<article-title>An Alu-mediated rearrangement as cause of exon skipping in Hunter disease</article-title>. <source/>Hum. Genet.
<volume>112</volume>, <fpage>419</fpage>–<lpage>425</lpage>. (<pub-id pub-id-type="doi">10.1007/s00439-002-0900-6</pub-id>)<pub-id pub-id-type="pmid">12579417</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C200">
<label>200</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Kodama</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Watanabe</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Kikuchi</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Ishitsuka</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Ozawa</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Fujisawa</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Shiga</surname><given-names>K</given-names></name></person-group>
<year>2007</year>
<article-title>The first reported case of Menkes disease caused by an Alu insertion mutation</article-title>. <source/>Brain Dev.
<volume>29</volume>, <fpage>105</fpage>–<lpage>108</lpage>. (<pub-id pub-id-type="doi">10.1016/j.braindev.2006.05.012</pub-id>)<pub-id pub-id-type="pmid">17178205</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C201">
<label>201</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bouchet</surname><given-names>C</given-names></name><etal>et al.</etal></person-group>
<year>2007</year>
<article-title>Detection of an Alu insertion in the POMT1 gene from three French Walker Warburg syndrome families</article-title>. <source/>Mol. Genet. Metab.
<volume>90</volume>, <fpage>93</fpage>–<lpage>96</lpage>. (<pub-id pub-id-type="doi">10.1016/j.ymgme.2006.09.005</pub-id>)<pub-id pub-id-type="pmid">17079174</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C202">
<label>202</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brooks</surname><given-names>EM</given-names></name>, <name name-style="western"><surname>Branda</surname><given-names>RF</given-names></name>, <name name-style="western"><surname>Nicklas</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>O'Neill</surname><given-names>JP</given-names></name></person-group>
<year>2001</year>
<article-title>Molecular description of three macro-deletions and an Alu–Alu recombination-mediated duplication in the HPRT gene in four patients with Lesch–Nyhan disease</article-title>. <source/>Mutat. Res.
<volume>476</volume>, <fpage>43</fpage>–<lpage>54</lpage>. (<pub-id pub-id-type="doi">10.1016/S0027-5107(01)00065-3</pub-id>)<pub-id pub-id-type="pmid">11336982</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C203">
<label>203</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huie</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Shanske</surname><given-names>AL</given-names></name>, <name name-style="western"><surname>Kasper</surname><given-names>JS</given-names></name>, <name name-style="western"><surname>Marion</surname><given-names>RW</given-names></name>, <name name-style="western"><surname>Hirschhorn</surname><given-names>R</given-names></name></person-group>
<year>1999</year>
<article-title>A large Alu-mediated deletion, identified by PCR, as the molecular basis for glycogen storage disease type II (GSDII)</article-title>. <source/>Hum. Genet.
<volume>104</volume>, <fpage>94</fpage>–<lpage>98</lpage>. (<pub-id pub-id-type="doi">10.1007/s004390050916</pub-id>)<pub-id pub-id-type="pmid">10071199</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C204">
<label>204</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vogt</surname><given-names>J</given-names></name><etal>et al.</etal></person-group>
<year>2014</year>
<article-title>SVA retrotransposon insertion-associated deletion represents a novel mutational mechanism underlying large genomic copy number changes with non-recurrent breakpoints</article-title>. <source/>Genome Biol.
<volume>15</volume>, <fpage>R80</fpage> (<pub-id pub-id-type="doi">10.1186/gb-2014-15-6-r80</pub-id>)<pub-id pub-id-type="pmid">24958239</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C205">
<label>205</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Makino</surname><given-names>S</given-names></name><etal>et al.</etal></person-group>
<year>2007</year>
<article-title>Reduced neuron-specific expression of the TAF1 gene is associated with X-linked dystonia-parkinsonism</article-title>. <source/>Am. J. Hum. Genet.
<volume>80</volume>, <fpage>393</fpage>–<lpage>406</lpage>. (<pub-id pub-id-type="doi">10.1086/512129</pub-id>)<pub-id pub-id-type="pmid">17273961</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C206">
<label>206</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Taniguchi-Ikeda</surname><given-names>M</given-names></name><etal>et al.</etal></person-group>
<year>2011</year>
<article-title>Pathogenic exon-trapping by SVA retrotransposon and rescue in Fukuyama muscular dystrophy</article-title>. <source/>Nature
<volume>478</volume>, <fpage>127</fpage>–<lpage>131</lpage>. (<pub-id pub-id-type="doi">10.1038/nature10456</pub-id>)<pub-id pub-id-type="pmid">21979053</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C207">
<label>207</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Selig</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Bruno</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Scharf</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>CH</given-names></name>, <name name-style="western"><surname>Vitale</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Gilliam</surname><given-names>TC</given-names></name>, <name name-style="western"><surname>Kunkel</surname><given-names>LM</given-names></name></person-group>
<year>1995</year>
<article-title>Expressed cadherin pseudogenes are localized to the critical region of the spinal muscular atrophy gene</article-title>. <source/>Proc. Natl Acad. Sci. USA
<volume>92</volume>, <fpage>3702</fpage>–<lpage>3706</lpage>. (<pub-id pub-id-type="doi">10.1073/pnas.92.9.3702</pub-id>)<pub-id pub-id-type="pmid">7731968</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C208">
<label>208</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bagot</surname><given-names>RC</given-names></name>, <name name-style="western"><surname>Labonté</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Peña</surname><given-names>CJ</given-names></name>, <name name-style="western"><surname>Nestler</surname><given-names>EJ</given-names></name></person-group>
<year>2014</year>
<article-title>Epigenetic signaling in psychiatric disorders: stress and depression</article-title>. <source/>Dialogues Clin. Neurosci.
<volume>16</volume>, <fpage>281</fpage>–<lpage>295</lpage>.<pub-id pub-id-type="pmid">25364280</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C209">
<label>209</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Douville</surname><given-names>RN</given-names></name>, <name name-style="western"><surname>Nath</surname><given-names>A</given-names></name></person-group>
<year>2014</year>
<article-title>Human endogenous retroviruses and the nervous system</article-title>. <source/>Handb. Clin. Neurol.
<volume>123</volume>, <fpage>465</fpage>–<lpage>485</lpage>. (<pub-id pub-id-type="doi">10.1016/B978-0-444-53488-0.00022-5</pub-id>)<pub-id pub-id-type="pmid">25015500</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C210">
<label>210</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Meyer</surname><given-names>TJ</given-names></name>, <name name-style="western"><surname>Rosenkrantz</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Carbone</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Chavez</surname><given-names>SL</given-names></name></person-group>
<year>2017</year>
<article-title>Endogenous retroviruses: with us and against us</article-title>. <source/>Front. Chem.
<volume>5</volume>, <fpage>23</fpage> (<pub-id pub-id-type="doi">10.3389/fchem.2017.00023</pub-id>)<pub-id pub-id-type="pmid">28439515</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C211">
<label>211</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Quinn</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Bubb</surname><given-names>VJ</given-names></name></person-group>
<year>2014</year>
<article-title>SVA retrotransposons as modulators of gene expression</article-title>. <source/>Mob. Genet. Elements
<volume>4</volume>, <fpage>e32102</fpage> (<pub-id pub-id-type="doi">10.4161/mge.32102</pub-id>)<pub-id pub-id-type="pmid">25077041</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C212">
<label>212</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gianfrancesco</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Bubb</surname><given-names>VJ</given-names></name>, <name name-style="western"><surname>Quinn</surname><given-names>JP</given-names></name></person-group>
<year>2017</year>
<article-title>SVA retrotransposons as potential modulators of neuropeptide gene expression</article-title>. <source/>Neuropeptides
<volume>64</volume>, <fpage>3</fpage>–<lpage>7</lpage>. (<pub-id pub-id-type="doi">10.1016/j.npep.2016.09.006</pub-id>)<pub-id pub-id-type="pmid">27743609</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C213">
<label>213</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Amir</surname><given-names>RE</given-names></name>, <name name-style="western"><surname>Van den Veyver</surname><given-names>IB</given-names></name>, <name name-style="western"><surname>Wan</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Tran</surname><given-names>CQ</given-names></name>, <name name-style="western"><surname>Francke</surname><given-names>U</given-names></name>, <name name-style="western"><surname>Zoghbi</surname><given-names>HY</given-names></name></person-group>
<year>1999</year>
<article-title>Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2</article-title>. <source/>Nat. Genet.
<volume>23</volume>, <fpage>185</fpage>–<lpage>188</lpage>. (<pub-id pub-id-type="doi">10.1038/13810</pub-id>)<pub-id pub-id-type="pmid">10508514</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C214">
<label>214</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Akindipe</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Wilson</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Stein</surname><given-names>DJ</given-names></name></person-group>
<year>2014</year>
<article-title>Psychiatric disorders in individuals with methamphetamine dependence: prevalence and risk factors</article-title>. <source/>Metab. Brain Dis.
<volume>29</volume>, <fpage>351</fpage>–<lpage>357</lpage>. (<pub-id pub-id-type="doi">10.1007/s11011-014-9496-5</pub-id>)<pub-id pub-id-type="pmid">24532047</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C215">
<label>215</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhornitsky</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Tikàsz</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Rizkallah</surname><given-names>É</given-names></name>, <name name-style="western"><surname>Chiasson</surname><given-names>J-P</given-names></name>, <name name-style="western"><surname>Potvin</surname><given-names>S</given-names></name></person-group>
<year>2015</year>
<article-title>Psychopathology in substance use disorder patients with and without substance-induced psychosis</article-title>. <source/>J. Addict.
<volume>2015</volume>, <fpage>843762</fpage> (<pub-id pub-id-type="doi">10.1155/2015/843762</pub-id>)<pub-id pub-id-type="pmid">26417473</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C216">
<label>216</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Okudaira</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Ishizaka</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Nishio</surname><given-names>H</given-names></name></person-group>
<year>2014</year>
<article-title>Retrotransposition of long interspersed element 1 induced by methamphetamine or cocaine</article-title>. <source/>J. Biol. Chem.
<volume>289</volume>, <fpage>25 476</fpage>–<lpage>25 485</lpage>. (<pub-id pub-id-type="doi">10.1074/jbc.M114.559419</pub-id>)</mixed-citation>
</ref>
<ref id="RSOB180074C217">
<label>217</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moszczynska</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Flack</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Qiu</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Muotri</surname><given-names>AR</given-names></name>, <name name-style="western"><surname>Killinger</surname><given-names>BA</given-names></name></person-group>
<year>2015</year>
<article-title>Neurotoxic methamphetamine doses increase LINE-1 expression in the neurogenic zones of the adult rat brain</article-title>. <source/>Sci. Rep.
<volume>5</volume>, <fpage>14356</fpage> (<pub-id pub-id-type="doi">10.1038/srep14356</pub-id>)<pub-id pub-id-type="pmid">26463126</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C218">
<label>218</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bassett</surname><given-names>AS</given-names></name>, <name name-style="western"><surname>Chow</surname><given-names>EWC</given-names></name>, <name name-style="western"><surname>AbdelMalik</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Gheorghiu</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Husted</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Weksberg</surname><given-names>R</given-names></name></person-group>
<year>2003</year>
<article-title>The schizophrenia phenotype in 22q11 deletion syndrome</article-title>. <source/>Am. J. Psychiatry
<volume>160</volume>, <fpage>1580</fpage>–<lpage>1586</lpage>. (<pub-id pub-id-type="doi">10.1176/appi.ajp.160.9.1580</pub-id>)<pub-id pub-id-type="pmid">12944331</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C219">
<label>219</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Basil</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Dempster</surname><given-names>EL</given-names></name>, <name name-style="western"><surname>Mill</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Sham</surname><given-names>P-C</given-names></name>, <name name-style="western"><surname>Wong</surname><given-names>CCY</given-names></name>, <name name-style="western"><surname>McAlonan</surname><given-names>GM</given-names></name></person-group>
<year>2014</year>
<article-title>Prenatal maternal immune activation causes epigenetic differences in adolescent mouse brain</article-title>. <source/>Transl. Psychiatry
<volume>4</volume>, <fpage>e434</fpage> (<pub-id pub-id-type="doi">10.1038/tp.2014.80</pub-id>)<pub-id pub-id-type="pmid">25180573</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C220">
<label>220</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>T-H</given-names></name>, <name name-style="western"><surname>Schmid</surname><given-names>CW</given-names></name></person-group>
<year>2001</year>
<article-title>Differential stress induction of individual Alu loci: implications for transcription and retrotransposition</article-title>. <source/>Gene
<volume>276</volume>, <fpage>135</fpage>–<lpage>141</lpage>. (<pub-id pub-id-type="doi">10.1016/S0378-1119(01)00637-0</pub-id>)<pub-id pub-id-type="pmid">11591480</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C221">
<label>221</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jellinger</surname><given-names>KA</given-names></name></person-group>
<year>2001</year>
<article-title>Cell death mechanisms in neurodegeneration</article-title>. <source/>J. Cell. Mol. Med.
<volume>5</volume>, <fpage>1</fpage>–<lpage>17</lpage>. (<pub-id pub-id-type="doi">10.1111/j.1582-4934.2001.tb00134.x</pub-id>)<pub-id pub-id-type="pmid">12067447</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C222">
<label>222</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Savitsky</surname><given-names>K</given-names></name><etal>et al.</etal></person-group>
<year>1995</year>
<article-title>A single ataxia telangiectasia gene with a product similar to PI-3 kinase</article-title>. <source/>Science
<volume>268</volume>, <fpage>1749</fpage>–<lpage>1753</lpage>. (<pub-id pub-id-type="doi">10.1126/science.7792600</pub-id>)<pub-id pub-id-type="pmid">7792600</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C223">
<label>223</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shiloh</surname><given-names>Y</given-names></name></person-group>
<year>2001</year>
<article-title>ATM (ataxia telangiectasia mutated): expanding roles in the DNA damage response and cellular homeostasis</article-title>. <source/>Biochem. Soc. Trans.
<volume>29</volume>, <fpage>661</fpage>–<lpage>666</lpage>. (<pub-id pub-id-type="doi">10.1042/bst0290661</pub-id>)<pub-id pub-id-type="pmid">11709050</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C224">
<label>224</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wilson</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>Dugger</surname><given-names>BN</given-names></name>, <name name-style="western"><surname>Dickson</surname><given-names>DW</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>D-S</given-names></name></person-group>
<year>2011</year>
<article-title>TDP-43 in aging and Alzheimer's disease—a review</article-title>. <source/>Int. J. Clin. Exp. Pathol.
<volume>4</volume>, <fpage>147</fpage>–<lpage>155</lpage>.<pub-id pub-id-type="pmid">21326809</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C225">
<label>225</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cohen</surname><given-names>TJ</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>VMY</given-names></name>, <name name-style="western"><surname>Trojanowski</surname><given-names>JQ</given-names></name></person-group>
<year>2011</year>
<article-title>TDP-43 functions and pathogenic mechanisms implicated in TDP-43 proteinopathies</article-title>. <source/>Trends Mol. Med.
<volume>17</volume>, <fpage>659</fpage>–<lpage>667</lpage>. (<pub-id pub-id-type="doi">10.1016/j.molmed.2011.06.004</pub-id>)<pub-id pub-id-type="pmid">21783422</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C226">
<label>226</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Jin</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Prazak</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Hammell</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Dubnau</surname><given-names>J</given-names></name></person-group>
<year>2012</year>
<article-title>Transposable elements in TDP-43-mediated neurodegenerative disorders</article-title>. <source/>PLoS ONE
<volume>7</volume>, <fpage>e44099</fpage> (<pub-id pub-id-type="doi">10.1371/journal.pone.0044099</pub-id>)<pub-id pub-id-type="pmid">22957047</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C227">
<label>227</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Krug</surname><given-names>L</given-names></name><etal>et al.</etal></person-group>
<year>2017</year>
<article-title>Retrotransposon activation contributes to neurodegeneration in a <italic>Drosophila</italic> TDP-43 model of ALS</article-title>. <source/>PLoS Genet.
<volume>13</volume>, <fpage>e1006635</fpage> (<pub-id pub-id-type="doi">10.1371/journal.pgen.1006635</pub-id>)<pub-id pub-id-type="pmid">28301478</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C228">
<label>228</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Prazak</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Chatterjee</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Grüninger</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Krug</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Theodorou</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Dubnau</surname><given-names>J</given-names></name></person-group>
<year>2013</year>
<article-title>Activation of transposable elements during aging and neuronal decline in <italic>Drosophila</italic></article-title>. <source/>Nat. Neurosci.
<volume>16</volume>, <fpage>1</fpage>–<lpage>4</lpage>. (<pub-id pub-id-type="doi">10.1038/nn.3368</pub-id>)</mixed-citation>
</ref>
<ref id="RSOB180074C229">
<label>229</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Larsen</surname><given-names>PA</given-names></name>, <name name-style="western"><surname>Lutz</surname><given-names>MW</given-names></name>, <name name-style="western"><surname>Hunnicutt</surname><given-names>KE</given-names></name>, <name name-style="western"><surname>Mihovilovic</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Saunders</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Yoder</surname><given-names>AD</given-names></name>, <name name-style="western"><surname>Roses</surname><given-names>AD</given-names></name></person-group>
<year>2017</year>
<article-title>The Alu neurodegeneration hypothesis: a primate-specific mechanism for neuronal transcription noise, mitochondrial dysfunction, and manifestation of neurodegenerative disease</article-title>. <source/>Alzheimers. Dement.
<volume>13</volume>, <fpage>828</fpage>–<lpage>838</lpage>. (<pub-id pub-id-type="doi">10.1016/j.jalz.2017.01.017</pub-id>)<pub-id pub-id-type="pmid">28242298</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C230">
<label>230</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>de Andrade</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Bonaldo</surname><given-names>MF</given-names></name>, <name name-style="western"><surname>Xie</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Soares</surname><given-names>MB</given-names></name></person-group>
<year>2011</year>
<article-title>Genetic and epigenetic variations contributed by Alu retrotransposition</article-title>. <source/>BMC Genomics
<volume>12</volume>, <fpage>617</fpage> (<pub-id pub-id-type="doi">10.1186/1471-2164-12-617</pub-id>)<pub-id pub-id-type="pmid">22185517</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C231">
<label>231</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lin</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Jiang</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Park</surname><given-names>JW</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Lu</surname><given-names>Z-X</given-names></name>, <name name-style="western"><surname>Lam</surname><given-names>MPY</given-names></name>, <name name-style="western"><surname>Ping</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Xing</surname><given-names>Y</given-names></name></person-group>
<year>2016</year>
<article-title>The contribution of Alu exons to the human proteome</article-title>. <source/>Genome Biol.
<volume>17</volume>, <fpage>15</fpage> (<pub-id pub-id-type="doi">10.1186/s13059-016-0876-5</pub-id>)<pub-id pub-id-type="pmid">26821878</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C232">
<label>232</label>
<mixed-citation publication-type="journal"><year>2006</year>
<article-title>NerveCenter: (1) Eric Kandel on the path to the Nobel Prize: one cell at a time (2) short- and long-term memory in aplysia</article-title>. <source/>Ann. Neurol.
<volume>59</volume>, <fpage>A11</fpage>–<lpage>A13</lpage>. (<pub-id pub-id-type="doi">10.1002/ana.20909</pub-id>)<pub-id pub-id-type="pmid">16718698</pub-id></mixed-citation>
</ref>
<ref id="RSOB180074C233">
<label>233</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Metzakopian</surname><given-names>E</given-names></name><etal>et al.</etal></person-group>
<year>2017</year>
<article-title>Enhancing the genome editing toolbox: genome wide CRISPR arrayed libraries</article-title>. <source/>Sci. Rep.
<volume>7</volume>, <fpage>2244</fpage> (<pub-id pub-id-type="doi">10.1038/s41598-017-01766-5</pub-id>)<pub-id pub-id-type="pmid">28533524</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>